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APPENDIX A: PHYSICAL PLATFORM AND OPTICAL 
DESIGN 
 
In any optical system, it is important to properly focus and deliver light to the sample.  In 
this chapter, we will describe the optical design and physical layout of the urea 
monitoring system.  There are several concerns that must be addressed in the physical 
design of this system.  These include: 
•= How the dialysis fluid is to be transferred to the sample compartment. 
•= The design of the measurement cuvette. 
•= The optical layout of the system, including compartments and mounting hardware. 
•= The design of the position control system. 
Many of these issues have been the subject of a separate research project done by Jamie 
Murdock at WPI.  Mr. Murdock’s Master’s Thesis involves the design of a measurement 
cuvette for a general analyte monitor that utilizes the Optical Bridge principle.  Mr. 
Murdock designed the position control system, fluid delivery system and the 
measurement cuvette.  He also designed a first generation prototype of the optical layout 
during an earlier research project.  This design has been reworked into a more compact 
prototype.  We shall now describe the current prototype design in the context of how it 
implements the Optical Bridge principle.  The overall optical system design in shown in 
Figure A.1.1. 
A.1 Optical Path 
The system design requires that the light must be focused at two places: the input to the 
AOTF and at the sample.  Two major optical assemblies are used to accomplish this task.  
A set of two plano-convex (PCX) lenses are used as a condensing lens to focus the light 
into the input aperture of the AOTF.  Following the condensing lenses are an Infrared 
sheet film polarizer (Polaroid Corp.) and a circular aperture.  These components are 
contained in the block labeled “Lens and Polarizer Holder #1” in Figure A.1.1. These  
components are used to fill the AOTF operating parameters.  These operating parameters 
state that light entering the AOTF must be polarized, and be at a maximum angle of 3.5° 
from normal.   
 
After the AOTF, another set of condensing lenses are mounted in order to focus light 
onto the sample.  A second polarizer, rotated 90° from the first, is used to cut out the 
stray light from the beam.  This reduces the amount of the zeroth order beam from the 
AOTF that enters the sample, since the zeroth order beam is unpolarized.  A beam cutter 
made from a piece of 1/8” brass is also placed in the path to further block the zero order 
beam.  This beam cutter can be moved in and out in order to optimize the blockage.  
After the condensing lenses, a beam splitter made from a piece of glass is mounted at a 
45° angle to the beam. In Figure A.1.1, these components are contained in the block 
labeled  “Lens and Polarizer Holder #2”.  The splitter directs about 8% of the incident 
light to the Input Light Detector (ILD). The detector is therefore able to record how much 
light is transmitted to the entrance of the sample.  The rest of the light then passes straight 
through the sample, and hits the Sample Light Detector (SLD).  
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A.1.1 Mounting Hardware 
All of the optical components required to focus, tune, and deliver the light to the sample 
are mounted on an aluminum channel.  Bert Kupcinskas of A.K. Machine Co., Inc.,  
(Millbury, MA) donated time, materials and expertise to the design of this channel and 
the mounting components.  This channel is U-shaped with an outer width of 3” and an 
inner width of 2”.  The channel is ¼” deep, and the overall height of the piece is 1 ½”.  
This channel is mounted on a 4” tall base enclosure which contains electronic 
connections and is enclosed by a 4” tall aluminum sheet metal cover to block ambient 
light.  Figure A.1.1 shows an isometric drawing of the channel and the mounting 
components.   
 
Figure A.1.1: The Optical mounting channel is fabricated from aluminum.  The 
mounting components are, from left to right, the lamp and holder, condensing lens 
holder 1, AOTF mounting block and AOTF, condensing lens holder 2 and beam 
splitter, and the measurement cuvette.  The baffle has been omitted for clarity. Figure 
adapted from [77].  
A.1.2 Optical Components 
The light source for this system is a 100W halogen lamp.  The light source is mounted on 
a holding base.  The holding base is mounted inside a 1 ¼” circular pocket that is 
approximately ¼” deep.  A 3/8” diameter through hole is drilled at the center of this 
pocket for the lamp power wires to pass through.  The center of the lamp mounting 
pocket is located 1 ½” from the end of the channel.  The lamp is enclosed by a baffle, 
which is made of a sheet of 1/8” thick aluminum that has been bent into an L-shape.  The 
baffle has a ¾” diameter hole that allows light to enter the lens assembly.  The baffle is 
used to prevent unwanted light from entering the rest of the optical system.  The light is 
then coupled into the rest of the system, where the control of wavelength and intensity is 
accomplished.  Please note that dimensions of machined parts are given in inches due to 
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machinist’s conventions, while many of the dimensions for the optical components are 
given in mm, due to optical conventions.   
 
Wavelength and intensity control of the light that hits the sample is accomplished using 
an Acousto-Optical Tunable Filter (AOTF – See Appendix F).  As stated earlier in this 
section, there are three requirements for the light that enters the AOTF.  First, the light 
must be polarized.  Second, the light should be focused on the input of the AOTF.  
Finally, the AOTF has a maximum acceptance angle of 7º, which means that light 
entering the device can deviate no more that 3.5º from the normal.  In order to fill these 
requirements, several components are inserted into the optical path.  The first is a set of 
condensing lenses.  These lenses have focal lengths of 50mm and diameters of 25mm.  
The second is an aperture, which has an inner diameter of  9mm.  The final component is 
a sheet of infrared polarizing filter film.  All of these components are mounted in a Delrin 
block.  The relative placement of the components is shown in Figure A.1.2.   
 
The mounting block is composed of two sections, each of which has a ¾” diameter hole 
drilled in the center.  The mounting block is 1 ½” long, 2” wide, and 1 ¾” high.  The first 
section is ½” long.  A 1” square pocket is milled into the inside of this piece to hold the 
polarizing film.  The pocket is 0.003” deep.  This piece is mated to the other section with 
four screws.  The second section has a 1” diameter hole drilled 0.456” into the center.  
The condensing lenses are inserted into this hole, separated by a rubber O-ring. 
 
Figure A.1.2: Side view of the spacing of optical components used to fulfill the AOTF 
light input requirements.  Figure adapted from [77]. 
  At the bottom of the hole is the aperture, which is a made from a 1/16” thick ring of 
Mercarto.  The leading edge of the mounting block is mounted 3 1/8” from the end of the 
channel.  Refer to Figure A.1.1 for the location of the mounting block in the optical path.    
One the left is the piece that holds the aperture, lenses, and O-rings.  On the right is the 
mating piece, showing the pocket that holds the polarizer. 
 
The AOTF mounting platform is a ½” thick aluminum block. The block is 2” square.  It 
is located 5.5” from the end of the channel.  The AOTF is mounted directly onto this 
block with four screws.  The block is slotted to allow lateral movement for system 
optimization.  Figure A.1.1 shows the location of this mounting block and the AOTF in 
the optical path.  The second set of focusing lenses are contained in a larger mounting 
block assembly.  This mounting block consists of three pieces.  The first piece is similar 
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to the polarizer holder that is part of the first lens mounting.  The second piece is a lens 
holder, again similar to the lens holder of the first mounting block. The lens assembly in 
this block is slightly different.  The first lens is similar to those in the other block, having 
a diameter of 25mm and a focal length of 50mm.  The second lens has a diameter of 25 
mm and a focal length of 100mm.  This gives some magnification to the system.  These 
lenses are also mounted 1.1mm apart.  They are separated by two O-rings, since the 100 
mm f.l. lens is thicker.  This block has a 45° cut on back side.  The front side of this block 
also has a pocket milled into the face.  This pocket is 0.003” deep and is meant to hold 
the beam cutter.  The beam cutter is fabricated from a piece of 1” x 1 ½” x 1/8” brass.  
The brass has been painted with a flat black paint to reduce light reflectance.  The beam 
cutter slides into and out of the optical path in order to remove the zeroth order beam, 
which is split off to the left of the desired first order beam.  The third piece mates to this 
cut.  The third piece also has a 45° face, but it has a pocket milled into the face.  This 
pocket, which is 1/8” thick, holds a piece of glass that acts as a beam splitter.  This block 
has a ¾” hole drilled through it to complete the light path.  A second ¾” inch hole is 
drilled at right angles to the first that leads from the beam splitter.  The Input Light 
Detector is mounted into this hole.  The straight path leads to the measurement cuvette.  
Figure A.2.1 shows the three-piece lens mount assembly.  Please refer back to Figure 
A.1.1 to see the relative placement of this mounting block.  The leading edge of the 
mounting block is 7 7/8” from the end of the channel. 
A.2 Measurement Cuvette and Position Control System 
In the description of the Optical Bridge that has been given in the previous chapters, it 
was stated that the balancing stage of the measurement was done with only the clean 
dialysate in the optical path.  It is also necessary to change the pathlength through this 
sample.  The measurement stage of the reading is performed with both the clean and 
spent dialysate solutions in the optical path.  It was necessary to find a way to implement 
these requirements. 
 
 
Figure A.2.1: Lens mount 2.  The piece on the left mates to the middle piece and has a 
pocket to hold a sheet of polarizing film.  The middle piece mates to the beam splitter 
holder and contains the second set of lenses and O-rings.  The piece on the right holds 
the beam splitter and has two through holes at right angles to each other.  The input 
light detector is attached to the top through one hole, and the measurement cuvette is 
placed on the right hand side.  (The holes are on the right and top of the figure. ) 
A special measurement cuvette was designed to fulfill these requirements.  The 
measurement cuvette has two compartments.  The cuvette itself is manufactured from a 
block of Delrin.  It has two drainage holes in the bottom, and a keyway that holds a 
moveable piece of 1/8” thick acrylic.  At the front of the cuvette, a piece of ¼” thick 
acrylic is attached.  A slider made from another Delrin block fits into the keyway cut into 
the back face.  The Sample Light Detector is mounted inside this slider.  The thin acrylic 
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piece floats in the center of the cuvette, and is held in place by two leaf springs made 
from ¼” thick spring steel. This forms a two-chamber cuvette.  A clear bag made of 
Teflon is placed in each chamber.  The Teflon bag is shown in Figure A.2.2.  The bag 
closest to the front face contains the clean dialysate.  The second bag contains the spent 
dialysate.  During the balancing stage of the measurement, the slider is moved into the 
cuvette, and it displaces the spent fluid from the bag, leaving only the clean dialysis fluid 
in the optical path.  When the measurement stage begins, the slider moves out of the 
compartment, which allows the spent fluid back into the bag, and therefore into the 
optical path.  Figure A.2.3 is an isometric drawing of the measurement cuvette. 
 
Figure A.2.2: The measurement fluid is contained in a Teflon bag. Figure adapted 
from [77]. 
 
 
Figure A.2.3: The measurement cuvette has two chambers, each of which contains a 
teflon bag (not shown.)  A slider moves in and out of the cuvette to change the 
pathlength and occlude the spent dialysate from the optical path. Figure adapted from 
[77]. 
The movements of the slider are generated by a stepper motor (Airpax) that is coupled to 
the slider.  The stepper motor has a resolution of 200 steps per revolution of the motor 
shaft.  It is coupled to a precision lead screw (Edmund Scientific) that has a pitch of 1 
thread per mm, for an overall resolution of approximately 5 µm per step.  The movement 
of the motor are generated by the PC and sent from the digital board.  See Chapter 
Appendix B: for a complete description of the software required to control the stepper 
motor.  The motor assembly is shown in Figure A.2.4. 
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Figure A.2.4: The Position Control System mounting hardware is coupled to the 
measurement cuvette by a precision lead screw. Figure adapted from [77]. 
A.3 Fluid Transfer Control System 
The fluid control transfer system consists of a peristaltic pump, tubing set, heater, and 
temperature controller.  The pump, under control from the PC, transfers equal amounts of 
the clean and spent dialysate, approximately 10 ml, to each of the Teflon measurement 
bags.  At the end of the measurement, approximately 30 ml of each fluid is pumped 
through the system in order to reduce sample carryover.  This is currently done under 
manual control by the user, but could be automated in future designs.  The fluid is 
delivered through 18 inches of Masterflex™ tubing.  The tubing is wrapped with heating 
tape, and is kept at 37° C through the use of a commercial heat controller (Omega Inc.)  
The tubing is connected to the measurement bags through the use of 4 way luer lock 
adapters.  The side entrances of the luer adapter are fitted with specially modified caps 
that contain either a thermistor or a T-type thermocouple.  The thermocouple is used as 
an input to the temperature controller, while the thermistor is used to give temperature 
information to the software to be used in the urea concentration algorithm.   
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Figure A.3.1: The measurement fluids are delivered to the measurement cuvette by the 
fluid control system, which consists of a pump and solenoid valves.  The temperature of 
the fluids are carefully controlled by the heating unit and the heating tape. Figure 
adapted from [77]. 
 
This pump and temperature control system has been designed by Jamie Murdock as a part 
of his Master’s thesis.   The hardware and software for controlling the pump and solenoid 
valves are given in Appendix B and C. The overall system is represented in Figure A.3.1.  
A.4 Tissue Simulator for Use in NIV Instrument 
As stated in Chapters 2 and 3, we intend to compare the performance of the instrument 
designed for this research with the NIV instrument.  It was therefore necessary to design 
and build a measurement cuvette that would fit into that instrument.  The term tissue 
simulator is used to mean a two compartment cuvette This presented somewhat of  a 
practical challenge, as that instrument was designed to measure a human earlobe rather 
than an aqueous sample.  The cuvette had the following design requirements: 
•= Two compartments, one of which contains the sample and the other contains the 
background fluid 
•= The sample compartment must be completely compressible 
•= The background fluid compartment must be slightly compressible 
•= The cuvette must transmit adequate amounts of light 
•= The cuvette must provide a measure of temperature stability 
Measurement
Cuvette
Heating Tape
Temp Control Unit 
Peristaltic Pump w/ 
inlet Solenoid
Inlet for
background
Outlet 
Inlet for 
Spent
To Drain 
Heating tape 
control leads 
Filtered light from 
optical system
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•= The cuvette must fit into the measurement head of the NIV instrument, shown 
below in Figure A.4.1. 
 
Figure A.4.1: Dimensions of the measurement head of the NIV Prototype. 
The final design is shown in an assembly drawing in Figure A.4.3.  It consists of three 1” 
square copper plates with holes in the middle.  The bottom plate contains a piece of 1 mm 
thick optical glass that has been fixed to the copper plate with optical adhesive.  The 
background fluid is inserted into the resulting well.  A piece of 0.010” silicon membrane 
(Allied Biomedical, Santa Clara, CA) is placed over this compartment.  Earlier tests had 
used a piece of latex (Trojan Brands, New York, NY) as a barrier.  It was determined that 
the latex could be easily punctured when stretched, and was not very uniform in its 
transmission characteristics.  The silicon membrane was much more resilient and 
uniform, and transmitted more light.  Figure A.4.2 shows the transmission of two layers 
of the silicon sheeting as a function of wavelength.  
Transmittance through 2 layers of membrane
0%
20%
40%
60%
80%
100%
1200 1300 1400 1500 1600 1700 1800
nm
%T
 
Figure A.4.2: Transmission of two layers of 0.01" silicon membrane. 
 A second copper plate is then placed over the sheeting, and the sample fluid is placed 
into the top well. This compartment is also covered with a piece of silicon membrane, 
and the final copper plate is placed on top.  The copper plates have grooves and ridges 
that help to position them properly and keep the fluid from leaking.  The entire cuvette is 
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held together with screws.  The assembly of this cuvette is somewhat tedious by hand, 
and would not be suitable for clinical use.  The concept could be easily adapted to a more 
automated design.   
 
Figure A.4.3: Assembly drawing of the measurement cuvette. 
 
A.5 Calculation of Expected Power 
The optical path of this system contains the following components: 
1) 100 W halogen lamp 
2) set of condensing lenses (Plano-convex, 50 mm focal length) 
3) 9 mm aperture 
4) 2 crossed polarizers 
5) AOTF 
6) set of condensing lenses (Plano-convex, 25 and 50 mm focal length) 
7) sample 
 
A.5.1 Surface Losses  
Approximately 4% of light is lost per surface.  The lenses used in this design are 
uncoated. There are 4 lenses, each of which loses 8%.  These losses multiply, for a 
fractional loss of  92%4 = 71.6% 
A.5.2 Filtering 
 The AOTF selects a narrow spectral band of light which contains only a fraction of the 
total spectrum of power.  In order to obtain an estimate of the power in the wavelength 
band of interest, we can apply Planck’s Law.  Planck’s Law gives a method of calculating 
the radiant flux, in Watts per unit wavelength per unit area for an emitter.  The emitter in 
this case is a halogen lamp.  The radiant flux depends on several factors, including the 
wavelength (λ), temperature of operation (T), and blackbody character of the emitter (ε).  
There are also two constants, C1 and C2.  In equation form, Planck’s Law is:  
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In order to find the power in a wavelength band, we must integrate this expression over 
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It is possible to normalize this expression, to obtain the fraction of the total power that 
resides in a given band, rather than the W/cm2 form given above.  The total power is 
given by: 
4TWt ⋅⋅= σε , W/cm
2.   (A.3) 
The variable σ is Planck’s constant, which has a value of 5.67⋅10-12 W/cm2⋅K4.  By 
dividing the expression for Wb by the expression for Wt, we obtain a fractional measure 
of the power in a given wavelength band.  Note that this eliminates the need to for a value 
for ε or the area of the emitter. 
 
There is no closed form for the integral in equation A.2, but a numerical solution can be 
found.  The software package Mathcad, Professional edition, v. 7.0 (Mathsoft, Inc.) was 
used for this purpose.  The bandwidth of the AOTF which is being used for this project is 
approximately 7 nm. Figure A.5.1 shows the power spectrum of a lamp operated at a 
temperature of 3000 K.  It also shows the integrated curve over the entire spectrum.  To 
the right of the curve are three sample power bands.  Each has a bandwidth of 7 nm to 
correspond to the AOTF bandwidth.  The first calculation is the maximum power area of 
the band.  This can be found by differentiating the Planck’s equation (A.1), setting it 
equal to zero, and solving for λ.  The maximum power occurs at approximately 996 nm.  
The second band is the region we use for the Reference wavelength, and the third is the 
region we use for the Principal wavelength.  Each of these bands contains approximately 
0.47 % of the total lamp power, or approximately 0.47 W for a 100 W bulb.  The 
transmission factor including surface losses and filtering effects is now 0.33%, or 0.33 W 
for a 100 W bulb. 
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Figure A.5.1: Power Spectrum for a halogen lamp being operated at 3000 K. The total 
power integration curve is shown by the solid line, while the dotted line shows the 
power per unit wavelength.  Sample power calculations for several bands of interest 
are shown to the right of the figure. 
A.5.3 Absorption/Polarization Losses  
Each polarizer transmits approximately 34% of the light that hits it.  When crossed, the 
transmission drops to 0.2%.  In parallel, they transmission averages 24%.  Absorption 
also occurs in the sample.  The sample contains two pieces of acrylic.  In total, the 
transmission factor for the two acrylic pieces is 88.4%.  There are also two Teflon ™ 
bags that each transmit 98% of light, for an overall transmission of 96%.  The sample 
itself, if assumed to be mainly water, has an extinction coefficient of 39 m-1 at 1000 nm.  
This indicates that the sample will have approximately 26% transmission over a 1.5 cm 
maximum pathlength.  Therefore, the overall transmission factor for the sample 
compartment is 22.1%.  If the two crossed polarizers are included, the result drops to 
.044%.  When the transmission for the filtering and surface effects in multiplied in, we 
now have a power of 146 µW, for a transmission factor of 1.46⋅10-4%. 
A.5.4 Geometric  
The aperture limits the amount of light that can physically enter the optical path.  The 
light intensity also falls off with the square of the distance from the source.  This is 
necessary to meet the acceptance angle requirements of the AOTF, as well as to prevent 
excess broadband light from reaching the detector by physically blocking it from the 
path.  The aperture opening is 9 mm in diameter.  The aperture is located 66 mm from the 
center of the lamp filament.  The aperture therefore subtends a solid angle of 
approximately 7.8° from the sphere of light that radiates from the filament.  While this is 
slightly over the acceptance angle for the AOTF, it is a consequence of adjustments that 
were made to optimize the optical path after the components were made.  It does not 
seem to significantly affect the operation of the device.  In order to calculate the 
percentage of power in this 7.8° solid angle, it is necessary to find the percentage of the 
sphere surface that this covers.  We can use the solid angle formula for this purpose.  This 
formula states that the surface area on a sphere of the area subtended by a circular section 
is given by: 
0
0.5
1
0.1 1 10
Wb( ),0.1 λ
W( )λ
λ
=Wb( ),.9925 .9995 0.004733
=Wb( ),.9265 .9335 0.004726
=Wb( ),1.0135 1.0205 0.004714
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θθπ 2sin2)2cos1(2 =−=Ω , Ω in steradians.   (A.4) 
To convert to sphere units, divide by 4π.  Substituting 2θ = 7.8°, we find that the aperture 
lets through .463% of the light.  The distance from source to detector also causes the 
power output to fall off by approximately a factor of 10.   
 
Our overall transmission figure, including surface, absorbtion, filtering, and geometric 
effects is therefore 6.8⋅10-8%, for an expected power output of 0.068 µW.  Note that this 
is the maximum power expected, and will decrease as factors such as the light intensity 
decrease and factors such as the sample absorbance increase.  This factor of 0.068 µW is 
merely an estimate which we can use to calculate the maximum allowable signal gain, as 
found in Appendix C.  
 B—1
APPENDIX B: SOFTWARE DESIGN 
 
The Urea Monitoring System (UMS) that has been developed as described in Chapters 5-
7 requires an IBM compatible personal computer (PC) to control its operation, as it is not  
a standalone system. The requirements of the research prototype that has been developed 
here are different than would be required for a clinical instrument.  This approach allows 
maximum flexibility in development of control algorithms for the UMS.  For the 
purposes of this project a special software system was developed that supports urea 
concentration and clearance monitoring.  The software system controls the operation of 
the urea clearance monitor, initiates urea level measurements, and collects, stores, and 
analyzes the recorded data.  This software system runs under Microsoft Windows 3.1™ 
or higher and provides the operator with a graphical user interface (GUI).  This provides 
a high level of automation and ease of use while still providing low-level access to the 
system parameters.  The system data is shown graphically on the screen, and the operator 
is allowed to change the operating parameters in real time.  The GUI also displays 
measured data values and results of the data analysis. 
 
The software system was developed using National Instruments’ Lab Windows/CVI™  
(version 4.0) software development package.  Lab Windows/CVI is a development tool 
that provides an interactive tool for developing C language programs.  It is geared 
towards development of instrument control and data acquisition applications.   
 
In this chapter, the basic software structure of the UMS is described.  The major system 
function, design, and operations are explained, as are basic user instructions where 
needed. All of the GUI controls are explained in terms of their purpose, action, and 
operating constraints.  The goal of this chapter is to provide a reference for understanding 
and utilizing the UMS software system. 
B.1 Software System Structure 
The UMS software system allows the operator to control the urea level measurements 
and the overall operation of the instrument.  The program can change the UMS operating 
parameters, perform near-continuous urea level measurements, present both measured 
and calculated data, and store obtained results.  A simplified block diagram of the 
software system is presented in Figure B.1.1.   
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Figure B.1.1: Urea Monitoring System Software block diagram. 
The operator interacts with the software system through a GUI within the MS-Windows 
environment. The operator can select one of several options in the main interface 
window, and the software activates a corresponding function to handle the event.  See § 
B.2 for more details about the GUI operation.  The general functions that can be 
performed with this software system through the GUI are: 
•= Read current system parameters; 
•= Set new system parameters; 
•= Initiate a urea concentration measurement, save the output data and plot the results. 
•= Calibrate the urea measurement system and change, load, or save calibration data 
files. 
The system may be in one of two modes of operation: Idle Loop or Measurement.  In Idle 
Loop mode, the software system performs maintenance tasks only.  It tries to maintain 
light intensities at certain target levels (This keeps the AOTF at a constant temperature, 
which in turn helps to keep the wavelength control more stable).  It also updates an on-
screen clock, updates measured data parameters, and checks for user input.  If the user 
updates an on-screen parameter, the software sends a control command to adjust the 
hardware, and resumes the Idle Loop mode of operation. 
 
The other operation mode is the Measurement mode.  In this mode, the system performs 
one urea concentration measurement when the user presses a button.  A typical urea 
concentration measurement takes 80 seconds, after which the results are presented to the 
user.  The results of the last 100 measurements are plotted on the GUI.   
B.1.1 Idle Loop Operation 
During the normal (non-measurement) state of operation, the system is performing 
several simple tasks.  It is continually reading the system parameters from the analog to 
digital converters, updating the display, and refreshing the digital to analog converters 
and wavelength controls.  This update takes place approximately twice per second.  
(Display updates will be discussed further in § B.2)   
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Figure B.1.2: Flowchart of the Idle Loop Control Software. 
In addition to the normal updates, a second routine is entered once every 20 seconds.  
This routine tries to set a target light intensity by monitoring the received light at the 
input light detector.  The target light intensity is read from the initialization file, and is 
usually on the order of 0.4 V.  The system calculates the difference between DCIP and 
the target intensity, and ramps PRI_INT up or down by a value proportional to the 
difference.  The converters are then read again, and this process is repeated iteratively 
until the actual intensity is within 1 mV of the target intensity.  The process will also stop 
if PRI_INT gets above 10V or below 0V.  This prevents the system from running away 
if the light bulb is turned off or is otherwise acting unusual.  This target intensity setting 
protocol is invoked upon startup as well, immediately after the initialization file is read.  
For a description of the initialization file, see § B.1.5.  A flow chart of the idle loop is 
given in Figure B.1.2. 
B.1.2 Urea Measurements 
A urea measurement is initiated by the user through the GUI.  (See § B.2).  Once the start 
button is pressed, the system goes through several preparatory steps before any data is 
recorded.  The system transfers approximately 8 ml of fluid from a water bath through the 
sample compartments in order to flush and prime the measurement cuvette. The clean 
dialysis fluid is then locked into the cuvette and the spent dialysate is evacuated, in order 
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to allow balancing to begin.  The system then moves the measurement head to the home 
position, and does a preliminary series of data integrity tests.  The home position is the 
point at which the spent fluid compartment is completely compressed and the 
measurement head is slightly pressing on the clean fluid compartment (about 3mm into 
the compartment).  This data integrity test checks the initial light intensity being received 
through the sample and the system temperature.  The current values are tested against set 
limits.   The value of these limits are set in the initial setup file (See § B.1.5).  If any of 
the parameters are out of range, the measurement is stopped and the user is advised of the 
problem.  If too much light has been received through the sample, then the sample 
compartment may have been inadequately filled.  If too little light is being received from 
the sample, the problem may be more serious.  In this case, the light bulb may be failing, 
or the AOTF may not be receiving adequate power.   In either case, the user should 
attempt to correct the problem, and restart the measurement.  The temperature conditions 
are also checked, and the user advised to make corrections if the values are out of scale.  
The overall measurement cycle is shown in flowchart form in Figure B.1.3.  
 
If the data conditions are acceptable, the balancing phase of the measurement begins at 
this point.  The first task is intensity balancing.  This involves adjusting the OFFSET 
signal iteratively until the AC signal is smaller than a given value.  The size of this 
acceptance window is specified in the initial setup file.  Increasing the OFFSET signal 
has the affect of increasing the REF_INT signal.  This is accomplished by the PI Control 
loop in the hardware.   
 
The iterative balancing process proceeds as follows.  The current value of the AC signal 
is read from the data converters.  If this value is negative, the offset value is increased by 
an initial starting step.  If the value is positive, the offset value is decreased by the same 
step size.  This process is repeated 15 times.  If the sign of the AC signal changes 
between successive iterations, the size of the step is cut in half.  If the AC signal is still 
more than 0.5V from zero, the step size is doubled.  Once fifteen iterations have been 
performed, the system checks to see if the AC signal is within the acceptance window.  If 
not, the measurement is rejected and an error message is given.  Otherwise, the 
measurement data is stored.  The measurement head is then moved by the system to the 
wavelength balancing position, which involves a slight (approximately 2mm) 
decompression of the clean fluid compartment.  The exact distance is specified by the 
balancing_distance parameter.  The wavelength balancing procedure takes place in the 
same manner as the intensity balancing procedure.  The only difference is that the 
Reference Wavelength is adjusted rather than the OFFSET signal.  The flowchart of the 
balancing process is shown in Figure B.1.4.  This figure shows the intensity balancing 
process, but would be the same for the wavelength balancing process. 
These two procedures are repeated twice, at which point, if successful, the system is 
considered balanced.  During the second set of  balancing iterations, a stray light 
recording is made by shutting off the intensity control signal to the AOTF after the 
balancing data has been recorded in that position.  Stray light is defined as any residual 
detected light that does not originate from the first order beam of the AOTF.   
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The second phase of the measurement begins at this point.  The measurement head is 
moved further out of the compartment, approximately 0.5mm, releasing the pressure on 
the spent fluid compartment.  The exact distance is specified by the 
measurement_distance parameter.   The system then transfers approximately 0.8 ml of 
spent dialysis fluid into the cuvette.  The system data is then recorded.  If there are more 
than three measurement positions specified, i.e. for a profile type measurement, the total 
measurement distance is divided by the number of measurement positions, and the 
measurement head moves in increments, while the system records data at all positions. 
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Figure B.1.3: Flowchart of a urea measurement cycle. 
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Figure B.1.4: Flowchart of the intensity balancing process algorithm.  The wavelength 
balancing algorithm is similar. 
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The measurement head then moves out 3.5mm, the fluids are flushed from the cuvette, 
and the measurement is considered complete.  The data integrity test is then repeated, 
with the addition of several new tests.  These new tests involve testing the K ratio, which 
is the ratio between DCPH00 and DCPH1, the stray light ratio between position 00 and 1, 
and the temperature difference between the clean and spent fluid lines.  If the data is 
acceptable, a data file is saved, and a urea concentration level is calculated.  (See §s B.1.5 
and B.1.4).  The calculated concentration is saved into a file, along with the time and date 
of the measurement.  The result is then presented to the user both graphically and 
numerically. 
B.1.3 Urea Monitoring System Calibration 
The data that are recorded after every measurement are processed according to a specially 
developed algorithm to yield a urea concentration measurement.  The discussion of this 
algorithm is given in Chapter 9.  The system software first applies the correction factors 
to the measured signal, and then applies a linear model to the data.  The new data point is 
then plotted on a chart through the GUI and the value is displayed to the user.  
B.1.4 Input/Output Data File Format 
The UMS system software has four types of input/output files: initial system setup, urea 
measurement results, urea measurement data, and system spectrum.  Each of these files 
has a specific format.   
The initial system setup file has the extension .ini.  Its  first line is: 
Urea Monitoring System Initial Setup File; Version October 99
If the user tries to open a .ini file when this line is not present in the file, an error code is 
returned, and a default file is opened instead.  The rest of this file gives setup information 
to the UMS software system, including initial values, and parameter limits for flagging 
error conditions.  A sample file is shown below. 
Urea Monitoring System Initial Setup File; Version October 99
Squeeze_positions=3
Balancing_distance=0.5
Measuring_distance=1.0
Maximum_stray_light=10
Minimum_stray_light=-10
Maximum_dc_intensity=10
Minimum_dc_intensity=-10
Maximum_temperature=40
Minimum_temperature=0.0
Maximum_delta_temp=2.0
Maximum_k_ratio=10
Minimum_k_ratio=-10
Pri_wl-Ref_wl-Tar_int-Off-WL_win-Off_win-WL_step-O_step-Max_wl-Max_o
1491.0 1406.0 1 0 0.8 0.8 0.2 0.2 2.0 5.0
 
The next three lines of the file contain information about the movements of the motor 
during the measurement.  The first line (Squeeze_positions=3) indicates the total 
number of measurement positions, including two balancing positions.  (The minimum 
number of positions is 3).  The next line (Balancing_distance=0.5) indicates the 
distance, in mm, that is traveled by the motor head during the balancing phase of the 
measurement.  The third line (Measuring_distance=1.0) specifies the total distance that 
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the motor should travel during the measurement phase once balancing is complete.  In 
other words, the motor should finish the measurement cycle at a distance equal to the sum 
of the balancing distance and the measurement distance, regardless of the total number of 
measurement positions.   
 
The next nine lines are used to specify error flagging limits on the data.  The first two are 
minimum and maximum levels of stray light (Maximum_stray_light=10,
Minimum_stray_light=-10). (Stray light is defined as any light that is detected that has 
not been derived from the first order beam coming from the AOTF.  It is measured by 
shutting off the intensity control signal to the AOTF and measuring the level of the signal 
at the detector.)  The second two lines specify limits for the initial amount of received 
light at the Sample Light Detector (SLD). (Maximum_dc_intensity=10,
Minimum_dc_intensity=-10). A measurement outside of the limits may indicate a 
positioning error or failure of the lamp.  The next three lines are concerned with the 
system temperature. (Maximum_temperature=40, Minimum_temperature=0.0,
Maximum_delta_temp=2.0). The first two specify a minimum and maximum temperature 
for the measurement, and the third specifies the maximum allowable temperature 
difference between the spent and clean fluid lines.  The final two lines deal with the light 
absorbance ratio K. (Maximum_k_ratio=10, Minimum_k_ratio=-10). 
K is defined as the ratio between light transmittance at the thinnest sample distance and 
the thickest sample distance.  (i.e. DCPH00/DCPH1)  If this ratio is outside of acceptable 
limits, the sample may have been poorly compressed, or contained an air bubble, or else 
have been otherwise unacceptable. 
 
The next line in the file is a reference for the user who may need to modify the file.  The 
line below it specifies ten parameters that are used to set initial parameters and to control 
the balancing process:   
Pri_wl-Ref_wl-Tar_int-Off-WL_win-Off_win-WL_step-O_step-Max_wl-Max_o
 
The first two parameters specify the Principal wavelength and the initial guess for the 
Reference wavelength, respectively. The third parameter specifies the target intensity that 
is recorded at the Input Light Detector (ILD).  The fourth parameter is the offset, which 
controls the difference between DCIP and DCIR.   
 
The fifth and sixth parameters are error flagging limits as well.  They specify the 
acceptable degree of residual AC signal after each stage of balancing.  WL_win specifies 
the size of the acceptance window for wavelength balancing, while Off_win specifies the 
size of the acceptance window for intensity balancing.  The seventh and eighth 
parameters (WL_step O_step) specify the initial step sizes that the system uses when 
beginning the balancing process.  The final two parameters are currently unused.   
The urea measurement results file has the extension .umd.  It contains one line for each 
measurement.  Each line consists of a time, date, and urea level (in mg/dl).    A sample 
line might read: 
10:05:20 01/22/99 120
The most recent measurement appears at the end of the file. 
The urea measurement data file has the extension .ums.  This file is used for parameter 
extraction and data analysis.  It contains information about the system that was recorded 
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during the measurement.  It also contains one line per measurement record.  The 
individual data are comma-delimited in the file, and can be loaded into a spreadsheet 
such as MS-Excel for data analysis.  The line begins with a measurement number, 
followed by the date and time, and then a marker for a calibrating urea level point.  The 
principal and reference wavelength appear next, followed by the principal intensity, 
offset, and system bias.  The next two pieces of data are the amount of time (in seconds) 
spent in each balancing position (wavelength and intensity).  The rest of the line contains 
data about the system parameters as read during each phase of the measurement.  For 
each parameter, at least three records appear, one for each measurement position 
(wavelength balancing, intensity balancing, and each measuring position).  In other 
words, the next three pieces of information that appear in the file after the clock 
information are AC00, AC0, and AC1.  Each signal that is entered into the data file 
follows this pattern.  The order of the data is: AC, DCSP, DCSR, REF_INT, DCIP, 
DCIR, STRAY_I, STRAY_S, T_CLEAN, T_SPENT. 
A typical data  file record line might appear as below: 
10, 1/22/99, 10:05:20, &, 1491, 1406, 5.2, .1, .0073, 18.542, 12.412,
0.0001213, 0.00012412, 0.0001921, .8987, .8354, .8001, .7632, .7654,
.7521, 6.801, 6.802, 6.806, 1.1231, 1.1023 1.032, 1.2232, 1.2003,
1.1032, .3564, .3654, .3546, .3465, .3401, .3321, 37.2, 37.2, 37.2,
37.5, 37.5, 37.6
The system spectrum file has the extension .spc.  The file has 400 lines, since the 
spectrum is recorded at 400 different wavelengths over the range from 800 to 1200 nm.  
The format of each line is the wavelength, followed by the SLD signal, and finally the 
ILD signal.  A typical line might be:  
1050 1.231 1.892. 
B.1.5 Data Acquisition 
In § C.2, the DEM hardware system was described, including the implementation of the 
data acquisition system.  Recall that all data acquisition for this system take place through 
the parallel port.  The exception is the wavelength control, which is done through the ISA 
bus.  In this §, the software required to control the data acquisition is presented. 
B.1.5.1 Parallel Port Operation 
The typical PC has between one and four parallel ports.  We use the first parallel port, 
which is the device known as LPT1, or PRN to the PC.  The parallel port has three 8 bit 
wide registers associated with it that can be programmed by the user.  For the purposes of 
this research, we assume a standard mode of operation.  This indicates that the registers 
are not bi-directional, except where stated.  A complete description of the modes of 
operation (standard vs. enhanced) is beyond the scope of this dissertation, and will be 
omitted here). The first register usually resides at address 378h.  This is the Data register.  
The  signal configuration for this register is: 
Data Register (378h) 
Bit 7 6 5 4 3 2 1 0 
Signal MOT_EN PUMP VALVE DIR SDATA SCLK LD_DA STRB 
 
Any of these signals can be turned on or off with a simple write instruction to the Data 
register.  For example, to turn on MOT_EN, the following instruction would be given: 
outp(0x378, 0xA0);
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The signal level stays valid until the next write instruction. 
The second register is the Status register.  This register has an offset of one from the Data 
Register, and is read-only in standard mode.  Only two bits of this register are used.  In 
order to determine the status of these two bits, a read instruction is given (The two byte 
version of the IN instruction is used here): 
status = inpw(0x379);
Status Register (379h) 
Bit 7 6 5 4 3 2 1 0 
Signal X X AD_DATA AD_STATUS X X X X 
 
The final register is a write-only register called the Control register.  Two bits of this 
register are used as well.  The Control register has an offset of 02h from the Data register.  
It is programmed in the same manner as the Data register. 
Control Register (37Ah) 
Bit 7 6 5 4 3 2 1 0 
Signal X X X X X X UC_COM PP_EN 
 
B.1.5.2 Device Selection 
Since the parallel port has a limited number of pins, it would not be possible to provide 
all of the required signals to each of the chips in the data acquisition system.  Instead, a 
device select circuit is provided on the digital board.  (See § C.2.2)  In order to program 
this circuit, the lower nibble of the Data register is used.  A sequence of 10 bits is clocked 
out for every change in the device select signal.  This sequence is converted to a parallel 
word by the hardware, which waits for a latching signal before updating the device select 
signal.  The signal LD_DA remains high during the device selection phase.  Each device 
in the system has a selection sequence, which is listed in the table below.  (Although 10 
bits are clocked out, there are only three devices in the system.  There is one ‘unselect’ 
signal  (CS_OFF) that can be activated as well when no device is active).  Bit 3 in the 
sequence is always high. 
Signal CS_AD16 CS_AD12 CS_DA CS_OFF 
SCLK 010101010101010101010 010101010101010101010 010101010101010101010 010101010101010101010
SDATA 000000000000111111110 000000000000111100110 000000000000111111000 000000000000110000000
LD_DA 111111111111111111111 111111111111111111111 111111111111111111111 111111111111111111111
STRB 000000000000000000001 000000000000000000001 000000000000000000001 000000000000000000001
 
For each code that is sent in the sequence, the SDATA line is held at the desired level, 
and the SCLK line is brought through a low to high transition.  After 10 bits have been 
sent, the STRB line is pulsed to latch the updated device select signal.  The device select 
signal stays activated until the STRB line is activated again. 
B.1.5.3 Analog to Digital Conversion 
There are two different Analog to Digital Converters (ADC’s) in the hardware system.  
The first is a 16 bit single channel converter used to digitize the instrument output signal. 
The second is an 8 channel 12 bit converter used to digitize other important system 
signals.  Each of these converters require different control signals in order to direct their 
operation.  Refer to the system hardware description given in § C.2.   
The 16 bit converter requires only a chip select to initiate a conversion, which is 
generated as described in the previous section.  After the chip select falls, a brief (~10µs) 
 B—12
delay is programmed to allow the conversion to complete.  After the delay, 16 clock 
pulses are given using the SCLK signal.  After the clock is brought low, a word is read 
from the Status register.  The result is then masked to read the fifth bit.  If the bit is a one, 
then the corresponding value of the bit is accumulated into the result.  This result is in 
two’s complement format.  In order to convert the bit result into a voltage, the 
accumulated value is divided by 3276.8.  This translates to an LSB weight of 0.3055 mV.  
If the accumulated result is over 8000h, the result was negative, so the full scale range 
(20 Volts) of the converter is subtracted from the voltage value in this case.  Once the 
conversion is complete, the chip select is released by activating the CSOFF signal.   
 
The second converter is somewhat more complex in its operation.  Since it has eight 
channels, it requires a control word which is programmed serially into the device.  This 
control word sets up the conversion parameters and selects the channel.  The format of 
this control word is shown in Figure B.1.5.  The device is operated in bipolar, single 
ended mode with an internal clock.  The format of the control word is therefore 1xxx0110 
where the xxx represents the channel selection bits.  The channel selection bits and their 
corresponding signals are given below: 
Channel Code Signal 
0 000 REF_INT 
1 100 POSITION 
2 001 TEMP1 
3 101 TEMP2 
4 010 DCIR 
5 110 DCSR 
6 011 DCIP 
7 111 DCSP 
   
A conversion using this device also begins by activating the correct device select signal 
(CS_AD12).  After this, the control word is clocked into the device using SCLK and 
SDATA.  Once the last bit of the control word is clocked into the device, a conversion 
begins.  As before, a brief delay (~10 µs) is programmed to allow the conversion to 
complete.  The conversion result is read back in the same way as it was for the 16 bit 
converter.  The data is read back from the device with a leading zero bit and three trailing 
zeroes that must be discarded from the conversion.  This data is also in two’s complement 
format.  The LSB weight of this converter is 1 mV, and the full scale range is 4.096V.  
For accumulated values over 8000h, 4.096 is subtracted from the voltage reading to yield 
a negative value.  The chip select is then deactivated by programming the CS_OFF  
signal. 
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Figure B.1.5: Control word format for the 12 bit converter.  (Taken from the MAX186 
datasheet) 
 
The software has an outer loop that completes several readings of each channel. The 
number of readings is selectable through the GUI.  These readings are accumulated and 
averaged to improve the signal to noise ratio of the conversion. 
B.1.5.4 Digital to Analog Conversion 
The Digital to Analog Converter (DAC) is a four channel device, three of which are 
currently in use.  This device is programmed by activating the corresponding device 
select line (CS_DA), and then sending a control word.  This control word selects the 
desired channel, programs the mode of operation, and the desired voltage.   The format of 
this word is [A1:A0 C1:C0 D11:D0].  C1 and C0 are always 0.  For A1:A0, the format is:  
Channel A1:A0 Signal 
0 00 OFFSET 
1 01 - 
2 10 PRI_INT 
3 11 BRIDGE_OFFSET 
 
D11:D0 is calculated by converting the desired voltage to a bit stream in two’s 
complement format.  The weight of the LSB is 4.88 mV.  Once the final bit is 
programmed into the DAC using the SCLK and SDATA lines, the LD_DA signal is 
programmed to go low, causing the DAC to latch the signal onto the desired output 
channel.  At this time, the chip select signal is released by activating CS_OFF. 
B.1.5.5 Motor Control 
Control of the motor is very straightforward.  Three pins are programmed to control the 
number of steps and the direction.  The hardware does the rest of the signal generation.  
The MOT_EN pin causes the signal SCLK to be connected to the motor control circuit.  
The state of the DIR pin can cause the driver chip to reverse the order of pulse sent to the 
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motor, causing the motor to spin in the opposite direction.  If DIR is 0, the motor spins 
forward.  The motor will spin backward when DIR is 1.  In order to turn the motor one 
step, the MOT_EN pin is brought high, and SCLK is transitioned between low and high.  
A delay is programmed between the low to high transition to account for the motor’s 
response time.  Each step corresponds to 1/200th of a full revolution.  The physical system 
moves 1mm for each revolution, for a resolution of 5 µm.  Once the motor has been 
turned the desired number of steps, the MOT_EN signal is brought low again, disabling 
the motor control circuit.  During a motor movement, the desired position is checked 
against the value that is read from the Space Age Controls ™ position feedback device.  
The position is iteratively adjusted until the actual position is within .1mm of the desired 
value. 
B.1.5.6 Pump Control 
The software control of the pump is also very simple, as the actual state transitions of the 
pump driver circuit are done with an Altera™ chip.  The pump only  requires one 
software control signal, PUMP.  In order to advance the pump motor one step, the 
PUMP signal must be pulsed low then high.  The pump also requires at least a 10 ms 
delay between steps.  One click is approximately 0.4 ml. This calibration is built into the 
software, so that a specific amount of fluid can be pumped as desired by the user. 
B.1.5.7  Solenoid Valve Control 
In order to keep the fluid in the Teflon  bags during a measurement, a set of four solenoid 
pinch valves are used.  In order to reduce the number of digital lines which are required 
to control these valves, an Altera™ chip was used to make a ‘state machine’.  (See 
Appendix J for a hardware/firmware description of this system).  In order to cause the 
valves to transition to their next state, two digital lines must be pulsed.  The valve 
controller has eight states that correspond to different phases of the measurement.  These 
states control whether fluid is being flushed or filling the measurement cuvette.  There is 
an entrance and an exit valve for both compartments of the measurement cuvette. 
 
B.1.5.8 Wavelength Control 
In § C.2.4, the RF signal control hardware was discussed.  Recall that there are two input 
controls to the device.  The first is the intensity, which is an analog voltage.  The second 
is the wavelength, which is a 32 bit digital control.  This control word is converted in the 
NEOS driver to a frequency, which in turn selects the wavelength of light that is passed 
by the AOTF.  The driver has a base frequency of 1024 MHz.  In order to select the 
desired frequency, the following formula is used:  
1024
231⋅
=
outfcode , where fout is expressed in MHz.   
It is necessary to calibrate the driver frequency to the AOTF wavelength, since this 
control is not strictly linear.  An external device called a monochromator is required to 
complete this calibration.  This device, manufactured by CVI, Inc., has an entrance and 
exit slit that light can pass through.  The device allows the user to select a desired 
wavelength of light to pass.  In order to do the wavelength calibration, the 
monochromator is placed so that the slit is in line with the light path of the UMS.  An 
external silicon detector is placed at the exit slit of the monochromator.  This detector 
will only see a signal when both the monochromator and the AOTF are passing the same 
wavelength.  The wavelength range of the AOTF is 1100 to 1800 nm, so the 
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monochromator is set to 1100 nm at the start.  The frequency sent to the driver is stepped 
in increments of 1 MHz, until an increase in signal is seen at the detector.  The frequency 
increment is decreased at this time, and the frequency at which the maximal signal occurs 
is recorded .  The monochromator wavelength is then increased, and the calibration 
continues in the same manner.  Approximately 30 points are recorded.  This data is then 
entered into a Microsoft ® Excel spreadsheet.  A five point multiple linear regression is 
performed on the data in order to obtain a calibration curve.  The coefficients from the 
MLR are then used in the software to convert the desired wavelength to the necessary 
drive word.  The fifth order polynomial coefficients obtained from the MLR are: 
order coefficient 
a 4.505027194752E+03 
b -1.821738083231E+01 
c 3.049222842297E-02 
d -2.560096270007E-05 
e 1.070483944157E-08 
f -1.778722430193E-12 
 
The frequency is then calculated as f = a + b·wl + c·wl2 + d·wl3 + e·wl4 + f·wl5.  In order 
to set the wavelength, the calculated drive word is sent to the RF control card that resides 
on the PC’s ISA bus at a base address of 400h.  This control card has four byte wide 
registers.  The first two hold the control word for the principal wavelength, and the 
second two hold the control word for the reference wavelength.  The controller card 
sends these two words to the NEOS driver in an alternating fashion at the frequency 
specified by CLK_REF, which is connected to the card through a 2 mm microphone 
jack.  Since the PC has no 32 bit data writing (output) instruction, the control word must 
be broken into a high byte and a low byte. The low byte is determined by ANDing the 
number with the hexadecimal value FFFFh.  The high byte is determined by left shifting 
the number 16 places, then ANDing the result with the hexadecimal value FFFFh.  The 
result is then sent out with a byte wide output instruction 
 
B.2 Urea Monitoring System Graphical User Interface 
 
In order to simplify the operation of the UMS, a graphical user interface (GUI) was 
developed.  The main functions of the GUI is to provide a means by which the user can 
control the hardware,  initiate measurements, and monitor the status of the system.   
 
This interaction is accomplished by means of window controls and/or window menus.  
The main GUI window contains several groups of function controls in the form of text 
boxes, control buttons, and indicators.  These controls may give information to the user 
about the system, or be used to activate subroutines and hardware changes.  Most of the 
function buttons in the window correspond to an element in the pull-down menu as well.  
When one of the function buttons or menu items is activated by the user, the GUI sends a 
control event code to the software, and the desired subroutine is carried out.   
 
When no user or system events are pending, (user events occur when a button is clicked, 
a value is changed, or a menu item is activated; system events occur when hardware 
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interrupts or timer interrupts are present), the GUI is operating in idle mode.  This frees 
the system to perform necessary tasks.  The GUI stays in idle mode until a system or user 
event intervenes.  Once the event is handled, the GUI returns to idle mode and waits for 
the next event. 
 
The GUI for this system consists of four windows for controlling and optimizing the 
system and presenting results: 
•= Main Urea Monitoring System Window – allows the user to setup the hardware, 
initiate measurements, load and save initial system configuration files, and change 
other operating and calibration parameters.   
•= System Spectrum Window – displays the transmittance of the system as a function of 
frequency over the useful range of the AOTF.  This is mainly a diagnostic tool, since 
the spectrum will show large deviations when the light bulb is beginning to fail.  It 
may also help diagnose problems with the detectors or the AOTF.   
•= Noise Analysis/Bias Cancellation Window – displays the level of system noise and 
the hardware system bias.   
•= Stray Light Optimization Window – displays the stray light ratio for the system.  The 
stray light ratio is defined as the amount of received light at the input light detector 
when the light intensity is at full scale versus when the light intensity is at zero. 
B.2.1 Main User Interface 
The main user interface window is shown in Figure B.2.1.  This window is titled “Optical 
Bridge Urea Monitoring System”.   Twenty-two groups of controls are found on the 
figure: 
1. Start Measurement – The user initiates a measurement by pressing this button.  An 
indicator light informs the user whether or not the instrument is ready to begin a 
measurement. 
2. Quit – Pressing this button will terminate the session. 
3. System Time – Output control for displaying the present time. 
4. Motor Indicators – This is a set of two LED output controls that indicate when the 
motor is in motion and in which direction it is turning.  When the motor turns 
forward, the direction indicator turns yellow.  When the direction is reversed, the 
direction indicator is blue. 
5. Measurement Progress Indicators – This is a set of three LED’s and a slide control 
that indicate the progress of a measurement.  The first LED is labeled Ready to Start.  
This indicates that the system is currently able to begin a measurement.  The second 
LED is labeled Balancing.  This LED is used to indicate the a measurement is in 
progress, and that the system is attempting to balance the background signal.  The 
final LED is labeled Measuring.  This LED indicates that the system has successfully 
been balanced, and the measurement phase has begun.  The slide control is used to 
indicate the current position of the measurement head: intensity balancing, 
wavelength balancing, or measuring. 
6. Pump Volume – Output control for displaying the amount of fluid that is being 
pumped through the system. 
7. Elapsed Time – Output control for displaying the total length of the measurement, in 
seconds. 
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8. Urea Measurement Graph – Output control graph used to display a record of recent 
urea readings.  The points show the 100 most recent readings. 
9. AC and Normalized AC – This is a set of output controls that show the value of the 
raw signal and the normalized signal (raw signal divided by DCSP) as well.   
10. DC Values – These four output controls show the four DC components of the signal: 
DCSP, DCSR, DCIP, and DCIR. 
11. Loop – This output control shows the value of the Reference Wavelength Intensity 
(REF_INT), otherwise known as the loop voltage. 
12. System Bias – This is the voltage, in mV that is set on the third DA channel to cancel 
the offset in the signal.  The system bias is determined from the noise analysis.    
13. Head Position – This control is a slide control that indicates the position of the 
measurement head.  The zero position is when the head is fully closed.  The rightmost 
control in this group shows the actual position (as read by the AD converter from the 
Space Age Controls potentiometer).  The left control is the position which was set by 
the user or the software. 
14. System Temperature – This is a set of two thermometer controls that display the 
current temperature of the spent and clean dialysis fluid lines.   
15. File Utilities – This set of buttons will open a File Utilities dialog box, either to save 
or open an initial setup file. 
16. User Profile – This text box gives the name of the current setup file. 
17. Number of Averages – This is an input control that is used to control the number of 
averages that is done every time the A/D converters are read.  Repeating and 
averaging the readings improves the signal to noise ratio of the measurement by a 
factor of 2 . 
18. Hardware Setup – This set of four input/output controls are used to control the 
intensity and wavelength of the light beam.  The first two controls are used to control 
the wavelength of the principal and reference wavelength.  The third control is the 
offset, and the final control is the principal intensity.    
19. Model – This final control box allows the user to input a slope and an intercept for the 
linear model relating the signal to the urea concentration. 
20. Valve – This control directs the hardware to advance the state of the solenoid pinch 
valves. 
21. Pump – This control allows the user to pump a specified amount of fluid through the 
system. 
22. AC Strip Chart – This control, only used for testing purposes, is a strip chart that plots 
the value of the normalized signal over time. 
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Figure B.2.1: The main user interface window for the UMS software system. 
B.2.2 System Spectrum Window 
The user may access a system spectrum function through the Spectrum Analysis menu 
option.  Once this function is called, a second window opens up that contains a large 
graph.  See Figure B.2.2.  Three buttons appear at the bottom of the window.  The first is 
labeled Acquire, the second is labeled Save Data, and the final is labeled Quit.  Pressing 
the Acquire button will start a spectral acquisition, which measures all four DC signals 
over the wavelength range of 1100 to 1800 nm.  The wavelength is stepped in units of 2 
nm.  After the scan is complete, the spectral data is plotted in the graph window.  
Pressing the Save Data button will open a file dialog box, and the user can save a file 
with the extension .spc that contains the spectral data.   
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Figure B.2.2: The system spectrum window from the UMS system software 
B.2.3 Stray Light Optimization Window 
This is a simple window that is accessed through the Calibration menu, under the 
Optimize Stray Light function. This function contains three output controls, one labeled 
On, one labeled Off, and one labeled Stray Light Ratio.  The Stray Light Optimization 
window is shown in . When this function is activated, the principal intensity is alternated 
between 10 V and 0 V.  These boxes display the signal DCIP for the two phases of the 
alternating signal.  The On box displays DCIP when the principal intensity is fully on, 
and the Off box displays the zero intensity part of the cycle.  The Stray Light Ratio box 
displays the ratio between the on and off signals.  In order to optimize the stray light level 
in the system, the beam cutter is slid in and out of the optical path until the point at which 
the ratio is maximized is found.  The function can then be terminated by pressing the Quit 
button. 
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Figure B.2.3: The Stray Light Optimization Window from the UMS system software 
B.2.4 Noise Performance/Bias Cancellation Window 
One of the most important performance tests of the UMS is the noise level.  The signal to 
noise ratio of the measurement is largely responsible for determining the accuracy and 
precision of the system.  This window, which is accessed through the Noise Analysis 
menu item, has several output controls and two control buttons.  A noise test is begun by 
pressing the Start button.  At this point, the system takes 50 readings of the AC  signal, 
and two calculations are performed.  The first is the system bias level, in mV, which is 
define as the average of the 50 readings. The second is the noise level, in mV, which is 
defined as the standard deviation of all 50 readings, or: 
( ) ( )
49
50 22 ⋅−
=
ii xxNoise     (B.1) 
These two values are then displayed on the System Bias and Noise control boxes.  During 
the signal acquisition, the number of readings that have been accumulated is displayed on 
the Reading number control, and the current AC signal is updated as well.  After the 
measurement, the system bias level is sent out to the third DA channel in order to 
compensate for the system bias.  When the user presses the Quit button, the window is 
dismissed. 
Figure B.2.4: The noise performance/bias cancellation window from the UMS system 
software 
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B.2.5 The GUI Menu Bar 
The UMS menu bar contains five pull down menus: File, Start Acquisition, Calibration, 
Scans, and Noise. 
File: This menu, shown in Figure B.2.5, provides functions for handling the initial setup 
files and for quitting the UMS system software. 
1. Read Setup – Opens an existing initial setup file 
2. Save Setup – Saves the current initial setup file, either with the same name or a new 
name. 
3. Quit – ends the current session of the UMS system software. 
 
File… Start Acquisition… Calibration… Scans… Noise … 
Read Setup…     
Save Setup…     
Quit     
Figure B.2.5: The menu bar and File pull down menu from the UMS system software. 
Start Acquisition: This menu, shown in Figure B.2.6, will begin either a series of 
continuous urea measurements or a single urea measurement. 
1. Perform Urea Measurement – This menu option will begin a single urea 
measurement as described in § B.1.2.  
 
File… Start Acquisition… Calibration… Scans… Noise… 
 Perform Urea Measurement    
    
Figure B.2.6: The menu bar and Start Acquisition pull down menu from the UMS 
system software. 
Calibration:  This menu, shown in Figure B.2.7 offers functions for optimizing and 
calibrating the UMS system software. 
1. Enter Calibration Point – This function can be used before or after a urea 
measurement to enter a urea reading that has been obtained by an external method.   
2. Optimize Stray Light – This menu option opens the stray light optimization window.  
The operation of this window is described in § B.2.3 
 
File.. Start Acquisition… Calibration… Spectrum Analysis… Noise Analysis… 
  Enter Calibration Point   
  Optimize Stray Light   
Figure B.2.7: The menu bar and Calibration pull down menu from the UMS system 
software. 
Scans: This menu, shown in Figure B.2.8, opens the spectrum analysis window.  The 
operation of this window is described in § B.2.2. 
 
File… Start Acquisition… Calibration… Scans… Noise … 
   Spectrum  
Figure B.2.8: The menu bar and Spectrum Analysis pull down menu from the UMS 
system software. 
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Noise Analysis: This menu, shown in Figure B.2.9, opens the noise analysis/bias 
cancellation window.  The operation of this window is described in § B.2.4. 
 
File… Start Acquisition… Calibration… Spectrum Analysis… Noise Analysis… 
    Start 
Figure B.2.9: The menu bar and Noise Analysis pull down menu from the UMS system 
software. 
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APPENDIX C: DIALYSIS EFFICIENCY MONITOR 
HARDWARE DESIGN 
 
There are two major hardware sections in this system.  The first is the instrumentation 
section, and the second is the IBM compatible personal computer (PC).  The 
instrumentation section is responsible for controlling the wavelength and intensity of the 
delivered light, as well as detecting, amplifying, filtering, and processing the light that 
passes through the sample.  The PC is responsible for controlling the instrumentation 
system, and for collection, storage, and processing of the recorded data. 
 
In this chapter, we describe the hardware of the dialysis efficiency monitor (DEM), 
including the realization of the Optical Bridge system.  The hardware modules of the 
system are discussed and presented in detail with regards to their performance 
specifications, intended function, and design.  Complete schematics of all modules are 
given in Appendix A. 
 
C.1 Hardware Modules 
 
There are several functions that the hardware performs in order to accomplish the 
measurement.   shows a block diagram of the overall system.   
 
The PC directs the operation of all hardware modules.  The PC used for this project has a 
Pentium processor (90 MHz) with a MS-Windows 95™ operating system.  (This is the 
minimum set of system requirements.) There are five main modules that comprise the 
instrumentation system.  These modules are listed in Figure C.1.1, together with names of 
the sub-modules, their basic tasks, and how the modules interface to the PC and/or the 
other modules.  In the following section, we will begin to discuss each of the modules 
and their component parts. 
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Figure C.1.1:Block diagram of the DEM system hardware shows there are two main 
interfaces to the PC.  The first is the parallel port, which controls data acquisition.  The 
other is the ISA bus, which controls the wavelength selection. 
C.2 Specifics of DEM Hardware Design  
In this section, the circuitry that was designed for the DEM system is described.  Each 
main module is described in terms of its overall function, component sub-modules, and 
interfaces to other modules. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PC 
Parallel Port 
Interface 
Motor 
Control 
Optical Isolation/Device 
Selection Logic 
Analog Signal  
Processing / Data 
Conversion Board 
ISA interface
RF Signal 
Generator 
Light 
Detection 
Hardware 
AOTF: Light 
Wavelength 
Selection 
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Table C.2.1:Hardware Modules that comprise the Dialysis Efficiency Monitoring 
system (I: Input, O: Output, B: Bidirectional) 
Module Name Interfaces 
(Input/Output/Bidirectional) 
Sub-modules Contained 
Digital Board 1. PC (B) 
2. Motor (B) 
3. RF (O) 
4. Analog Board (B) 
5. Pump Control (O) 
1. Optical Isolation Unit 
2. Device Select Circuitry 
3. Clock Generator Circuitry 
Analog Board 1. Digital Board (B) 
2. Detector Boards (2) (I) 
1. Signal Transducers/Pre-
Amplifiers and Filters (2) 
2. Signal Demodulator 
3. Lock in Amplifier 
4. PIC Intensity Controller 
5. Analog to Digital Converters 
6. Digital to Analog Converters 
7. Temperature Monitor  
Motor Controller  1. Digital Board (B) 1.   Stepper Motor Controller 
Pump and 
Temperature 
Controller 
1. Digital Board (B) 1. Temperature Controller 
2. Pump Controller 
RF Signal 
Generator 
1. AOTF (O) 
2. Digital Board (O) 
3. PC ISA slot (I) 
1. Frequency controller card 
2. Direct Digital Synthesizer Unit 
3. Power Amplifier 
C.2.1 Analog Board 
 
The Analog Board is responsible for most of the hardware signal processing.  It is a four 
layer Printed Circuit Board  (PCB).  It has two trace layers, an analog ground plane, and a 
digital ground plane.  The dimensions of the board are approximately 6” by 8”.  Professor 
Stevan Kun of the Biomedical Engineering Department at WPI was responsible for much 
of the design of both the analog and digital boards. 
 
C.2.1.1 Signal Transducers/Amplifiers  
In addition to the main analog board, there are also two small signal boards that are 
considered part of this module.  These signal boards contain the light detectors, current to 
voltage converters, and pre-amplifiers that are used to convert the received light to an 
electrical signal.  The first signal board, called the Input Light Detector (ILD), is used to 
provide a reference, or normalizing factor for the signal.  Its optical detector is 
strategically placed in the light path so that it receives a small portion of the light that 
enters the sample compartment.  The ILD board transduces the light signal to a current, 
converts the current to a voltage, amplifies and filters this signal.  The signal from the 
ILD used to normalize the signal from the other detector board, the Sample Light 
Detector (SLD).  The SLD is used to record the light intensity at the exit of the sample 
compartment.  See Chapter Appendix A: for a description of the placement of the two 
detector boards.  The optical signal is in the range of a few microWatts (µW).  The 
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photodetector that is used for this system is an Indium Gallium Arsenide (InGaAs) type.  
Its sensitivity bandwidth is 800 to 1700 nm.  The absolute responsivity of the detector is 
defined as the current produced per Watt of optical power that reaches the detector.  For 
this detector, the maximum responsivity is approximately 1 A/W.  
 
Figure C.2.1 shows a plot of the responsivity of an InGaAs detector.  The maximum 
signal power reaching the detector is expected to be on the order of 0.07 µW, which will 
yield a maximum of 0.07 µA of signal from this detector‡.  We desire a maximum signal 
output of 10 V.  This means that our signal amplifier should have a gain of 1.5⋅108 
Volts/Amp.  The gain in this part of the circuit is approximately -1⋅106 V/A.  (The rest of 
the gain is produced in a later stage).  Since the photodetector produces a current, the 
necessary amplifier must convert the current to a voltage.  It must also filter the signal in 
order to improve the signal to noise ratio.  The light signal is switched between the 
Principal and Reference wavelength at a frequency of 60 Hz.  The cutoff frequency for 
the low pass filter in the amplifier circuit is about 600 Hz, which was chosen to pass 
several harmonics of the received light intensity signal, which has a fundamental 
frequency of 60 Hz. 
                                                 
‡ The figure of 0.07 µW is arrived at by calculating the percentage of power from the 100 W lamp which 
arrives at the detector.  This calculation involves geometrical considerations, surface losses, and sample 
absorbances.  This calculation is performed in Chapter Appendix A:. 
 C—5
 
Figure C.2.1:Responsivity curve of an InGaAs photodetector [Epitaxx]. 
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APPENDIX D: INTERFERING SUBSTANCE 
ABSORBANCE TABLE 
Substance/structure
[78] 
mol. 
wt. 
[78] 
significant bands 
(nm) [78] 
[Level], 
mg/dl [90]
Notes [91] 
Urea 
           O 
                 || 
         H2NCNH2 
60.06 5945, 3092, 2906 70 major marker 
glucose 
 
CH2OH 
                   H 
                OH   
H                         OH 
OH                     H 
   OH               H 
          H      OH  
180.16 3017,  7460 100 Present in dialysate 
1-Methylguanidine 
      NH 
         || 
H2N-C-N-CH3 
             H 
73.10 6024, 3680, 3158, 
2910 
0.00424 product of 
putrefaction 
 
guanidine 
                NH 
                 | 
         H2NCNH2 
59.07 6095, 3665, 3289 0.00141 strong organic base 
Creatinine 
                O 
                ||       NH 
 
                           =NH 
                   N 
                   CH3 
 
113.12  6283, 5991, 3074 0.7 End product of 
Creatine catabolism 
Creatine 
              NH        O 
              ||             || 
    H2N-C-N-CH2-C-OH 
                CH3 
131.13 5905, 3230, 2997 0.45 Present in muscle 
tissue, normally 
excreted as creatinine 
Arginine 
                           NH2 
                           | 
H2NCNH(CH2)3CHCOH 
        ||                       || 
       NH                   O 
210.24 5861, 3064, 2863 1.87 Essential amino acid 
Homoarginine 
                           NH2 
                           | 
H2NCNH(CH2)4CHCOH 
        ||                       || 
       NH                   O 
224.26 6007, 3637, 3150 0.983 Amino acid 
Phenol 
                      OH 
 
 
 
 
94.11 6672, 6268, 2965 0.0083 Derived from coal 
tar. Higher levels in 
smokers and miners 
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o-Cresol 
                         OH  
                                CH3 
 
 
 
108.14 6830, 6280, 2900 0.064 Derived from wood 
tar.  Higher levels in 
smokers 
p-Cresol 
                           OH 
 
 
 
                    
                           CH3 
108.14 6608, 6255, 2973 0.071 Derived from wood 
tar.  Higher levels in 
smokers 
Benzyl alcohol 
                      CH2OH 
 
 
 
 
108.14 6880, 3300, 3002 0.0004 Constituent of eastern 
aromatics oils e.g. 
jasmine, ylang ylang 
Tyrosine 
                        OH 
 
 
                                    O 
                                    || 
                       CH2CHCOH 
                              NH2 
181.19 6290, 3658, 3121 1.3 Precursor of 
catecholamines 
3-
Hydroxyphenylacetic 
acid 
                                     O 
                                      ||     
                            -CH2-C-OH 
 
          HO 
                             
152.15 5880, 3327, 3022 0.0033  
o-Hydroxyhippuric 
acid 
                         O          O 
                          ||           ||        
                        -CNHH2COH 
 
                    OH 
 
195.17 5814, 3264, 2988 0.0028  
Hippuric acid 
                         O          O 
                          ||           ||        
                        -CNHH2COH 
 
179.18 5733, 3256, 2994 0.041 Present in normal 
urine 
Benzoic acid 
                         O           
                          ||                  
                        -COH 
 
122.12 5925, 3738, 3255 0.0054 Normally excreted as 
hippuric acid 
Indol-3-acetic acid 
 
                          CH2COH 
                                  || 
                                 O 
 
 
175.19 5874, 2952 0.1 Plant growth 
regulator 
N
H 
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5-Hydroxyindol-3- 
acetic acid 
 
 
 
    HO                     CH2COH 
                                      || 
                                     O 
 
 
191.19 5810, 2928 0.065  
Indol-3-acrylic acid 
 
                          CHCHCOH 
                                      || 
                                     O 
 
 
187.20 6219, 5917, 2917 0.08  
5-Hydroxytryptophol 
                            
                                  NH2 
 HO                     CH2CHCOH 
                                         || 
                                        O 
 
 
220.23 3668, 3301, 2937 0.0841 Precursor of 
serotonin 
N-acetyltryptophan 
                                    O 
                                     || 
                        CH2CHCOH 
                               NH-C-CH3 
                                       || 
                                      O 
 
274.32 6130, 5805, 3277, 
2948 
0.000654  
Tryptophan 
                                  NH2 
                           CH2CHCOH 
                                         || 
                                        O 
 
 
294.23 6003, 3420, 2938 1.77 Essential amino acid. 
Serotonin precursor 
Uric acid 
    
                O 
                                  O  
      HN                              
                                  
       O                      NH 
               NH 
 
 
168.11 5973, 3235 4.51 Derived from urea 
Cyclic AMP 
                   NH2 
             N                    N 
 
 
  
                    N 
        O  CH   O 
 
 
 
    O=P      O       OH 
 
329.22 5963, 3235 0.00036 Key intracellular 
regulator 
N
H 
N
H 
N
H 
N
H 
N
H 
N
H 
N 
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Amino acids (e.g. 
glycine) 
                          O 
                           || 
          H2N-CH2-C-OH 
 
75.07 6270, 3829, 3299 15 Non-essential amino 
acid.  Inhibitory 
neurotransmitter 
Mannitol 
              CH2OH 
               | 
        HOCH 
               | 
        HOCH 
               | 
           HCOH 
               | 
           HCOH 
               | 
              CH2OH 
 
182.17 7045, 3042 1.44 Anticaking agent.  
Poorly excreted by 
diseased kidneys, 
often used as a 
diagnostic aid 
Oxalate 
          O          O O 
           ||           ||   || 
   HO-C=CH2-C-C-OH  
 
132.07 6088, 5819, 3784, 
3308 
0.12 Part of urea cycle 
Glucuronamide 
                  O 
                   || 
                   C-NH2 
                   |       O   OH 
               |                 | 
             HO |        | 
                            OH 
193.16 6066, 2944 0.0054 Formed in liver to 
detoxify poisonous 
hydroxyls, especially 
chloral hydrate, 
morphine, camphor, 
or turpentine 
Glycols 
               O 
                || 
HO-CH2-C-OH 
 
76.05 5780, 3904, 3328 0.0065 Derived from 
reduction of oxalates 
during the urea cycle 
Xanthine 
    
                O 
                                   
      HN                              
                                  
       O                      NH 
               NH 
 
 
 
152.11 6371, 5877, 3192 0.006 derived from guanine 
Hypoxanthine 
                O 
                                    
      HN                              
                                  
                                N 
                N 
136.11 6328, 5990, 3285 0.0063 Formed from the 
breakdown of nucleic 
acids 
Putrescine 
NH2(CH2)4NH2 
88.15 6250 0.02 Precursor to 
spermidine 
Spermine 
H2N(CH2)3NH(CH2)3CH2NH 
                                          | 
                              (CH3)3N H2 
202.35 6234, 3418, 3041 0.008 Formed from 
spermidine 
N 
N
H 
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Spermidine 
NH2(CH2)4NH(CH2)3NH2 
145.2 6224, 3968, 3652 0.02 Formed from 
Putrescine. First 
found in sperm 
Dimethylamine 
H2CNCH3 
       H 
45.09 6085, 3386, 2924 0.14 Formed from 
methanol and 
ammonia 
Water 18.02 6117, 3087, 2902 98%  
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APPENDIX E: HUMAN SUBJECTS STUDY PROTOCOL 
Project # 683
Saint Vincent Hospital/Fallon Clinic/Fallon Community Health Plan
Chart Review Study
This particular form may be used for chart review studies only.
Please answer all questions. We can only accept completed forms.
Please attach the formal protocol (if available) and a copy of
your chart abstraction form. The attached finance form will need
to be completed only for funded projects.
1. PROJECT TITLE:
Evaluation of Performance in Human Dialysate Solutions of a New Urea Monitor  
2. PRINCIPAL INVESTIGATOR & INSTITUTION:
Robert A. Peura, PhD.  Worcester Polytechnic Institute 
Rebecca A. Kupcinskas, ME Worcester Polytechnic Institute 
3. FALLON OR SVH LIASON(S) AND DEPARTMENT (IF DIFFERENT):
Dr. Robert M. Black, Renal Medicine 
4. PURPOSE OF STUDY:
A new urea monitor has been developed for the purpose of monitoring urea levels in 
spent hemodialysis fluid.  This study is intended to provide clinical validation in terms of 
accuracy for the urea monitor. We intend to publish the results of this study in a peer-
reviewed journal.  
5. PLAN OF INVESTIGATION: (Include: length of study; how subjects
will be selected; approximate number of records that will be
reviewed.) PLEASE INCLUDE A COPY OF THE DATA ABSTRACTION FORM.
Spent (used) hemodialysate solution will be obtained from 15 patients in the St. Vincent 
Hospital Dialysis Unit.  The patients will be chosen randomly from the patient population 
on a single day.  Hepatitis B antigen patients will be excluded.  For each patient, a 20 ml 
sample will be obtained from the spent (waste) dialysate line at three times during the 
dialysis session, for a total of 45 samples.  Off site we will then analyze these samples 
for their urea concentration and determine the urea concentration by standard 
independent means.   
6. METHOD FOR COLLECTING DATA: How will the data be collected and
who will be extracting the information? (Will the information be
extracted from the medical record and/or through a computer
terminal?)
A clean 20 ml syringe will be used to sample the waste stream.  A clean 20 ml sample 
vial will be filled and identified by number with no patient identification.  The samples will 
be frozen for later analysis offsite.  All personnel who handle the samples will be 
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required to wear protective gloves, and all work areas will be wiped with bleach after 
testing. 
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7. SUBJECT CONFIDENTIALITY:
A. Will the data be recorded whereby human subjects can be identified (either directly or 
indirectly through identifiers linked to subjects)? 
No identification of the patient will be associated with the spent hemodialysis 
sample.  
B. Where will patient’s names be kept and who has access to these names? 
N/A 
C. Where will data be kept and who has access?
PLEASE NOTE THAT ALL RESEARCH RECORDS MUST BE KEPT IN A LOCKED 
DRAWER. 
8. FUNDING: How will this research be supported?
A) Source of funding________________________
Both internal and external funding sources should be listed. Please complete attached 
finance form. 
_____X_________ There is no funding.
B)  What Clinic/Hospital Resources will be required to conduct the study? (i.e. personnel, 
equipment, supplies) 
None. 
SIGNATURES:
 
_________________________    _________________________   __________________ 
Principal Fallon or SVH Signature
Investigator     Investigator      Division Director
                                                                     
--------------------------------------------------------------------------------------------------------------- 
Internal Use Only:
_________________ ____________ ___________________ _______
Finance Committee Date Expedited Approval Date
Approval
Revised 6/20/95
 F—1
APPENDIX F: ACOUSTO-OPTICAL TUNABLE FILTERS 
Brimrose Corporation defines an acousto-optical tunable filter (AOTF) as a solid-state 
electronically tunable spectral bandpass filter, which operates on the principle of acousto-
optical (AO) interaction in an anisotropic medium.  This principle states that whenever an 
acoustic wave enters the optical medium, it sets up a refractive index wave that behaves 
like a sinusoidal grating [75].  An incident light beam that is directed through this grating 
will be diffracted into several orders.  This principle can be utilized to create a spectral 
bandpass filter.   shows how these orders are separated in an acousto-optic medium.  For 
filtering applications, the first order beam contains the desired light wavelengths, and the 
zeroth order beam contains the rest of the light wavelengths in the incident beam. 
Figure F.1.1:Setup of typical AO diffraction system.  The incident beam is separated 
into first and zeroth order components upon the application of a radio frequency signal 
to the ultrasonic transducer attached to the AO medium.  Adapted from[75]. 
AOTF devices are generally single crystals made from Tellurium Dioxide, but may also 
be made of quartz.  They can be manufactured to work over a wide wavelength range and 
have a large tunable bandwidth.  For example, the device to be used in this research has a 
tunable range from 1100 to 1800 nm.  The AOTF is also referred to as the crystal in this 
document.  The major advantages of using an AOTF for spectral filtering are rapid 
tunability and narrow spectral bandwidth.  The switching frequency is limited only by the 
transit time of sound across the AO medium.  The spectral bandwidth of a typical AOTF 
is less than 5 nm at 1 µm.  The spectral bandwidth is directly proportional to the square of 
the center wavelength.  A third advantage of these devices is that they have a high 
diffraction efficiency, often on the order of 50%.  The diffraction efficiency is a 
dimensionless quantity that describes how much of the incident acoustic power is 
converted to light energy.  The diffraction efficiency η is proportional to the material 
figure of merit M2, the acoustic power Pac, and factors due to the geometry L/H.  It is also 
inversely proportional to the square of the wavelength.  (This proportionality is due to the 
fact that the argument of the sin2 function is small, and the fact the sin x ≈ x for small 
numbers).  This property can be seen in the following equation [75;76]: 
Incident Beam 
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Geometric considerations are important when designing a system containing an AOTF.  
The first and zeroth order beams generally diverge at angles of approximately 5°.  A 
beam cutter is generally inserted into the optical path at a distance from the output of the 
device in order to block the zeroth order beam.  The closer this cutter is placed to the 
device, the more accurate the placement must be, or stray light from the zeroth order 
beam will leak into the optical path.  There are two additional requirements for using an 
AOTF.  The first is that light entering the device must be polarized.  This ensures that the 
phase matching condition is necessary for proper operation of the device. (The phase 
matching condition involves the way that the sound and light waves interact in the crystal 
to implement a bandpass filter.)  A second polarizer is placed after the AOTF, at right 
angles to the first.  The second polarizer is used to help decrease the stray light in the 
optical path.  The last requirement is that the focused light that is incident on the device 
may enter at a maximum angle of five to seven degrees [75]. 
NOTICE 
This Appendix contains information that was left out of the original dissertation 
document at the request of the author and advisor.  This information is presented here for 
members of the WPI Community only and should not be distributed to the general public. 
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APPENDIX: HARDWARE
The circuit gain is actually produced in two stages, in order to reduce the chance of 
oscillation.  Ultra-high precision, ultra-low noise, and ultra-low distortion operational 
amplifiers were required for this application, due to the extremely small signal that is 
produced by the photodetectors.  An OPA-2111 (Burr-Brown) was chosen.  This dual 
FET (field effect transistor) op-amp meets the precision, noise, and distortion 
requirements of this application.  The dual packaging allows us to keep the detector 
circuitry small in size.   Figure A.1 is a circuit diagram of the detector board.  
  
 Figure A.1: The Input Light Detector and Sample Light Detector amplifier circuits.  
S_SIG is the amplified signal coming from the Sample Light Detector, and I_SIG is the 
amplified signal coming from the Input Light Detector. 
The first stage is a current to voltage converter.  The InGaAs detector supplies a current 
proportional to the number of photons that hit it.  For the SLD, the gain of this first stage 
is -1.0 ⋅ 106 V/A.  The second stage is an inverting amplifier with a gain of –100, for an 
overall gain of 1.0 ⋅ 108 V/A.  Both stages have a 220 pF filtering capacitor in the 
feedback loop to reduce electrical noise.  The cutoff frequency for this circuit is 720 Hz.  
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The output of the SLD amplifier circuit is known as S_SIG, and the output of the ILD 
amplifier circuit is known as I_SIG.  For the ILD, the first stage gain is –2.2 ⋅ 105 V/A, 
and the second stage gain is –100, for an overall gain of 2.2 ⋅ 107 V/A.  The cutoff 
frequency for the ILD is 21.9 kHz. 
 
A.1.1.1 Signal Demodulator 
 
Once the two light signals have been transduced into electrical signals (I_SIG and 
S_SIG), and amplified by the two-stage amplifier, it is necessary to separate each phase 
of the signals based on the active wavelength.  In Figure A.2, the circuitry required to 
perform this function is shown.  In the top part of the figure, the signals I_SIG and 
S_SIG are both passed through low pass filters (fc = 33 kHz), and given gains of 2.6 and 
1.5, respectively.  The two signals are then sent to an SMP-04 (PMI) Sample and Hold 
module.  This IC (Integrated Circuit) provides four separate sample and hold circuits, 
each with their own input signal.  Two of these inputs are connected to the Principal 
wavelength gating signal CLK_P, and the other two are connected to the Reference 
wavelength gating signal CLK_R.  These signals have an active-low duty cycle of 25%.  
CLK_P is active during the last half of the Principal wavelength portion of the cycle.  
CLR_R is active during the last half of the Reference wavelength portion of the cycle.  
The duty cycle for these waveforms is 25% rather than 50% to account for the transients 
that occur when the wavelengths are switched.  See Figure A.3.  The signal inputs are 
I_SIG and S_SIG, which have been amplified and filtered as stated above.  The outputs 
of the SMP-04 are four DC signals.  Signal S_SIG is separated into two signals: DCSP 
and DCSR.  DCSP corresponds to the value of S_SIG during the period of time when 
the Principal wavelength is active, while DCSR corresponds to the value of S_SIG 
during the period of time when the Reference wavelength is active.  I_SIG is similarly 
separated into DCIP and DCIR.  These four signals are low passed filtered (fc=36 Hz).  
This separation is illustrated in Figure A.3.  The lower portion of Figure A.2 is a gating 
circuit that is necessary to remove the large transients that are produced by the switching 
of wavelengths.  This portion of the circuit prepares S_SIG to enter the Lock In 
Amplifier (LIA), which performs the differential comparison between S_SIG amplitudes 
at the two wavelength phases.  The signal CLK_G has a frequency twice that of the 
wavelength switching frequency CLK_REF.  It is applied to an analog switch 
(MAX313, Maxim), and the first half of each cycle is gated out.  In addition to transient 
gating, the signal also passes through a high pass filter.  This is because the signal must 
be AC-coupled into the LIA.  The signals CLK_P and CLK_R have a 25% low duty 
cycle,  
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Figure A.2: The signals S_SIG and I_SIG are demodulated into two separate signals, 
one for each phase of the light signal.  S_SIG is also gated in order to suppress the 
large transient signals that result from the switching of wavelengths. 
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Figure A.3: S_SIG and I_SIG are demodulated into four separate DC signals by the 
signals CLK_P and CLK_R.  In (a), the input signals are shown.  In (b), the output 
signals are shown.  Figures (c) and (d) show the clocking signals CLK_P and CLK_R. 
 
A.1.1.2 Lock in Amplifier 
 
The lock in amplifier module is used to extract the signal from S_SIG.  The electrical 
diagram of this sub-module is shown in Figure A.5.  The input to this circuit is the 
transient-gated, high pass filtered signal that originated at the SLD.  The high pass filter 
is necessary so that the signal can be AC coupled into the lock in amplifier.  This is 
necessary to remove the DC component of the signal.  This signal is then low pass 
filtered (fc=53 kHz), and given a gain of approximately 7.  The signal then splits into two 
different paths.  In the top path, the signal remains unchanged.  In the bottom path, it is 
inverted.  It then passes to an analog switch, the MAX4526 (Maxim).  The switch is 
toggled by the CLK_REF signal.  During the “on” part of the CLK_REF cycle, the Y 
output of the MAX4526 is connected to the non-inverted signal that is on the A input.  
During the other part of the cycle, the Y output is connected to the inverted signal that is 
present on the B input.  The X output is connected to the other signal.  This has the effect 
of putting the positive portion of the signal always on the Y output and the negative 
portion of the signal on the X input.  This process is illustrated in Figure A.4.  Now that 
the signal has been separated into positive and negative portions, it is put into a current 
summing circuit.  The signals then enter a differential amplifier, a low pass filter (fc = 7.2 
Hz), and finally an op-amp buffer.  The overall gain in this portion of the circuit was 
S_SIG
I_SIG
DC_SP
DC_SR
DC_IP
DC_IR
CLK_P
CLK_R
                       (a) (d)
(b)
(c)
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found to be 74.8. The DC output of the lock-in amplifier is proportional to the amplitude 
of the LIA_in signal.  To achieve zero output for zero input, the DC offset of the LIA can 
be adjusted by applying a DC voltage (from the D/A converter) to the DCOFF input. 
 
Figure A.4: Operation of the Lock In Amplifier.  The gated and high pass filter version 
of S_SIG is split into two branches.  CLK_REF is the switch control input for the 
MAX4526 analog switch.  The positive part of S_SIG is selected for the Y output of the 
analog switch, and the negative part appears on the X output.   
 
Figure A.5: The Lock In Amplifier is a phase-sensitive detector and low pass filter that 
subtracts one phase of the transient-gated SLD signal from the other. 
S_SIG, after HPF and gating
MAX4526 input A ( S_SIG)
MAX4526 input B (inverted S_SIG) MAX4526 output X
MAX4526 output Y
CLK_REF
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A.1.1.3 PIC Intensity Controller 
 
The Proportional-Integral Intensity Controller is used to control the Reference Intensity 
(R_INT).  We wish to be able to set the difference between the signals DCIP and DCIR.  
Expressed differently, we want to control the difference in light intensity between the 
Principal and Reference wavelength phases before the light enters the sample.  This is so 
that we can equilibrate the light intensity at the exit of the sample during the balancing 
stage of the measurement.  The input to the PIC is the difference in intensity between the 
two phases as measured at the Input Light Detector.  This circuit is shown in  Figure A.6.  
This difference is obtained by putting the signals DCIP and DCIR into a differential 
amplifier (AMP-02, Analog Devices).  This differential amplifier has a gain of 
approximately 14.  (Gain = 1+50k/2.81k).  This signal, I_AC, is then put into a summing 
amplifier with OFFSET.  Both signals have a gain of approximately 6 through the 
summing amplifier.  The summing amplifier uses a section of an OP400 (Burr-Brown), 
which is a quad op-amp.  The circuit then branches into a proportional branch with a gain 
of 10, and an integrator branch. The two branches are then added into a version of a 
summing amplifier.  The summing amplifier has capacitors in the feedback to set a bias.  
This is necessary because we do not want a zero output on R_INT for a zero input on the 
PIC.  The capacitor in the output integrator charges to a value that is necessary to provide 
the proper Reference Intensity. The proportional, integral, and summing circuits use the 
other three op-amps in the OP-400 package.  At this point, the output of the PIC is equal 
to the Reference Intensity control signal R_INT.  The overall effect is that the system 
sets the signal R_INT so that DCIR is equal to DCIP minus 1/10th of the value of 
OFFSET.  It is now time to mix R_INT with the Principal Intensity control signal 
P_INT.  This is done with an analog multiplexer, the ADG433  (Analog Devices).  This 
IC has two normally open (NO) contacts, and two normally closed (NC) contacts.  The 
switches are all connected to the CLK_REF signal.  The NO switches are connected to 
P_INT, while the NC switches are connected to R_INT.  The outputs of the ADG433 are 
hooked together, and the result is a signal that consists of P_INT during the Principal 
wavelength phase and R_INT during the Reference wavelength phase.  This signal is 
then low pass filtered (fc=48 kHz), and put into a follower.  The follower uses an OP-27.  
The RC load attached to pins 10 and 7 of the ADG433 is needed to balance the load, 
thereby reducing reflective waves on the signal lines.  The voltage divider/diode circuit is 
needed to limit the output voltage to a range of 0 – 10 V. 
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 Figure A.6: The Proportional Integral Control Loop adjusts the Reference Intensity 
(R_INT) to be equal to the Principal Intensity (P_INT) minus the value of the 
OFFSET signal.  The analog switch then multiplexes P_INT and R_INT at the system 
clock frequency to produce the overall intensity control signal (INT_CTRL) that is sent 
to the RF generator. 
 
A.1.1.4 Data Acquisition Circuitry 
 
Software processing of the data is necessary to obtain the urea concentration 
measurements.  We must therefore convert the analog signals into digital signals so that 
they can be sent to the PC for processing.  Conversely, the PC must be able to control the 
hardware setup.  Since a PC is not capable of generating an analog voltage, digital to 
analog converters are required as well. 
 
In all, nine signals must be sent to the computer: 
•= The four DC intensity signals (DCSP, DCSR, DCIP, DCIR), 
•= The two temperature reading signals (TEMP1, TEMP2), 
•= The output of the PIC Intensity Control Loop (R_INT or LOOP), 
•= The position control signal from the Space Age Controls feedback device, 
POSITION, 
•= The Optical Bridge signal (LIA_OUT, also known as AC). 
For all signals except LIA_OUT, 1 mV of resolution is sufficient.  These signals will be 
used mainly as normalization and correction factors by the urea concentration algorithm.  
(See Chapter 9.)  For LIA_OUT, 16-bit accuracy is required.  Previous glucose studies 
done on NIV prototype instrument have indicated that 1 mV of signal translates to 
approximately 5 mg/dl of glucose.  This indicates that the sensitivity is approximately 0.2 
mV/mg/dl. Over a range of ± 10V, a 16-bit converter would yield a theoretical accuracy 
of 1.5 mg/dl.† (The resolution of a 16-bit converter over 20 V is .305 mV.) The sensitivity 
                                                 
† Due to system noise, this accuracy has not yet been achieved with an Optical Bridge system. The system 
is limited by the optical detector noise, not quantization noise.  Optical detector noise is mainly a function 
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to urea is expected to be similar to that of glucose. There are three signals that the PC 
must be able to control.  The first is P_INT, the Principal Intensity.  This is the intensity 
of the light beam during the Principal wavelength phase.  The second is OFFSET, the 
signal that sets the difference between P_INT and R_INT.  The final signal, DCOFF, is 
used to control the system bias.  (See § A.1.1.2.)  A resolution of approximately 5 mV 
was chosen for P_INT and OFFSET.  This requires a 12-bit converter.  While a finer 
accuracy is required for DCOFF, this is achieved with a resistive divider (≈ 50:1), rather 
than a separate converter.   
 
The overall data acquisition circuit therefore contains one 16 bit A/D converter, one 8 
channel, 12 bit A/D converter, and one 4 channel 12 bit D/A converter.  When selecting 
these devices, one factor became apparent quickly.  All data transfer must be 
accomplished through the PC’s parallel port.  This means that only 18 data lines are 
available to generate chip select signals, select channels, receive/transmit data, etc.  For 
this reason, we needed to use serial data converters.  These devices send out and receive 
their data in a stream of bits, rather than on a sequence of pins.   
 
The device that was chosen as the 16-bit A/D converter was the AD7813 (Burr-Brown).  
This device has a selectable input range.  As it is configured in Figure C.2.11, the input 
range is ±10V.  This yields a resolution of 0.305 mV.  In order to start a conversion, the 
input CS_AD16 is pulled low.  This input is used both as a chip select and a conversion 
start signal.  When the conversion is finished, the device pulls the BUSY pin low.  The 
PC is monitoring the status of this pin, and once it is activated, the PC sends out a 
clocking signal (SCLK) in order to read the data.  The AD7813 sends out one bit of the 
conversion for each low to high transition of SCLK.  The data appears on the 
AD_DATA line, which is then read back to the PC through the parallel port.  Figure A.7, 
below, shows a typical conversion timing sequence for the AD7813. 
Figure A.7: Conversion timing sequence for the AD7813.  (Figure taken from the 
AD7813 datasheet). 
 
                                                                                                                                                 
of detector area, temperature, and bandwidth.  Quantization noise depends only on the number of bits in the 
converter. 
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The MAX 186 (Maxim) was selected as the 8 channel 12 bit converter.  The operation of 
this device is slightly more complex that the AD7813, mainly because of the need to 
select the desired channel.  This converter is configured to have an input range of ± 
2.048V, for a resolution of 1 mV.  In order to start a conversion, the chip is activated by 
pulling CS_AD12 low, and an 8 bit serial word is then written to the pin DIN.  This serial 
word selects the conversion channel (0-7), the clock source (external or internal) and the 
conversion format (unipolar or bipolar, single ended or differential).  The actual format of 
the control word is discussed in Appendix B.  The conversion is finished when the 
converter pulses the SSTRB pin high for one clock cycle.  The PC is monitoring the 
AD_STATUS line.  Once this line pulses high, the MAX186 will begin outputting the 
data, one bit per pulse of the SCLK line.  The data has one leading zero and three trailing 
zeroes that frame the conversion result.  The data is read back to the PC using the 
AD_DATA line.  Figure A.8 shows the conversion timing for a MAX186 conversion 
sequence. 
Figure A.8: A typical conversion timing sequence for the MAX186.  (Figure taken 
from the MAX186 datasheet) 
The final data conversion device is the 4 channel DAC.  A DAC8420 (Analog Devices) 
was chosen for this purpose.  This device requires a ± 10V reference (the AD688, also 
from Analog Devices).  In order to update the DAC voltage, CS_DA is pulled low.  A 
serial word is then sent to the device.  This is a sixteen bit word.  The first two bits select 
the channel, the next two are don’t care bits, and the final twelve bits set the voltage.  The 
bits are clocked in on the SDATA line at each transition of SCLK.  Finally, the LD_DA 
signal is pulled low, which initiates the converter update.  The range of this converter is ± 
10V, yielding a resolution of ≈ 5 mV.  A typical conversion timing sequence for the 
DAC8420 is shown in Figure A.10.  The full data acquisition circuit is shown in  Figure 
A.9.  
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 Figure A.9: The data acquisition circuitry consists of one 16 bit A/D converter, one 8 
channel, 12 bit A/D converter, and one 4 channel, 12 bit D/A converter. 
Figure A.10: Conversion timing sequence for the DAC8420.  (Figure taken from the 
DAC8420 datasheet). 
 
A.1.1.5 Temperature Monitor 
Since the measurement is sensitive to temperature variations, it is necessary to monitor 
and control the system temperature.  Two 3kΩ thermistors are used, one in the spent 
dialysis fluid, and the other in the clean dialysis fluid.  Thermistors generally have a 
negative temperature coefficient, which means that as the temperature surrounding the 
thermistor increases, the resistance decreases.  The thermistors are supplied with a 
constant 100 µA current, which is obtained from a REF200 (Burr-Brown).  The REF200 
has two 100 µA constant current sources.  The voltage on the thermistor is put into an 
AMP-02 instrumentation amplifier (PMI).  The maximum voltage that will appear on the 
thermistor is 0.3V (100 µA ⋅3 kΩ).  The A/D converter can handle a maximum of 2.048 
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V, so a signal amplification of approximately 8 can be safely used.  The gain equation for 
the AMP-02 is G = 1 + 50k/Rg.  Rg was selected to be 7kΩ.  The output of the 
instrumentation amplifier is also low pass filtered (fc = 8 Hz).  
Figure A.11: The temperature monitoring circuitry consists of a constant current 
source, thermistor, and instrumentation amplifier. 
 
A.1.1.6 Connectors to the Analog Board 
 
The analog board has two connectors that receive and transmit signals to other electronics 
in the system.  There is a 25 pin DB-25 connector that connects to the digital board, and a 
14 pin lock type connector that receives signals from the two optical detectors and the 
thermistors.  There is also a 5 V/ground power connector.  Note: The ±15V power that is 
required for many of the analog circuits is generated by a special module on the analog 
board.  This module, the SP7015 (Analogic) accepts a 5V input, and produces the 
necessary 5V and ±15V power.  The signal connections to the digital board are given in 
Table A.1.  The signal connections to the optical detector are given in  
Table A.2.  The name, connector pin, and function of each signal are given in the tables. 
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Table A.1: 25 Pin Digital Board Connector Signal List 
 
Signal Name Pin Function 
CLK_P 1 Clock signal for identifying the Principal Phase 
CLK_R 2 Clock signal for identifying the Reference Phase 
NC 3 No Connect 
CLK_REF 4 4 kHz System Clock 
NC 5 No Connect 
NC 6 No Connect 
AD_DATA 7 Transmits bit stream from the A/D converters 
CS_AD12 8 Chip Select signal for the MAX186 
CLK_G 9 Transient gating clock signal 
SDATA 10 Serial Data 
SCLK 11 Serial Clock  
INT_CTRL 12 Light Intensity Control Signal  
Vs+ 13 +15 V supply voltage 
NC 14 No Connect 
NC 15 No Connect 
LD_DA 16 Causes D/A converter to update its value 
NC 17 No Connect 
NC 18 No Connect 
NC 19 No Connect 
AD_STATUS 20 Indicates whether an A/D conversion has completed 
CS_DA 21 Chip Select signal for the DAC8420 
CS_AD16 22 Chip Select signal for the ADS7813 
NC 23 No Connect 
AGND 24 Analog Ground Signal 
Vs- 25 -15 V supply voltage 
 
Table A.2: 14 Pin Signal Connector Pin List 
Signal Name Pin Function 
NC 1 No Connect 
POSITION 2 Space Age Controls Position Feedback 
NC 3 No Connect 
NC 4 No Connect 
TEMP_RET 5 Thermistor ground return signal 
TEMP1 6 Thermistor 1 signal 
GND 7 Ground 
TEMP2 8 Thermistor 2 signal 
I_SIG_RET 9 Input Light Detector ground return signal 
I_SIG 10 Input Light Detector signal 
S_SIG_RET 11 Sample Light Detector ground return signal 
S_SIG 12 Sample Light Detector signal 
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Vs- 13 -15V power signal 
Vs+ 14 +15V power signal 
A.1.2 Digital Board 
The Digital Board is responsible for optically isolating the instrument from the PC, 
generating communication between the instrument and the PC, and generating control 
signals for the analog board.  It is a two layer Printed Circuit Board.  The dimensions of 
the board are approximately 4” by 6”.  This section describes the sub-modules that make 
up the digital board. 
 
A.1.2.1 Optical Isolation and Parallel Port Interface Unit 
The hardware of any medical device that includes connections to a PC must be optically 
isolated from the PC.  This is for two reasons: First, it is necessary to protect the patient 
from any current spikes and/or leakage currents that may cause a shock hazard.  Second, 
noise from the PC would infect the rest of the electronics.  For this reason, all lines that 
connect the PC to the hardware have been optically isolated using the HCPL2231 
(Hewlett-Packard).  This is a dual digital optical isolator.  The optical isolation unit 
consists of a low pass filter (τ = 1µs or fc = 318 kHz), buffer (usually a 4010 or an 
‘ALS16), and the optical isolator.  The common 5V supply (its ground is connected to the 
chassis ground) is generated by another Burr-Brown IC, the DCP0105.   
 
The parallel port (LPT) connection is used to transmit all data between the PC and the 
rest of the instrument.  The connector pinout is given below in Table A.3.  A second 
method of interface is also available.  This connection is to a microcontroller, but this 
option is not used at this time. 
 
Table A.3: Parallel Port Connector Pin List 
Pin Signal Name Function 
1 NC No Connect 
2 STRB Chip Select Update Signal 
3 LD_DA D/A converter update signal 
4 SCLK Serial Clock 
5 SDATA Serial Data 
6 NC No Connect 
7 PUMP_A Pump Control Signal A 
8 PUMP_B Pump Control Signal B  
9 MOT_EN Motor Enable 
10 NC No Connect 
11 LIMIT Motor Limit Switch 
12 AD_DATA Data Signal from the A/D converters 
13 AD_STATUS Conversion finished signal 
14 NC No Connect 
15 NC No Connect 
16 PP_EN Enables the parallel port interface 
17 UC_COM Enables control by a microcontroller 
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18 NC No Connect 
19 GND Signal Ground 
20 GND Signal Ground 
21 GND Signal Ground 
22 GND Signal Ground 
23 GND Signal Ground 
24 GND Signal Ground 
25 GND Signal Ground 
 
 
A.1.2.2 Device Select Circuitry 
In order to generate the chip select signals that are needed by various devices on the 
analog board, a decoding system is needed.  Since we do not have extra pins in the 
parallel port interface, we send a serial code word, which is then converted to a chip 
select signal.  Figure A.12 shows the decoder circuit.  The data is input to a serial to 
parallel converter chip on the SDATA line, and is clocked into the chip using the SCLK 
line.  When the correct number of bits has been sent, the STRB signal is activated to 
latch the output onto the LS673.  A second level decoder is used to select the proper chip 
select signal.  The signals LD_DA, SCLK, and SDATA are also sent to the analog board 
for device selection.  While the circuit in Figure A.12 may appear to be overkill, some 
unused signals have been omitted for clarity.  The extra lines also allow room for 
expanded functions of the device.   
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Figure A.12: This decoder is used to generate chip select signals for the data 
acquisition circuitry.  The signals SCLK, SDATA, and LD_DA are also used to control 
the data acquisition circuit. 
A.1.2.3 Clock Generator 
The clocking signals CLK_REF, CLK_P, CLR_R, and CLK_G have been previously 
discussed.  The circuit in Figure A.13 shows how these signals are generated.  This 
circuit was originally designed to operate around 1 kHz.  However, during hardware 
testing, it was discovered that the system suffered from significant 60 Hz noise 
contamination.  It was therefore decided to synchronize the system clock to the 60 Hz 
line voltage signal.  The circuit in Figure A.13 converts the 120V, 60 Hz line voltage into 
a 5 V square wave.  The signals CLK_REF, CLK_G, CLK_L and CLK_H  are then 
generated by the circuit.  A phase locked loop (CD4046) in conjunction with a ripple 
counter (CD4040) is used to generate 120 Hz and 240 Hz signals from the original 60 Hz. 
(In order to generate a 25% duty cycle signal such as CLK_L, a 240 Hz signal is 
required.   
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Figure A.13: The clock generator circuit generates a  60 Hz square wave (CLK_REF), 
in addition to the demultiplexing signals CLK_P and CLK_R.  It also generates the 
transient gating signal CLK_G. 
A.1.3 Motor and Pump Controller 
In order to make changes to the optical pathlength, a position control system is required.  
The movement of fluid in the system also requires a special fluid transfer system.  This 
dissertation includes a description of the physical and mechanical design of this system, 
including the position and fluid control systems.  The position control system uses a 
unipolar, 200 steps/revolution stepping motor.  A separate controller board provides the 
interface to this motor.  The controller board, which is approximately 1.25” square, 
contains one IC and three signal connectors.  A separate device provides position 
feedback to the computer.  This device will be described later in this section 
 
The first connector is for the motor windings.  A unipolar stepper motor has four 
windings.  The windings are connected in pairs, and a center tap wire is also present.  By 
energizing these windings in the proper sequence, the motor shaft will turn.  In order to 
simplify the motor drive, a specialized IC, the UCN5804 (Allegro Microsystems) was 
used.  The ‘5804 is a stepper motor translator/driver.  It has two mode select lines, an 
output enable pin, a direction control input, and a step input.  When the output is enabled, 
a pulse on the step input line causes the chip to send out a sequence of pulses on the four 
outputs that energize the windings in the proper order.  See Figure A.15 for a timing 
diagram.  The second connector on the motor control board has five pins.  The first is 
MOT_CLK, which is the step input signal.  It is generated by the digital board by 
combining two other signals: SCLK and MOT_EN.  The second motor control signal is 
DIR, which selects the direction that the shaft will turn.  This signal is generated by 
combining the MOT_EN signal and the SDATA signal.  The third and fifth pins are 
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ground and power connections, and the fourth pin is a LIMIT signal, which indicates 
when the motor has reached its movement limit.  The final connector is a power 
connector for the motor (+12 VDC).  Figure A.16 shows the schematic diagram of the 
motor control circuit.   
 
In order to obtain precise position information, a feedback device was required.  The 
Space Age Controls position transducer model # 150 was selected for this purpose.  This 
device consists of a linear potentiometer (full scale value: 5 kΩ) that is connected to a 
cable that is wound on a rotating drum.  As the fixed end of the cable is unwound from 
the drum, the resistance of the potentiometer changes.  This is illustrated in Figure A.14.  
The potentiometer is connected to a simple voltage divider circuit, and amplified to cover 
a –2V to +2V range.  It is then sent directly to the MAX186 analog to digital converter. 
 
Figure A.14: Schematic diagram of the Space Age Controls (R) model 150 rotating 
drum potentiometer. 
Figure A.15: Timing diagram showing the sequence of energizing windings carried out 
by the UCN5804.  (Taken from the UCN5804 datasheet). 
 A-18
Figure A.16: Circuit Diagram for the Stepper Motor Driver. 
The fluid control circuit also uses a stepper motor, but this is a bipolar motor.   A bipolar 
stepper motor requires a drive voltage that switches between positive and negative values 
on successive steps.  A different type of driver is required to move the pump motor in this 
case. In order to advance the pump motor one click, a sequence of four signal transitions 
is required.  The full step wave drive mode is used, which provides maximum torque as 
both motor windings are energized at all times.  The step transition sequence is: AB, 
AB*, A*B* AB*, where A and B represent logic high on PUMPA and PUMPB 
respectively, and A* and B* represent logic low.  PUMPA and PUMPB are generated by 
an Altera™ chip located on the pump controller board.  See Appendix C for the VHDL 
code and device pinout.  The Altera™ chip also controls the operation of four pinch type 
solenoid valves which control the filling and emptying of the measurement cuvette.  
PUMPA and PUMPB are then fed to a circuit designed around National Semiconductors 
LMD18245 H-Bridge Motor Driver.  Two of these interface chips are required to drive 
the circuit, one for each winding of the motor.  The circuit is shown in Figure A.17. 
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Figure A.17: The pump controller driver circuit, taken from the LMD18245 data sheet. 
A.1.4 RF Signal Generator 
In order to control the intensity and wavelength of the light that reaches the sample, the 
AOTF requires a Radio Frequency (RF) signal.  This signal needs to be fairly high 
powered (~ 3W), and have a frequency in the range of 50-150 MHz.  A commercial RF 
driver from NEOS Technologies was used for this purpose.  This device accepts a 0-1 V 
analog input for the intensity control, and a 32 bit digital word for the frequency control.  
The intensity control input is the INT_CTRL signal that has been previously discussed.  
It is also digitally isolated using an ISO122 analog optical isolator and buffered with an 
LT1010 (Linear Technologies) buffer amplifier.  The frequency control is done through a 
separate card that resides inside the PC on the ISA bus with a base address of 0x400.  It 
has an external input that is connected to CLK_REF that indicates which wavelength 
(Principal or Reference) is being activated.  It sends a 32-bit frequency control word for 
each part of the CLK_REF cycle.  It also receives updates from the PC to the frequency 
word.  This frequency word has been mapped in the software to the desired wavelength.  
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The NEOS driver is capable of generating frequencies from 20-200 MHz.  The NEOS 
driver receives the 32-bit word, converts it to a frequency, and gives the output signal the 
desired amplitude.  The NEOS driver is only capable of producing 1.5W however, so an 
external RF power amplifier is required.  The ZHL-03-5WF RF power amplifier from 
MiniCircuits, Inc., (Brooklyn, NY) is used to boost the signal output to the required 3W. 
This signal is then sent to the AOTF. 
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ABSTRACT 
 
 
The addition of urea clearance monitoring to the care regimen of renal failure 
patients provides a dramatic decrease in complications due to improper or inadequate 
dialysis.  Present methods of monitoring urea clearance are computationally complex and 
expensive to perform, resulting in poor rates of clinical acceptance of this measurement. 
 Dialysate-side urea levels have been shown to relate to traditional measures of 
dialysis adequacy without the need for complex calculations.  The requirements for 
photometric reagents or electrodes make determination of the urea level expensive and 
time consuming.  This research is focused on the development of an optical measurement 
system to determine the sample urea level without the need for reagents.  An algorithm 
was developed to predict the urea concentration of the sample from a set of optical 
transmission parameters recorded from the sample using a specially developed 
instrument.  This instrument records the difference in sample transmission at two 
different wavelengths.  Energy at the first wavelength is absorbed by urea, and the second 
wavelength is selected such that the matrix of the sample absorbs energy at both 
wavelengths equally.  This effectively nulls out the absorbance of the background matrix, 
significantly improving the urea detection sensitivity. 
 The algorithm was developed from an analysis of the instrument data and factors 
causing variations in the data.  Calibration, bench study, and clinical protocols were 
designed, and performed using these protocols.  Using a partial least squares approach, 
the algorithm was fit to a set of training data.  The resulting algorithm was used to predict 
the urea content of patient hemodialysis samples.  Compared to a reference standard 
(Beckman CX7, standard error <1 mg/dl), the standard error of prediction for this 
algorithm was 0.47 mg/dl (N = 34 patients). 
 The algorithm was able to predict dialysate urea at clinically relevant levels in 
samples collected from hemodialysis patients.  Qualitative relationships were developed 
between the sample urea level and the data recorded from the sample.  This system has 
the potential to provide a method that clinicians can use to efficiently and effectively 
monitor urea removal over the course of a dialysis session. 
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1 INTRODUCTION – PROBLEM IDENTIFICATION 
 
Kidney dialysis is a lifesaving procedure that is used to sustain the health of patients who 
have experienced renal failure.  Patients require dialysis for a variety of reasons.  The 
most common reason is chronic kidney failure due to scarring or necrosis of kidney tissue 
as a complication of diabetes.  A second cause of chronic kidney failure is uncontrolled 
high blood pressure.  Other reasons for requiring dialysis treatment include acute 
cessation of kidney function caused by poisoning or drug overdose.  Certain diseases, 
including urinary tract infection, polycystic kidney disease,  and acute 
glomerulonephritism may temporarily shut down kidney function sufficiently to require 
dialysis.  In the year 2000, there are approximately 250,000 patients undergoing dialysis 
treatment in the United States [1]. 
 
While dialysis is a simple process, many of its effects on the body are not fully 
understood.  This lack of knowledge translates to questions about whether or not the 
therapy patients receive is being delivered in an optimal fashion.  Articles appear in the 
literature relating to methods of quantifying and optimizing dialysis efficiency [2-48].  
These methods generally propose mathematical models relating the results of blood tests 
and parameters of the dialysis machine to the expected outcome, namely a measure of the 
patient’s total toxin clearance at the end of the session.  These methods are not widely 
used, ostensibly because of their computational complexity.   
 
Most practicing physicians choose to ignore these models, relying instead on empirical 
calculations of therapy requirements and subjective evaluations of the patient’s progress.  
Since many of the effects of dialysis on the body are subtle, and insufficiently understood 
at the present time, quantifying the effectiveness of dialysis is a significant problem for 
the clinical practitioner. A few instruments have been developed to calculate certain 
dialysis parameters, but they generally require regular maintenance and significant 
additional work from the caregivers [2-11].  In recent years, the technology used in 
dialysis machines has changed, reducing the amount of time that patients must spend in 
dialysis.  At the same time, the mortality rate of these patients has increased significantly 
[12-16, 49].   
 
The mortality data seems to suggest that newer dialysis methods are failing to adequately 
cleanse the patient’s blood of toxins.  To complicate the problem, the effects of 
inadequate dialysis are not immediately apparent.  It may take weeks, months, or even 
years for the effects of sub-optimal therapy to appear.  For this reason, it seems 
imperative that the patient’s progress be monitored during every dialysis session, and   
that an automatic method that can more accurately describe the effects of the dialysis 
process on the patient is needed to ensure that these patients receive the best possible 
care.  This method must be easy to use, and provide information that a physician would 
consider useful if it is to gain clinical acceptance. 
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1.1 Chronic Kidney Failure 
1.1.1 Complications of Diabetes 
Diabetic patients make up the largest fraction of all End Stage Renal Disease (ESRD) 
cases.  ESRD is a disease state in which the kidney function has fallen to below 25% of 
normal.  Approximately 55% of juvenile onset diabetes patients (30% of adult onset 
patients) will develop ESRD, beginning 16 years after the onset of diabetes on average.  
Diabetic nephropathy results from the thickening of the basement membrane of the 
glomerular capillaries and an increase in cellularity and deposition of hyaline material in 
the mesangium.  This is most likely the body’s response to an increase in hydrostatic 
pressure caused by high concentrations of glucose.  Approximately 36% of ESRD cases 
requiring dialysis result from complications of diabetes [1].   
1.1.2 Complications of High Blood Pressure 
Untreated high blood pressure is another leading cause of kidney failure.  When pressure 
is chronically high, the delicate capillary networks that make up the filtration network of 
the kidney become stressed.  Consequently, the capillaries become increasingly 
thickened, which reduces the filtering ability of the kidneys.  Approximately 29% of 
ESRD cases requiring dialysis are caused by untreated high blood pressure [1]. 
1.1.3 Polycystic Kidney Disease (PKD)   
This genetic disorder results in the formation of many small cysts in the kidney.  As these 
cysts enlarge and proliferate, the renal cortex begins to atrophy.  The vasculature of the 
kidneys is destroyed, resulting in a decrease in filtration and an increase in toxin levels in 
the blood.  PKD causes approximately 2.9% of all ESRD cases that result in the need for 
dialysis [1]. 
1.2 Acute Kidney Failure 
1.2.1 Poisoning or Overdose  
Certain narcotic and prescription drugs can temporarily overwhelm or damage the kidney 
when taken in large quantities.  Excess alcohol can also have a poisoning effect on the 
kidneys, if the cells in the nephrons absorb too much alcohol and are unable to filter 
properly.  While in most cases, the kidneys will begin to recover once the patient’s body 
has been cleared of the offending substance, they generally cannot function properly 
while the patient is intoxicated.  Dialysis is required to replace the lost function of the 
kidneys, and can aid in removal of the toxic material. 
1.2.2 Urinary Tract Infection  
 Infections that begin in the urinary tract can often progress into the kidneys, leading to 
cell swelling and loss of the kidney’s filtering ability.  In rare cases, this may progress to 
acute glomerulonephritism. 
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1.2.3 Acute Glomerulonephritism  
 This disease is often caused by a streptococcal infection.  The infection causes a rapid 
swelling of the kidney and a corresponding loss of function.  The tissues of the kidney 
become choked with leukocytes, and are unable to perform their filtering function.  
Dialysis is required to compensate for the kidney function while the infection is treated.  
Once the infection is clear, the kidneys are generally able to resume normal function.  
Approximately 11% of the patients who require dialysis have experienced 
glomerulonephritis [1].   
1.3 Monitoring of Dialysis Efficiency 
There are many factors that can be monitored during dialysis with the goal of quantifying 
dialysis effectiveness and efficiency.  These factors include, but are not limited to: toxin 
removal rate, protein catabolic rate, estimation of residual kidney function, and kinetics 
of fluid compartment shifts.  All of this information can be useful to the physician when 
deciding how well the prescribed treatment is helping the dialysis patient. 
 
In monitoring dialysis, it is necessary to solve one problem – how to quantify dialysis 
efficiency in a non-invasive, automatic, accurate, and continuous manner.  While many 
techniques exist to quantify some of these requirements, none exists which satisfies them 
all.  A general solution to this problem has not yet been developed.  
 
Development of a technique for monitoring dialysis efficiency would be a tremendous 
value to both clinical practitioners and dialysis patients.  The complications from 
inadequate dialysis could be reduced or prevented altogether.  In addition, such a 
technique could reduce the incidence of over-dialysis, which can be detrimental to the 
patient both mentally and physically.  In the case of chronic renal insufficiency, keeping 
toxin levels low could reduce further system failure.  In acute cases, monitoring could 
speed recovery time by ensuring that toxins are removed as quickly and completely as 
possible. 
1.4 Summary 
The lack of a method for assessing dialysis efficiency that is simple to use, non-invasive, 
continuous, accurate, and efficient, presents an important clinical problem.  The problem 
is original, and its solution requires application of the principles of scientific analysis and 
synthesis to develop new measurement systems.  However, major improvements can and 
must be made evident compared to other techniques in order for the new technique to 
find clinical acceptance.   
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2 THE SPECIFIC AIMS OF THE RESEARCH 
2.1 Project Statement 
The long-term goal of this research is to develop a clinical instrument that can be used to 
quantify the efficiency and effectiveness of a dialysis session in a non-invasive, 
automatic, and accurate manner for any patient undergoing dialysis.  To address this goal, 
we will develop a prototype instrumentation system that is able to measure the amount of 
urea that is being removed by dialysis from a patient with ESRD. Based on the use of this 
instrument, an algorithm will be developed that can produce an estimate of the urea 
content of an aqueous sample based on data obtained from this system.  
 
We do not intend to directly interface this system to a dialysis machine during this phase 
of research.  Rather, the development of this demonstration system represents a major 
advance in the field of renal failure therapy by providing a ‘closed loop’ approach to 
determining adequacy of therapy and eliminating the guesswork involved in current 
methods.  The automatic, low maintenance nature of this system provides a high potential 
for clinical acceptance of the technology and the possibility of saving lives by reducing 
complications from poor dialysis. 
 
In order to achieve the goals stated above, the specific aims that must be completed are 
to; 
  
1) Develop and build an instrument that is based on the principles of an Optical Bridge – 
an instrument that measures the difference in energy absorbance between two 
wavelengths of light.  The wavelengths of light are selected such that urea 
preferentially absorbs energy at the first, but not at the other.   
a) Design and build a completely automatic system that can deliver light at 
appropriate wavelengths and measure the light transmittance through a fluid 
sample, transferring the results to an IBM compatible personal computer.  The 
system should satisfy normal safety requirements for a medical instrument. 
b) Develop software for controlling the delivered light intensity and wavelength, 
controlling the operation of the prototype hardware, and collecting, storing, 
analyzing, and displaying the urea level measurements. 
 
2) Perform preliminary studies with this new system using samples of fluid spiked with 
urea and water.  Urea studies will also be done on an existing prototype instrument 
originally developed for non-invasive glucose monitoring, and compared to the 
results obtained with the new system. 
 
3)  Using the data obtained in Specific Aim 2, develop an algorithm for correlating the 
measurements with the urea concentration; 
a) Develop a mathematical model relating the instrument output to urea 
concentration. 
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b) Develop a mathematical model based on experimental data that describes how the 
instrument reading can be affected by variations in the environment (including 
temperature) and other major interferences. 
c) Determine which of these variations may prove significant, and propose and 
develop methods to compensate for them. 
d) Develop an algorithm for urea level monitoring. 
 
4) Perform preliminary clinical studies with the system using the algorithm developed in 
Specific Aim 3.   
a) Perform a pilot study using samples of spent dialysate from human subjects.   
b) Compare the predicted urea concentration of these samples to a clinically standard 
reference method.   
c) Compare the predicted vs. measured sample urea content statistically.  We 
propose that the difference in mean should be zero to a significance level of 0.01.  
Additionally, find a 95% confidence interval for the true difference in sample 
mean.  Find a 95% confidence interval for the variance ratio between the two 
measurements.  
2.2 General System Requirements 
There is no general agreement as to what the exact requirements and specifications of a 
dialysis monitoring system should be. In order to ensure that this instrument provides 
useful and accurate estimates of dialysis accuracy, performance specifications must be 
developed, and it must be shown that the instrument meets these specifications.  First, we 
need to know the expected ranges of the dialysate urea concentration, and to have an idea 
of how accurately we need to be able to determine its value.  We then need to know how 
often we need to measure this parameter in order to obtain a true representation of its 
time dependence.  We must also know how long the instrument must be stable for: In 
other words, for how long must a calibration be valid?  Finally, it is necessary to know 
how the instrument responds in the presence of other interfering inputs, or how specific 
its response is to the dialysate urea level in the presence of other analytes. We will now 
discuss the requirements that this instrument must meet:  
 
•= Range – Dialysate urea levels generally fall between 6 and 180 mg/dl [6].     
•= Accuracy/Precision – Standard clinical analysis tools provide an accuracy of ±1-2 
mg/dl for urea measurements.  Clinical practitioners indicate that an accuracy of 
10 mg/dl or better is acceptable [50].       
•= Frequency of measurement – The main advantage of an automated technique is 
that it provides information on the patient’s urea level as a function of time, rather 
than an indirect interpolation from start to finish Blood Urea Nitrogen (BUN) 
levels.  Most researchers agree that urea follows a double exponential removal 
profile in the body that is mirrored in the dialysate.  The measurement sampling 
frequency must be high enough to capture this profile.  The stream must be 
sampled at a rate fast enough to capture the time constant for each pool.  The 
results can then be plotted logarithmically and the time constant obtained from 
this graph.  In general, results should be taken for this measurement every fifteen 
to thirty minutes [6]. A second parameter that may be useful to the clinician is the 
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total amount of urea removed during the session.  This can be calculated by 
measuring the area under the curve of urea concentration versus time.  This 
measurement can be done every ten minutes or so.     
•= Stability – The measurement should be accurate without need for recalibration 
over a weekly cycle.  Most patients are dialyzed three times per week, and it is 
necessary to compare the results between sessions.   
•= Specificity – There are a myriad of other substances in the dialysate that can 
potentially interfere with the urea measurement.   
 
Finally, from an economic viewpoint, our approach has the potential to solve many of the 
problems with the existing technology in that the cost per test would be far lower due the 
lack of need for reagents and electrodes.  The final cost of the system is projected to be 
around $3000-$5000, compared to $1000 for existing technology (such as Baxter 
Healthcare’s Biostat 1000).  (Future research involving the use of tunable diode lasers as 
light sources could bring the cost of this device into the $300-$500 range).  The extra cost 
of the instrument could be easily offset by considering the cost of disposables items that 
are required by existing devices.  Assuming that one machine can support 10 patients, 
who are each dialyzed three times per week, 52 weeks per year, at $3.50 per test, three 
tests per session, the disposable cost for existing technology per machine per year is 
approximately $16,380.  This figure only includes electrodes and reagents, no extra 
supplies such as tubing, syringes, or extra laboratory tests.     
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3 HYPOTHESES AND RESEARCH METHODS 
The primary goal of this research is to develop a method to optically measure the 
concentration of urea in effluent dialysate without the need for reagents.  To date, no one 
has reported success in using optical techniques to measure urea in aqueous solutions. 
3.1 Hypotheses 
 
The central hypotheses of this research are:  
 
1) A method based on differences in transmission of near infrared light energy can be 
employed in the development of an instrument that could provide information related to 
biologically relevant levels of urea in a strongly absorbing background matrix composed 
primarily of water.  This urea information can be extracted amidst interferences such as 
temperature variations and the presence of other analytes (proteins and amino acids, 
sugars, electrolytes, metabolic wastes, etc.).   
 
2) It is possible to develop an algorithm using the information obtained from the 
instrument to quantitatively and qualitatively estimate the amount of urea in an effluent 
stream of dialysate, and from this to evaluate the effectiveness of the dialysis session. 
 
3) A list of major factors affecting the system response can be developed.  While it is 
possible to obtain a first-guess list of factors from the non-invasive glucose measurement 
research, it is unlikely that the same set of factors will fit the urea measurement.  We 
propose to determine how changes in temperature and dialysate composition affect the 
measurements, develop a list of parameters to represent these effects, and then perform a 
statistical analysis to determine the significance of each parameter to the overall 
measurements.   
 
4) A mathematical model and corresponding algorithm can be developed which 
approximates the expected response of the system to changing urea concentration in the 
presence of interferences (such as other metabolic analytes) and modifying factors (such 
as temperature changes).  This model will be based on a mathematical analysis of 
experimental data. A linear model based on a Multiple Linear Regression (MLR) or 
Partial Least Squares (PLS) approach can be used to correlate the output of the system 
with the expected urea concentration in dialysate.  This will involve the development of 
an algorithm to relate system data to urea concentration.   
3.2 Research Methods 
A method based on differences in transmission of near-IR light energy was chosen to 
solve the main research problem (see Chapter 1) for the following reasons: 
 
•= Optical measurements are well suited for this type of measurement.  Other 
possibilities in terms of measuring substances levels in a fluid stream such as 
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ultrasound and electromagnetic flowmeters are unable to distinguish between 
analytes, which prevents their use for this application.  Optical measurements can be 
made specific to urea by selecting appropriate analysis wavelengths.  
•= This is a non-invasive measurement method and is therefore not harmful to the 
patient.  The measurement can be done on the spent (effluent) dialysis stream, which 
is normally sent to a waste drain, and therefore does not interfere with the normal 
operation of the dialysis machine or other clinical devices.  The measurement is also 
automatic and easy to set up.  In addition, spent dialysate is not considered a 
biohazard, so no special handling protocols are required. 
•= Our preliminary results show that such wavelengths exist at which it is possible to 
measure urea with this “Optical Bridge” method [51].  Harjunmaa [52-56] has 
proposed that this method can be used in vivo for accurately measuring glucose levels 
in diabetic patients. Preliminary testing results with that application have been 
promising.  Urea levels and glucose levels are of the same order of magnitude.   
•= No one has reported results on using this method for measuring urea levels.  The 
application of this method for monitoring urea levels, and consequently dialysis 
efficiency is a novel approach, and will improve upon existing knowledge in the field 
of dialysis patient monitoring. 
 
In order to develop a system that is capable of monitoring urea, it is first necessary to 
establish a relationship between the signal and the dialysate urea concentration.  The 
overall relationship is expected to be a linear function, since equations relating the 
Optical Bridge signal to concentration have been developed previously and hypothesized 
to show a linear relationship [52].  In order to improve the algorithm, it may be necessary 
to include other factors and correction parameters into the overall system equation.  
These parameters are also expected to relate to the original model in a linear fashion.  It 
will be necessary to determine how each of the factors found in testing the third main 
hypothesis correlate to the overall signal in order to determine how an appropriate 
correction can be made. 
 
Our goal is to develop an instrument that is capable of monitoring the dialysate-side urea 
concentration without the need for electrodes or reagents. This has not been achieved by 
others.  (See §4.4 for a discussion of existing technology for dialysate urea monitoring.)  
A specially developed algorithm should relate optical transmission parameters to the urea 
content of the sample.  The proposed instrument directs a beam of light through a sample 
consisting of both spent and clean dialysate.  The light beam alternates between two 
wavelengths.  The first wavelength is one at which urea preferentially absorbs energy.  
The second wavelength is selected at measurement time so that the transmission through 
the clean dialysate is the same as at the first wavelength.  The urea level of the sample is 
then proportional to the difference in sample transmission between the two wavelengths.  
Because the measurement is in a differential rather than an absolute mode, a large gain 
can be applied to the signal, which overcomes dynamic range limitations of conventional 
optical measurements.   
 
At first glance, this system may seem unnecessarily complicated.  It would be simpler to 
measure the difference in transmission between the clean and spent dialysate at some 
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wavelength that is sensitive to urea, and then amplify this resulting signal.  An instrument 
based on this method is shown in Figure 3.2.1.  This instrument requires two optical 
detectors, one for the clean dialysate and one for the spent dialysate. The outputs of the 
two detectors are then fed into a differential amplifier.    
Figure 3.2.1: Schematic diagram of a differential spectrophotometer.   
  
In contrast, our design is shown in Figure 3.2.2.  Here, the two samples are juxtaposed 
and only one detector is required.  The light beam entering the samples consists of light 
energy two different wavelengths alternating at approximately 1 kHz. The signal coming 
from the detector is then AC coupled into a phase sensitive detector, and is then 
amplified.  The AC coupling is necessary to eliminate DC drift that occurs in the detector 
and associated electronics with temperature changes and over time.   
Figure 3.2.2: Schematic diagram of an optical bridge instrument 
 
The main problem with the first instrument is the existence of two light and signal paths.  
To date, no one has reported success using this method.  No matter how closely matched 
the detectors are, if they are at different temperatures, they will experience drift at 
different rates.  Since the detectors are physically separated, it is not possible to keep 
them at exactly the same temperature. There is no mechanism with this circuit to cancel 
this drift.  Our approach is to adopt the “Optical Bridge” configuration to address these 
issues.  In the single detector approach, temperature related drift may still occur, but it is 
largely eliminated by the AC coupling which is made possible by the fact that the signal 
is biphasic.  Early research with the dual beam spectrophotometer approach using 
available technology was only accurate to 20 g/dl, which is not clinically acceptable.  
While it is possible that further research on this path would have yielded acceptable 
results, we did not perform further testing with this method.    
 
This “Optical Bridge” method was invented by Harjunmaa [52] as a method for 
monitoring blood glucose in diabetic patients.  While it has always been assumed that it is 
possible to measure other analytes with this method, no research has been done in this 
area to date.  Traditional optical measurements of biologic analytes involve the use of 
reagents to convert the analyte in the sample to a visibly colored reaction product that can 
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be measured photometrically.  Alternatively, enzymes may be used to cleave the analyte 
and create ions, which can than be measured potentiometrically.  Two main problems 
arise when attempting to measure biologically relevant levels of toxin without reagents or 
enzymes.  First, the signal to noise ratio of the measurement is poor.  There is about 1000 
times more solvent (water) than there is solute (urea).  Second, the dynamic range 
required for the measurement cannot be achieved.  The water absorbance signal, 
normalized for concentration, is still much larger than that of urea.  Our proposed 
approach eliminates these problems by optically nullifying the background signal from 
the overall measurement.  The basic mathematical model equations for this method have 
been determined, which leads us to believe that it is possible to perform an analysis to 
estimate the accuracy of the method using a mathematical model [52-56].   
 
We intend to establish the accuracy of this method for measuring urea using two different 
instruments.  The first instrument was developed specifically for this research according 
to the principles described in this chapter, and in the rest of this document.  This 
instrument was located at WPI. The second instrument was developed separately, 
originally for the purpose of non-invasive (NIV) glucose monitoring of diabetic patients 
by VivaScan Corporation, a private company.  Testing performed using this NIV 
instrument was completed at VivaScan in Worcester, MA.  Table 3.2.1 shows the 
experimental design matrix of this compare and contrast study.  The cells in the matrix 
indicate the proposed measurement material.  The NIV instrument was originally 
designed to measure glucose in human ear tissue.  For this study, a special cuvette will be 
designed that fits into both instruments that hold an aqueous fluid sample. 
Table 3.2.1: Experimental Design Matrix. 
Clinical Dialysis 
Based Instrument 
Dissertation Instrument 
(first prototype) 
NIV Instrument 
(NIV or 2nd prototype) 
Projected accuracy of 
urea data in a dialysis 
machine. 
Urea data obtained using 
cuvette 
 
Urea data obtained using 
cuvette 
 
 
Figure 3.2.3 shows the flowchart of the approach to this research.  It can be grouped into 
three major divisions: design of the instrument, urea in dialysate studies, and urea 
monitoring and measurement algorithm development.  These three tasks must be 
performed in parallel, since they all are very closely dependent on each other. 
 
The starting point for this research is the design of the instrument, both hardware and 
system software.  This process involves many tasks, including: 
 
•= Consideration of the requirements of performing optical measurements; 
•= Definition of system requirements; 
•= Hardware, software, and optical design of the system; 
•= Development of the Optical Bridge based prototype; 
•= Building the physical platform; 
•= Integration of the hardware, system software, and optical system; and 
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•= Testing the performance of the instrument. 
 
Once the instrument has been designed and built, the testing phase can begin.  In order to 
establish the baseline performance of the instrument, it will first be tested with samples 
containing no urea, only water or dialysis fluid.  Ideally, the system will show no 
response to these tests.  Next, the instrument will be tested with samples of urea in water.  
This will provide data that will be used to develop the algorithm.   Finally, the 
performance of the instrument and algorithm will be verified by testing actual samples of 
post-patient hemodialysis fluid. 
 
By analyzing the data after the test, it will be possible to reach some conclusions about 
the performance of the instrument.  These conclusions may suggest some improvements 
that can be made in the design of the instrument, the design of the algorithm, or the 
design of the experiment.   
 
At this point, there are two major paths in the research plan.  The first is involved with 
refinements to the instrument itself.  As trends are discovered in the data that result from 
the design of the instrument, it may be possible to redesign the instrument to compensate 
for the trend.  This process also includes the definition of new requirements for the 
instrument as they become apparent.  This process will continue until the performance of 
the system is deemed satisfactory.   
 
At the same time, the experimental data will be used to develop the algorithm for urea 
monitoring and measurement.  This is a multi-step process.  Using the results of the 
sensitivity analysis, it will be possible to obtain a projected sensitivity coefficient, which 
relates the output signal of the system to the urea content of the sample.  An analysis can 
then be performed to see how well the actual data fits this projection.  This step also 
involves definition of the optimum running parameters of the instrument. 
 
The results of the steps above will allow us to establish a numerical algorithm for 
converting the system data into a urea concentration measurement.  Once this algorithm 
has been established, it will then be possible to establish a method to monitor the 
effectiveness of the dialysis session.  This is the final step in the process, which 
represents the development of a single, integrated algorithm for converting an optical 
signal into a method of monitoring the effectiveness of a dialysis session for a particular 
patient. 
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Figure 3.2.3: Flowchart of the research approach. 
 
 
Integration of Previous Work
System Software Hardware Design Optical Design
In vitro urea and clean dialysate
studies
In vitro spent dialysate studies of
urea and other interfering
substances
Development of mathematical models
of the system sensitivity
Instrument or experiment design
improvements
Recognition of modifying factors
affecting the reading
Establishment of mathematical
relationship between modifying
factors and the system output
Development of an algorithm for urea
concentration monitoring
Development  of an algorithm for
dialysis efficiency monitoring
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4 BACKGROUND 
 
In this chapter, six basic concepts are presented that are central for this research.  These 
topics are:  
 
1) kidney function and failure;  
2) dialysis and dialysis adequacy monitoring;  
3) classical absorption spectroscopy;  
4) the “Optical Bridge”;  
5) energy absorbance characteristics of urea and water; and,  
6) multiple linear regression.   
 
We present these concepts, which have been investigated by many different researchers, 
in such a way that they form a basis for the scientific research that must be done to 
successfully complete this project. 
4.1 Kidney Function and Failure  
The main functions of the human kidney are to remove toxic wastes and to maintain the 
water balance of the body.  This is accomplished by selectively retaining and excreting 
various substances by diffusion across a semi-permeable membrane.  Low molecular 
weight wastes and water are allowed to pass across the membrane, while proteins are not.  
In this section, the structure and function of normal kidneys are described, along with 
metabolic and hereditary conditions that can lead to kidney failure.  Finally, the 
physiological manifestations of renal failure are discussed.  
4.1.1 Function of Normal Kidneys 
The normal human kidney is pictured in Figure 4.1.1.  The kidneys are located dorsally in 
the lower abdominal cavity, one on either side of the spine.  The kidneys play many roles 
in the regulation of the environment of the body.  They accomplish these functions 
primarily through the formation of urine.  The tasks performed by the kidney include: 
 
•= Regulation of blood volume, and therefore blood pressure. 
•= Regulation of the level of waste products in the blood. 
•= Regulation of the concentration of electrolytes in the blood. 
•= Regulation of the pH of plasma. 
 
In Figure 4.1.1, several triangular regions that ring the outer surface of the kidney are 
visible.  These regions are called the renal pyramids.  The renal pyramids terminate into 
the minor calyxes, which in turn join to form a major calyx.  Urine formed in the renal 
pyramids collects in the major calyxes, and is emptied through the ureter into the bladder.   
 
The functional unit of the kidney is called a nephron.  Each kidney contains more than 
one million of these tiny filtration units.  A nephron consists of five main parts: The 
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glomerular (Bowman’s) capsule and glomerulus, the proximal convoluted tubule, the 
descending limb of the loop of Henle, the ascending limb of the loop of Henle, and the 
distal convoluted tubule.  These five structures will now be described in terms of their 
form and function in the removal of metabolic wastes.  The general structure of a nephron 
appears in Figure 4.1.2. 
 
 
Figure 4.1.1: Gross anatomy of the normal human kidneys.  On the left, the external 
anatomy is shown.  On the right, the kidney is shown in cross section [1]. 
Once the Bowman’s capsule and glomerulus (collectively known as the renal corpuscle) 
have accomplished the primary filtration of wastes into the glomerular filtrate, the filtrate 
then enters the proximal convoluted tubule.  This structure is lined with microvilli, in 
order to increase the surface area for reabsorption.  Here, water, salt, and other important 
molecules are transported out of the tubules into a capillary network that surround the 
tubule for use in the body.  This capillary network is known as the peritubular capillaries.  
The osmolarity of the filtrate is basically the same as that of plasma, since all plasma 
solutes (except proteins) can enter the glomerular filtrate.  A mechanism is therefore 
needed to draw the water out of the glomerular filtrate and back into the plasma.  This is 
done by the active transport of sodium into the space surrounding the proximal tubule.  
The cells that make up the proximal tubule have sodium/potassium pumps that use ATP 
to create a concentration gradient of sodium.  Chloride passively follows the sodium by 
electrical attraction, creating an osmotic gradient.  The water is then free to follow into 
the interstitial fluid surrounding the proximal convoluted tubule, and is then picked up by 
Renal 
Pyramid
Cortex 
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the peritubular capillaries.  Approximately 85% of water reabsorption occurs in the 
proximal tubule.   
Figure 4.1.2: Highly magnified diagram of a single nephron.  Important structures are 
labeled on the diagram.  Blood flows from the vessels on the left, into the glomerulus, 
through the peritubular capillaries, and exits by the intelobular vein.  Filtrate is 
produced in the Bowman’s capsule, and is concentrated as it passes through the 
convoluted tubules, loop of Henle, and into the collecting duct. 
 
After exiting the proximal convoluted tubule, the concentrated filtrate enters the 
descending limb of the loop of Henle.  The loop of Henle is located in the renal medulla, 
rather than the cortex.  The cells in the loop of Henle also excrete sodium actively into 
the interstitium, but they also absorb sodium, potassium, and chloride.  Chloride follows 
the sodium by electrical attraction, and potassium re-enters the filtrate.  However, the 
cells of the loop of Henle are not permeable to water, so the filtrate becomes increasingly 
less concentrated as it moves down the ascending limb.  At the same time, the 
surrounding fluid becomes more concentrated.   
 
The descending limb of the loop of Henle has opposite properties.  It is permeable to 
water, and does not actively transport salt.  The water in the descending limb diffuses out 
in response to the high concentration of salt in the interstitium that was created by the 
ascending loop.  This concentrates the filtrate and reduces its volume.  This concentration 
action is known as the countercurrent multiplier system [57]. 
This concentrated filtrate then enters the distal convoluted tubule for passage to the 
collecting duct.  Depending on the body’s need for water, the permeability of the 
Cortex 
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collecting duct to water can be modulated under the influence of anti-diuretic hormone 
(ADH).  When ADH is present, the walls of the tubule are more water permeable, and 
more water is reabsorbed.  A decrease in ADH reduces permeability, resulting in the 
excretion of a larger volume of urine.  ADH is secreted by the hypothalamus in response 
to osmoreceptors in the hypothalamus. 
 
The hormone aldosterone is responsible for regulating the balance of Na+ and K+ in the 
plasma.  The renal cortex secretes rennin, which triggers the release of aldosterone from 
the adrenal cortex.  When no aldosterone is present, 80% of the sodium and all of the 
potassium in the filtrate is reabsorbed in the distal convoluted tubule.  When aldosterone 
is present, all of the sodium present in the filtrate is reabsorbed in the distal convoluted 
tubule.  Potassium is actually secreted from the peritubular capillaries into the distal 
convoluted tubule under the influence of aldosterone.   
 
The kidneys are also responsible for acid base regulation in the blood.  This is 
accomplished by excreting H+ in the urine and by reabsorbing bicarbonate.  Reabsorption 
of bicarbonate occurs in the proximal convoluted tubule under the direction of the 
enzyme carbolic anhydrase.  Since bicarbonate is almost totally reabsorbed in the 
nephron, it cannot buffer H+ in the urine.  Instead, phosphates such as HPO42- and 
ammonia (NH3) are used. 
 
Certain molecules, such as glucose and amino acids, can be filtered by the glomeruli, but 
are not present in urine.  These molecules are therefore completely reabsorbed during 
passage through the nephron.  This is accomplished by carrier-mediated active transport.  
Since the number of carriers in the cells is finite, and their action occurs at a finite rate, it 
is possible to saturate these receptors.  When this occurs, the molecule to be transported 
appears in the urine.  This is one indication of a metabolic disturbance.  For example, 
glucose in the urine (glucosuria) is one indicator of diabetes, since the blood sugar has 
become too high for the carrier proteins to completely reabsorb all of the glucose from 
the glomerular filtrate [57]. 
4.1.2 Kidney Failure 
There are many causes of kidney failure.  It may be acute or chronic.  In the case of acute 
kidney failure, degradation of kidney function occurs rapidly.  Symptoms may begin to 
appear in as little as a few hours after the onset of failure.  Acute kidney failure may be 
brought on by low blood pressure caused by trauma, septic shock or infection, 
hemorrhaging, burns, dehydration, or exposure to certain metals, solvents, or chronic 
overuse of pain relievers such as aspirin, acetaminophen, or NSAIDS.  It is usually 
reversible if treatment is started quickly.  Chronic kidney failure shows a much slower 
rate of degradation, often taking months or even years before symptoms begin to show.  
Complications of diabetes, high blood pressure, or certain genetic diseases of the kidney, 
such as polycystic nephritis may cause chronic kidney failure.  System lupus 
erythmatosus (SLE) may also cause chronic kidney failure.  Unlike acute kidney failure, 
patients afflicted with chronic kidney failure do not experience recovery, and unless 
treatment is started promptly, their disease will ultimately lead to death.  In this section, 
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the metabolic disturbances associated with kidney failure are described, along with the 
physiological manifestations that are seen with the disease. 
4.1.3 Metabolic Changes Induced by Kidney Failure 
The most common metabolic changes that occur during kidney failure are elevated levels 
of serum creatinine and blood urea nitrogen (BUN).  With acute kidney failure, serum 
creatinine levels are known to rise as much as 2 mg/dl in two weeks.  Creatinine 
clearance also slows dramatically in both acute and chronic cases.  Clearance is defined 
as the amount of substance removed from the blood stream in a given time period 
(clearance is usually expressed in mg/min).  Blood analysis may also indicate that the 
patient is experiencing metabolic acidosis, which indicates a loss of bicarbonate ions in 
the blood and an increased production of acid, such as occurs during diabetic ketoacidosis 
[1]. 
 
The effects of kidney disease are collectively grouped under the term uremia.  Due to the 
kidney’s declining performance, toxins begin to build up in the bloodstream.  Two of 
these molecules, urea and creatinine, have already been mentioned.  Some of the 
metabolic disturbances associated with kidney failure are more difficult to quantify.  
There has been no definitive answer to the question of what actually causes the effects of 
uremia seen in kidney patients.  It is known that uremic patients also experience a buildup 
of larger protein fragments and metabolic wastes in their blood.  A partial list of these 
substances is given in Table 4.1.1.  The toxicity of urea has not been established, and 
indeed many researchers believe that it is not toxic to the body until concentrations are 
unreasonably high.  Many of these researchers believe that one or several of the 
substances listed in Table 4.1.1 is responsible for producing the symptoms of uremia 
[28,47,48,58-70].  There is much research currently underway concerning the effect of 
these so-called “middle molecules” on patients experiencing kidney failure.   
 
In addition to the buildup of toxins in the blood, water also begins to accumulate in the 
patient’s tissue.  The kidneys can no longer adequately reabsorb water and salts in the 
nephrons, and the water/salt balance in the body is therefore thrown off.  This situation 
must be rectified if the patient is to live, and is actually a more immediate danger than the 
buildup of uremic toxins. 
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Table 4.1.1: Partial list of substances that may be responsible for symptoms of uremia 
[28,47,48,59-70]. 
Urea Middle Molecules 
Guanidines Ammonia 
 Methylguanidine Alkaloids 
 Guanidine Trace metals (bromine a.o.) 
 β-Guanidinopropionic acid Uric acid 
 Guanidinosuccinic acid Cyclic AMP 
 γ-Guanidinobutryic acid Amino acids 
 Taurocyamine Myoinisitol 
 Creatinine Mannitol 
 Creatine Oxalate 
 Arginic Acid Glucuronate 
 Homoarginine Glycols 
 N-α-acetylarginine Lysozyme 
Phenols Hormones 
 O-cresol  Parathormone 
 P-cresol  Natriuretic Factor 
 Benzylalcohol  Glucagon 
 Phenol  Growth Hormone 
 Tyrosine  Gastrin 
Phenolic acids  Prolactin 
 P-hydroxyphenylacetic acid  Catecholamines 
 β-(m-hydroxyphenyl)-hydracrylic 
acid 
Xanthine 
Hippurates Hypoxanthine 
 P- (OH) hippuric acid Furanproprionic acid 
 O- (OH) hippuric acid Amines 
 Hippuric acid  Putrescine 
Benzoates  Spermine 
Polypeptides  Spermidine 
β2-microglobulin  Dimethylamine 
Indoles  Polyamines 
 Indol-3-acetic acid Endorphins 
 Indoxyl sulfate Pseudouridine 
 5-Hydroxyindol acetic acid Potassium 
 Indol-3-acrylic acid Phosphorus 
 5-Hydroxytryptophol Calcium 
 N-acetyltryptophan Sodium 
 Tryptophan Water 
 
4.1.4 Physiological Manifestations of Kidney Failure 
The symptoms of kidney failure are diverse and far-reaching.  Since the main function of 
the kidney is to cleanse the blood, there is no system that remains unaffected by 
inadequate removal of uremic toxins.  Despite this widespread effect, chronic cases of 
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kidney failure often remain undiagnosed for years.  The symptoms are generally not 
externally apparent until kidney function falls below 25% of normal.  The main 
physiological changes seen in uremia are a decreased ability to excrete waste, concentrate 
urine, or conserve electrolytes [1].  Other symptoms may include: 
 
•= Decreased or absent urination. 
•= Swelling of the ankles, feet, and legs. 
•= Generalized edema (fluid retention). 
•= Decrease in sensation in the extremities. 
•= Mental disturbances such as agitation, drowsiness, hallucination, or delirium. 
•= Coma. 
•= Severe itching (pruritis). 
•= Nausea. 
 
There are also several calcium-related diseases that tend to appear as uremia progresses.  
These include hyperparathyroidism, hypocalcemia, and renal osteodystrophy, all of 
which result from a loss of production of calcitriol by the kidneys.  This loss of calcitriol 
generally results from an overall decrease in the amount of kidney tissue as decay 
progresses [1].   
 
The symptoms are very similar for both acute and chronic cases of kidney failure.  Often 
further tests such as Magnetic Resonance Imaging (MRI) or Computed Tomography 
(CT) scans of the kidney are required to provide a definitive diagnosis.  The end result of 
chronic kidney failure is known as End Stage Renal Disease (ESRD).   
 
When the kidneys fail, there are two options for treatment.  The most common treatment 
is dialysis, which shall be described in the following section.  The other treatment option 
is a kidney transplant, which has serious drawbacks, but is often preferred for chronic 
renal failure cases.  The availability of donor kidneys is extremely limited.  Once a match 
has been made, and a transplant has been performed, the patient must continue to take 
powerful, expensive drugs for the rest of his or her life to prevent the body from rejecting 
the donor kidney.  There is also a large risk of infection from the transplant itself.  
Dialysis is often performed as a “bridge to transplant” for chronic kidney patients, in 
order to sustain their life and health until a suitable donor kidney can be found.  Acute 
kidney patients are also given dialysis to substitute for the function of their kidneys until 
they recover normal renal function. 
4.2 Dialysis  
The most common form of treatment for kidney failure is dialysis.  While a kidney 
transplant is the preferred, long-term solution, most renal failure patients spend some 
time on dialysis while waiting for a donor kidney.  Dialysis is a procedure that is 
performed periodically in order to remove excess water from a patient and to cleanse the 
blood of metabolic toxins.  The procedure is done by placing the patient’s blood in 
contact with a dialysate solution across a semipermeable membrane. There are two main 
methods of performing dialysis.  The first is hemodialysis, in which a shunt or fistula is 
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installed into the patient’s arm to prevent to need for repeated puncture with large bore 
needles.  A fistula is the surgical joining of an artery and a vein.  Hemodialysis then 
proceeds by taking toxic blood out of an artery, running it through the dialyzer, and then 
putting it back into the patient via a vein.  
4.2.1 Hemodialysis 
 Figure 4.2.1 presents a diagram of the basic components of a hemodialysis system.  A 
dialysis machine consists of a set of pumps, mixing chambers, and alarms (not shown) 
that are designed to pump blood and dialysis fluid into an artificial kidney so that 
filtration can occur.  Once the blood has been filtered and the toxins removed to the 
dialysis fluid, the used dialysis fluid is sent down the drain, and the cleaned blood is 
returned to the patient. 
Figure 4.2.1: Diagram of Hemodialysis Set-up.  The hemodialysis machine consists of 
equipment in which water and concentrated dialysis solution are mixed in the proper 
proportions, and pumped into the artificial kidney.  The patient’s arterial blood is 
pumped into the other chamber of the dialyzer, and waste exchange takes place across 
the semipermeable membrane.  The cleaned blood is then returned to the patient’s 
vein, and the spent dialysate is discarded. 
 
The blood exiting the body and sent to the dialyzer contains high concentrations of 
certain harmful waste products such as urea and creatinine.  The job of the dialyzer is to 
remove these waste products and leave behind proteins, glucose, and other necessary 
nutrients in the patient’s blood.  This is done by passive diffusion of toxins across the 
semipermeable membrane.  This membrane is usually made of cellulose, but often other 
synthetic materials such cuprophan may be employed.  Small molecules such as urea, 
creatinine, and uric acid are small enough to fit through the pores in the membrane.  They 
diffuse from the blood into the dialysate driven by a strong concentration gradient.  
Larger molecules, such as glucose and proteins cannot pass through the dialysis 
membrane, and are therefore conserved in the patient’s blood.  Amino acids and vitamins 
can pass the membrane at a slower rate.  For this reason, dialysis patients are often given 
protein and vitamin supplements to prevent nutritive deficiencies.  The second function 
of dialysis is to restore the water balance of the patient’s body by removing extra water 
from the blood.  Water moves across the membrane in a process called ultrafiltration.  
Uremic blood in
cleaned blood out
Dialyzer 
(Artificial 
kidney) 
Pump
Pump 
Mixing 
chamber 
Water Dialysis 
Concentrate 
To Drain 
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Driven by osmotic pressure, water leaves the patient’s blood and diffuses across the 
membrane into the dialysate.  As much as two to three liters of fluid may be removed 
from a dialysis patient during a three-hour session. 
 
There are three different types of artificial kidneys.  They are: 
 
•= Flat plate, in which stacks of membranes are sandwiched together.  Blood and 
dialysate flow through the dialyzer in alternating layers.  This design provides a large 
amount of surface area over which waste exchange can take place.  
•= Coil, which is made of a tube of semipermeable membrane wound into a coil.  The 
number of turns in the coil must be large to ensure adequate surface area, and 
therefore a pump is needed for both the dialysate and the blood in order to overcome 
the high resistance to flow of this design.  Ultrafiltration properties of this design are 
good because of the high pressure. 
•= Hollow fiber, in which approximately 10,000 thin fibers run longitudinally through 
the dialyzer.  The blood runs inside the fibers, and the dialysate circulates outside.  
The fibers have an inner diameter of about 0.2 mm, and a length of 150 mm [71]. 
 
The dialyzer component of hemodialysis machines was originally designed to be single-
use device.  However, these components are expensive, as manufacturing costs are high.  
Many dialysis centers therefore re-use dialyzers.  For reasons that are not fully 
understood, many patients display what is termed a ‘first-use’ syndrome, which means 
that they tend to feel worse after the session when a brand new dialyzer is used.  They 
may complain of nausea, headache, cramps, or other symptoms.  While these are all 
potentially normal side effects of dialysis, many patients claim that their occurrence is 
reduced when using recycled dialyzers.  The most likely explanation for this phenomenon 
is that certain chemicals are residual on the dialyzers after the manufacturing process that 
contribute to the patient’s post-session discomfort [71]. 
 
The length and amount of dialysis delivered is very important.  If dialysis is delivered too 
quickly, the side effects mentioned previously tend to be more pronounced.  If dialysis is 
delivered too slowly, the patient’s quality of life suffers because of excess time spent at 
the center.  If too much dialysis is delivered, the patient may lose more nutrients and 
become malnourished.  If not enough dialysis is delivered, the patient becomes uremic 
and builds up too much water.  Most patients receive dialysis three times per week, 
usually 2-3 hours per session.  The length of treatment is calculated by the physician 
based on the patient’s body weight and residual kidney function.  A discussion of the 
failings of this method follows in the next section. 
 
The dialysis fluid is a mixture of water, electrolytes, and either bicarbonate or acetate to 
act as a buffering medium.  At the site where dialysis is delivered, a concentrate of 
dialysis fluid is mixed by a proportioning pump with degassified water.  It is imperative 
that no air bubbles be present in the fluid, since these bubbles could enter the patient’s 
bloodstream, causing a life-threatening embolus.  All dialysis machines are equipped 
with alarms to warn of blood leaks or air bubbles in a line.  The mixed solution is then 
 22
warmed to body temperature, to prevent overheating or cooling the patient, and 
introduced into the artificial kidney [71]. 
4.2.2 Peritoneal dialysis 
The second type of dialysis is peritoneal dialysis, in which the patient’s own body 
supplies the dialyzer in the form of the peritoneal membrane.  The peritoneal cavity 
contains the various abdominal organs.  The organs and the cavity itself are all lined by a 
highly vascularized layer of peritoneal membrane.  This membrane is made of a layer of 
flattened mesothelial cells that lie over a loose fibrocellular interstitium that contains the 
blood capillary network.  The area covered by this membrane in an adult is 1-2 m2, and 
the diffusion distance into the capillaries is short.  This membrane is ideal for a natural 
dialyzer.  By introducing fluid into the peritoneal cavity, solutes in the blood will be 
equilibrated with the fluid in a matter of hours.  The peritoneal membrane will allow 
those solutes to pass whose molecular weights are below 30 kDa.  The fluid can then be 
removed and with it the waste materials.  The materials that are removed include uremic 
wastes, excess water, and excess minerals.  Since it is not possible to maintain useful 
hydrostatic pressure across the peritoneal membrane, the dialysate must be hypertonic in 
order to remove excess water.  Glucose, mannitol, or amino acids are usually used for this 
purpose.  The composition of the dialysate is such that balance of bicarbonate and other 
biologically important ions is restored.  Usually, exchanges of 2 L of fluid are made 
every 30 minutes [71].  This can be done by machine, which removes the tediousness of 
doing it by hand and helps preclude the possibility of infection by reducing the number of 
interruptions in the sterile circuit.  There are three different ways to perform peritoneal 
dialysis.  The first, intermittent peritoneal dialysis (IPD), is usually done three times per 
week in ten hour sessions.  The second, continuous ambulatory peritoneal dialysis 
(CAPD) is done daily for periods of 6-8 hours, and the third, continuous cycling 
peritoneal dialysis (CCPD) is performed as IPD, except that 2 L of fluid are left in the 
abdomen between sessions. 
 
There are many advantages to peritoneal dialysis (PD) over hemodialysis.  PD is simple 
to perform and does not require much training.  It is often performed at the patient’s 
home by his or her spouse, and the patient can often continue to hold a full time job.  The 
equipment required is much simpler.  The removal of fluid and solutes is much gentler on 
the patient.  Direct vascular access is not required, nor are anticoagulatory drugs.  Many 
of the other dangers of hemodialysis such as rapid drop in blood potassium do not occur 
with peritoneal dialysis [71].   
 
The most serious disadvantage associated with peritoneal dialysis is a risk of bacterial 
infection called peritonitis.  While usually not life-threatening, it is a painful condition for 
the patient, and repeated occurrences are the number one cause of drop out in PD 
programs.  One other problem with PD is the need for peritoneal access.  Once the 
catheter is surgically implanted, it usually remains clear to get fluid into the cavity, but 
can often be blocked when trying to remove fluid.  This problem is caused by the 
omentum, a loose sheet of mesothelial tissue that floats freely in the peritoneal cavity.  It 
can wrap around a catheter and block outflow.  This often must be corrected with 
surgery, but can occasionally correct itself spontaneously.  A final complication is that 
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repeated episodes of peritonitis may diminish the permeability of the peritoneal 
membrane to water and solutes.   
4.2.3 Practical Issues Regarding Hemodialysis 
The major problem with hemodialysis is maintaining adequate vascular access.  Large 
bore needles must be used to get an adequate blood flow.  For patients who have received 
a vascular graft or a fistula, approximately 6 weeks must be taken for the graft to be ready 
to use.  These grafts also have a tendency to close or weaken with time [71].  
4.2.4 Modeling the Effects of Hemodialysis 
It is important to note that dialysis is not a procedure that can be done quickly.  It would 
seem that once the blood has passed through the dialyzer, it is cleaned, and the patient 
should be able to go home.  However, most of the toxins to be removed do not reside 
solely in the blood.  Instead, they are distributed in several ‘compartments’.  The system 
may be modeled so that the distribution of these toxins has three such compartments.  
The first is the blood itself, called the extracellular compartment.  The second is the 
interstitial compartment, which is comprised of the fluid that bathes the cells of the body.  
The final compartment is the intracellular compartment, which is made up of all the fluid 
inside the cells.  When blood passes through the dialyzer, the extracellular compartment 
is cleaned at a fast rate.  The blood then re-enters the body, and picks up more toxins via 
exchange with the interstitial fluid compartment.  This also occurs at a relatively fast rate, 
though it is slower than the extracellular/dialysate exchange.  The interstitial 
compartment also exchanges toxins with the intracellular compartment.  This exchange is 
by far the slowest of the three, and limits the rate at which dialysis may be performed.  
The slowness of the exchange is a function of how much passive diffusion of the 
molecule is impeded by its size or electrical charge when traversing the cellular 
membrane.  The exchange of toxins between these three compartments is necessary in 
order to remove the toxins that have built up in the body.  When these models are used, a 
major assumption is made.  The assumption is that there is instantaneous uniform 
distribution between compartments.  That is, as a substance diffuses between 
compartments, it is assumed to be completely mixed throughout the compartment 
immediately.  This is obviously impossible in reality, but is a necessary approximation 
that is required to maintain a linear mathematical model.  Figure 4.2.2 shows a diagram 
of the exchanges that go on between these three compartments.  
Figure 4.2.2:  Exchange of toxins occurs between various fluid compartments during 
dialysis as a function of concentration and potential gradients.  The relative speed of 
exchange is represented by the width of the arrow. 
4.2.5 Markers of Dialysis Performance 
There is much debate about how to provide the best care for dialysis patients.  Dialysis 
patients are among the fastest growing medical population in America today.  In the year 
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2000, they numbered about 250,000, a figure which is growing rapidly [1].  This is due to 
the fact that the US population is aging rapidly, and older patients have far more renal 
problems than younger ones.  The number of diabetes patients, who make up the largest 
subpopulation of dialysis patients, is also growing.  While the technology for dialysis has 
improved markedly in the past 10-15 years, the mortality rate of these patients has also 
increased dramatically.  In 1970, the yearly mortality rate was 12-16%.  In 1990, this 
number jumped to 20-25%.  This data suggests that the improvements in dialysis 
technology are not necessarily benefiting the patients.  Routine testing of dialysis 
performance is performed on only 2% of dialysis patients, with the most common 
measure of performance being urea clearance levels [14]. 
 
It is important to know if the dialyzer is properly removing the wastes from the patient’s 
blood, since chronically high levels of urea and other toxins can lead to serious health 
problems.  Urea is the chief nitrogenous waste product of protein catabolism that results 
from the removal of the α-amino groups in order to detoxify NH3.  It is produced in the 
liver and is normally excreted by the kidneys in urine.  The chemical structure of urea is 
shown in Figure 4.2.3. 
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Figure 4.2.3: The chemical structure of urea.  Urea has a diamide functional group 
attached to a single carbon atom. 
An early attempt to introduce a quantitative scale to measure dialysis efficiency was done 
by Babb et al. in 1971 [17].  The scale relied on the product of surface area of the 
dialyzer and length of treatment.  Other studies have shown a non-linear relationship 
between length of the dialysis treatment and survival rates, but did not show a clear 
threshold level for inadequate dialysis.  However, the National Cooperative Dialysis 
Study did show that patients whose time-averaged BUN (blood urea nitrogen) was near 
50 mg/dl were better off than those with a BUN near 90 mg/dl [14].  BUN has become 
the chief measure of kidney function.  BUN levels are affected by protein metabolism, 
renal secretion, and kidney mass.  An elevated BUN may indicate urinary tract infection, 
chronic nephritis, tubular necrosis, nephrosclerosis, acute glomerulonephritism, and 
polycystic disease of the kidney.  A uremic patient is also at a higher risk for 
hypertension, since higher blood pressure is required to bring down the urea levels in 
blood.  Higher blood pressure is required to increase the glomerular filtration rate, 
resulting in decreased urea levels. 
  
Urea clearance has become the chief indicator of the adequacy of dialysis.  The 
concentration of urea in blood (in mg/dl) is measured at the inlet  (arterial side) of the 
dialyzer and the outlet (venous side) of the dialyzer.  Clearance is calculated as the 
difference in concentration from the inlet to the outlet divided by the concentration at the 
inlet.  It is then expressed as a percent.  Mathematically, the clearance is expressed as; 
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Dialysis is considered adequate if the urea clearance ratio is between 60% and 65%.  For 
an uremic patient, the BUN level at the inlet of the dialyzer may be as high as 150 mg/dl.  
(A normal BUN would be around 20 mg/dl).  For adequate dialysis of this patient, the 
dialyzer must remove at least 90 mg/dl of urea.  The adequacy threshold is determined by 
using another dialysis parameter known as the kT/V index, where k is the urea clearance 
rate (ml/min), T is the length of dialysis (min), and V is the volume of water in the body 
in which urea is assumed to be distributed (ml).  kT/V is the total clearance normalized 
by the body water distribution of urea.  V is usually considered to be 58% of the body 
weight, but may be higher in patients with a large amount of lean muscle mass.  This 
assumption is a frequent source of error when dialysis prescriptions are calculated, as this 
variability in V is rarely taken into account.  kT/V is a dimensionless quantity.  Gotch and 
Sargent found that if a patient’s kT/V index was greater than 1, the patients were 
generally being adequately dialyzed [14].  This was determined by comparing the number 
of hospitalization days for a multicenter dialysis patient population with the patient kT/V 
index.  This ratio can be approximated to the natural logarithm of the initial urea 
concentration divided by the final urea concentration.  Solving this equation for the final 
concentration of urea results in finding that the final urea concentration should be less 
than 36% of the initial concentration.  In this way, it is related to the percent removal 
equation (4.1).  Therefore, kT/V can be expressed as: 
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A second method of measuring the performance of dialysis is to find the concentration of 
urea in spent effluent dialysate.  Mathematical models have been developed which relate 
the concentration of urea and other solutes in dialysate to the concentration of the solutes 
in plasma.  This has the advantage of only requiring one measurement rather than two.  It 
also does not interrupt the dialysis process, since the measurement is taken from the 
waste stream rather than from the active dialyzing pathway.  It is also advantageous 
because the measurement is taken non-invasively and could be done automatically. 
 
4.2.6 Urea Kinetic Modeling 
 
There are many models that have been presented in the literature to predict the 
performance of the dialysis process.  These models generally fall into two distinct 
categories: One Pool models and Two Pool models.  We shall describe these two model 
categories in detail here.   
 
The most basic one pool model has already been described.  It involves the use of the 
kT/V parameter.  This model is very widely used, and is considered a clinical standard at 
the present time.  The model basically tries to predict an exchange rate between the 
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intracellular compartment and the dialysate.  These models usually take no account of the 
effects of ultrafiltration, urea generation during the course of the session, or residual 
kidney function on the amount of urea present in the body.  Nonetheless, they are simple 
estimators of dialysis performance than have been shown to correlate at a reasonable 
level with expected patient prognosis [9,24,27,43].  Many authorities reject these models 
as being oversimplified.  Indeed, they do ignore much information about the process, and 
cannot fully model the kinetics of urea removal.  However, they serve as a first 
approximation of the process.  There are several other equations that physicians use to 
gain information about the level of toxin removal that has been achieved during dialysis.  
These equations are given in Table 4.2.1. 
 
Some investigators choose instead to use the Two Pool modeling approach.  This 
assumes a second “pool”, or collective area of urea distribution.  It is possible to use 
higher order models, such as the three pool model presented in the previous section, but 
the inclusion of these other compartments provides a diminishing return in the 
complexity of the model.  As one would expect, the inclusion of two compartments in the 
model provides a double exponential character in terms of the expected removal curve.  
Each exponential represents the exchange rate between various compartments.  The 
models presented in the literature usually differ from each other in the assumptions that 
are made about urea generation, ultrafiltration, dialyzer recirculation, etc.  While these 
models are generally more accurate and descriptive than the One Pool models, it is 
doubtful if they will ever find wide clinical acceptance, due to their computational 
complexity. 
 
A final method of quantifying dialysis performance is the Direct Dialysate Quantization 
(DDQ) method, in which all of the spent dialysate is collected and analyzed after the 
session.  It is the most accurate method of quantifying how much toxin was removed 
from the patient, but it is time consuming, expensive, and impractical for large-scale 
operations [14, 15].    
 
Some researchers are beginning to dispute that urea should be used as a marker for 
dialysis performance at all [28,47,48,58-70].  They point to several facts in making this 
claim: 
 
•= Urea has no known toxicity. 
•= Urea is a small molecule, and can pass through the dialysis membrane relatively 
unhindered. 
•= Other molecules, such as the examples given in Table 4.1.1, are known to be far 
more toxic than urea, and are therefore better indicators of expected patient 
prognosis. 
•= These molecules are often larger, charged protein fragments that are somewhat 
hindered at crossing the dialysis membrane.  Their removal characteristics are 
likely to be quite different from that of urea. 
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Table 4.2.1: Equations for calculating solute removal during dialysis.  Symbols: CD: 
dialysate concentration. CMB: mean concentration in blood.  Co: blood side 
concentration at dialyzer outlet. CI: blood side concentration at dialyzer inlet.  Cp: 
concentration in peripheral blood. CPRE: concentration before dialysis. CPOST: 
concentration after dialysis. (subscripts 1 and 2 refer to the particular session of a 
weekly cycle). G: generation per minute. GU: generation per 24 hrs.  KR: residual 
clearance.  KT: total clearance (residual plus dialyzer).  PCR: protein catabolic rate. 
QB: dialyzer blood flow. QF: ultrafiltration rate. T: dialysis time. θ: interdialytic time 
interval. V: distribution volume. VD: dialysate volume. Adapted from [46]. 
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Ringoir, et al. [68], suggest that the ideal azotemic (uremic) marker is a molecule which:  
 
1. Is known to accumulate in the blood of undialyzed renal failure patients. 
2. Is removed by dialysis. 
3. Has proven toxicity. 
4. Is representative of the generation and elimination of other toxic molecules. 
5. Proven to have relation between concentration of solute and clinical outcome. 
6. Is simple and cost-effective to measure in either blood or dialysate. 
 
There are a variety of reasons why some molecules are removed at different rates than 
others during dialysis, and even why the removal rate of the same substance can vary 
between sessions.  Table 4.2.2 lists some of the factors that affect the removal rate of 
solutes during dialysis. 
 
The idea of using separate azotemic markers is fairly new, and has not yet gained wide 
clinical acceptance.  In addition, no one has agreed on a molecule or molecules that fit the 
intended profile.  Several investigators, including Vanholder and Ringoir have compiled 
a list of these so-called ‘middle molecules’ that may fit some or all of profile for a better 
marker molecule, and are believed to show more toxicity than urea [46-48,68].  See Table 
4.1.1 for a partial list of these substances.  Despite this new information, urea is still 
considered a very viable marker for monitoring the performance of a dialysis session.  In 
the following section, the biochemical pathways by which urea is generated in the body 
will be discussed.   
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Table 4.2.2: Factors influencing solute removal during dialysis [68]. 
Solute Related Factors 
 Compartmental distribution 
 Intracellular concentration (resistance of cell membrane) 
 Protein binding 
 Electrostatic charge 
 Steric configuration 
 Molecular weight 
Patient Related Factors 
 Distribution volume and body weight 
 Intake and generation 
  Solute 
  Metabolic precursors 
 Residual renal function 
 Vascular access quality  
 Absorption from the intestine 
 Hematocrit 
 Blood viscosity 
Dialysis Related Factors 
 Dialysis time 
 Interdialytic intervals 
 Blood flow (overall and extremity) 
 Concentration gradient 
 Dialysate flow rate 
 Dialyzer surface area 
 Dialyzer volume 
 Dialyzer membrane resistance 
 Dialyzer pore size 
 Adsorption (deposition of proteins or other constituents) 
  On the membrane 
  On other parts of the dialyzer circuit 
 Ultrafiltration rate 
 Intradialytic changes in efficiency 
 Changes with indirect effect on solute related factors 
  Blood pH 
  Heparinization 
  Free fatty acid concentration 
 
4.2.7 Biochemical Pathways for the Generation of Urea 
The biochemical pathway by which urea is generated in the liver is well understood.  
When amino acids are deaminated, the resulting NH3 is cytotoxic.  It must therefore be 
converted to another product before the process is complete.  Urea is a by-product of a 
cyclic pathway known as the urea cycle.  Most of the early work in understanding this set 
of reactions was done by Krebs and Henseleit in the early 1930’s.  The overall 
stoichiometry of the urea cycle is given by the following reaction [72]: 
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CO2 + NH4+ + 3 ATP + aspartate + 2 H2O →    (4.13) 
urea + 2 ADP + 2 Pi + AMP + PPi + fumarate + 5 H+ 
 
The production of urea occurs from the amino acid arginine as it is regenerated to 
ornithine.  For each turn of the urea cycle, two nitrogens are eliminated, and four high-
energy phosphates are consumed.  This includes the PPi group, which is subsequently 
hydrolyzed. Five enzymes are required, three of which are present in the cell matrix, and 
two of which are found in the inner mitochondrial membrane.  Also associated with the 
process are several membrane transport proteins for ferrying the intermediates and 
reagents across the mitochondrial membrane [72].  A diagram of the overall urea cycle is 
shown in Figure 4.2.6. 
 
In the first step of the pathway, the free NH3 that is produced is converted into carbamoyl 
phosphate by the following reaction: 
 
      NH4+ + HCO3- + H2O + 2ATP → carbamoyl phosphate + H2PO4- + 2ADP   (4.14) 
 
Most of the energy used in the urea cycle is consumed in this step.  Carbamoyl phosphate 
is a molecule that starts out as bicarbonate, and is phosphorylated through the action of 
ATP, forming carbonyl phosphate.  The carbonyl phosphate is then attacked by an 
ammonia ion, which results in the formation of carbamate plus a phosphate ion.  The 
carbamate is then acted upon again by a second ATP molecule.  This results in the 
phosphorylation of the carbamate molecule, forming carbamoyl phosphate.  The above 
reaction is completely catalyzed by the enzyme carbamoyl phosphate synthase.  The 
reaction is shown schematically in Figure 4.2.4.  The entire reaction is shown in Figure 
4.2.6.  Once the carbamoyl phosphate is formed in the mitochondria, it is able to interact 
with L-Ornithine, which is transported across the mitochondrial membrane by a carrier 
protein.  The carbamoyl group is transferred to L-Ornithine, forming L-Citrulline.  This 
reaction is catalyzed by the enzyme ornithine transcarbamoylase.  This process also 
releases an inorganic phosphate molecule.  L-Citrulline then combines with L-Aspartate 
and ATP to form Argininosuccinate.  Argininosuccinate synthase is the enzyme 
responsible for this conversion.  The ATP is converted to AMP + PPi.  The high-energy 
phosphate is subsequently broken down, resulting in a net cost of two ATP molecules.  
At this point, Argininosuccinate is broken down into L-Arginine and fumarate under the 
influence of Argininosuccinate lyase.  The L-Arginine is then hydrolyzed into urea and L-
Ornithine, thereby returning to the beginning of the cycle. 
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Figure 4.2.4: NH3 is converted to carbamoyl phosphate in the first step of the Kreb's 
cycle. 
Figure 4.2.5: The TCA cycle links together with the urea cycle to form the Kreb’s 
bicycle.  Adapted from [72]. 
The urea cycle as described by Krebs has significant interactions with the TriCarboxylic 
Acid (TCA) cycle.  The TCA cycle is responsible for the conversion of acetate to CO2 
and water.  The two reactions are often considered together in a process called the urea-
TCA or Kreb’s bicycle.  By viewing these interactions, it is possible to find the origin of 
the amino acid that is contributed by aspartate in the formation of argininosuccinate.  The 
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fumarate released by the breakdown of argininosuccinate also plays a part in this cycle.  
Figure 4.2.5 shows how TCA cycle and the urea cycle interact.  
Figure 4.2.6: The urea cycle takes place in the cytosol and mitochondria of the liver 
cell.  Urea is produced from the hydrolysis of Arginine.  The cycle uses five enzymes 
(shown in italics) and consumes 4 ATP.  Adapted from [72]. 
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4.3 Dialysate-Side vs. Blood-Side Measurements: A history of dialysis adequacy 
monitoring 
Since the early 1970’s, there has been a flurry of activity in the renal therapy research 
community aimed at finding the optimal way to dialyze a patient.  Most notably, the 
search has focused on finding a universal parameter that tells whether or not the patient is 
receiving adequate therapy.  A landmark study completed in 1985 by Gotch and Sargent 
showed that a parameter relating the clearance of the dialyzer, the time spent on dialysis, 
and the urea distribution volume of the patient’s body provided a strong predictor of the 
adequacy of dialysis [14].  This study showed that when this dimensionless parameter, 
known as kT/V, was greater than or equal to 1, complications from renal failure were 
dramatically reduced.   
 
There are many problems with making kT/V measurements in the clinical setting 
however.  First, there is little widespread agreement on how to make the measurements, 
mainly stemming from differences in how to calculate the urea distribution volume.  
Some researchers use a constant value of 58% of body weight (55% for women).  This is 
a simple approach, which can lead to large errors in persons with non-ideal body types 
[26,31,32,36-38,46,73] Other researchers use a single pool, variable volume model 
(VVSP), which assumes that urea is distributed only in one body compartment, but that 
the volume of this compartment is changing over time.  The distribution volume is found 
using bioimpedance methods.  More complicated models also exist, notably the double 
pool variable volume model, but these have not found widespread clinical use due to their 
increased complexity [20]. A third modeling method is the DDQ, direct dialysate 
quantification, in which all of the spent dialysate is collected over the course of a session.  
Since the volume can easily top 100 L per patient per session, this is impractical for 
large-scale operations [3,18,31,41]. 
 
A second problem involves calculation of the dialyzer clearance.  This involves 
knowledge of many parameters, including the exact blood flow rate at the dialyzer, 
volume of water removed from the patient, and several measurements of the patient’s 
BUN (Blood Urea Nitrogen) level.  The BUN level is determined from blood samples 
which generally must be analyzed away from the patient, preventing real time estimation 
of the progress of the session.  This also can introduce errors due to recirculation at the 
fistula or urea rebound after dialysis treatment [25]. Experience has shown however that 
this measurement is prone to sampling errors.  When blood samples are taken, they are 
generally taken from the same site as the blood being sent to the dialyzer.  Since blood 
access is achieved with a two bore needle, some recirculation of blood occurs between 
needles, which results in mixing of the uremic vs. clean blood.  The true urea value may 
be higher that what is obtained from the sample in this case.   
 
Another sampling problem is the timing of the sample.  One sample is taken at the 
beginning of the session, one at the halfway point, and one at the end.  The timing of the 
end sample is critical, because of two periods of urea rebound that are known to occur.  
The first occurs rapidly, within 20 seconds to 1 minute after dialysis is stopped.  The 
second occurs more slowly, and is generally complete within 30 minutes after dialysis is 
stopped [25].  Ideally, the last sample should be taken after this period of time, but this is 
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a serious inconvenience to the patient and the dialysis center.  This method is also 
expensive, both in terms of laboratory sample analysis and technician/nurse time 
associated with collecting the samples.  For this reason, this procedure is generally only 
done once per week or even once per month for a given patient.  This may lead to further 
errors if the session monitored is not typical of the rest [6].  Modeling the solution is 
complicated by the fact that the patient’s body is also generating new urea at all times.  
Measuring all of these parameters becomes a significant workload issue for the dialysis 
unit personnel.   
 
Once all of the important parameters have been recorded, the work is not yet done.  In 
order to arrive at a solution, a set of equations must be solved iteratively to obtain the 
desired result.  This must generally be done off line via computer.  The complexity, work, 
and expense involved in obtaining these results have prevented urea kinetic modeling 
from finding widespread use in the clinical setting [27,37]. 
 
In recent years, two alternate parameters known as the Solute Removal Index (SRI) and 
the Urea Reduction Ratio (URR) have been developed.  The URR is simply a ratio of pre 
vs. post dialysis BUN values.  This is a simplified measure that can be easily calculated at 
bedside and requires no blood sampling.  It is often considered to be inaccurate, because 
of the urea rebound [25]. For this reason, measurements that require blood-side BUN 
measurements tend to overestimate the adequacy of dialysis.  The SRI is a removal rate 
parameter calculated from the dialysate side urea content.  Experimentally, the SRI shows 
a double exponential characteristic, lending support to a double pool urea distribution 
model [5].  In addition, several authors have shown that kT/V can be calculated from 
dialysate-side urea measurements from the following equation: 
   
hr
dry
D
T
BW
BWT
t
C
V
kT
01786.01
3)(ln
−
∆
+
∂
∂
−
=  (4.15) 
 
∆BW refers to the amount of fluid removed from the patient during dialysis, BWdry refers 
to the patient’s weight when no edema is present, CD represents the dialysate side urea 
concentration, and T represents the length of the dialysis session in hours.  This model 
was developed by Garred, et al., and relies on the fact that dialysate urea has been seen to 
be a constant fraction of the blood urea concentration [25].  (CD = effective 
clearance/dialysate flow rate).  The dependence of the equation on rate indicates that a 
semi-continuous measurement of CD is required. Minor corrections are applied to correct 
for change in body water and urea generation during dialysis [6,25,27].  Results of these 
studies are generally good for anuric (advanced renal failure) patients, but they may 
underestimate the value of kT/V for patients with some residual renal function [2].  The 
SRI is gaining widespread clinical acceptance as the method of choice for quantifying 
dialysis efficiency.  It is subject to fewer errors than conventional blood side methods, 
and the calculations and measurements involved are far less involved.  The method lends 
itself well to on-line automatic measurements.   
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In summary, dialysate side urea monitoring methods provide many advantages over 
blood side methods, both in terms of measurement ease and accuracy of results. Because 
the measurement is continuous or semi-continuous, it is less prone to sampling and 
measurement errors. Traditional blood-side methods also require an accurately known 
value of effective clearance, including any correction for recirculation if it exists.  In 
order to determine these values, three additional blood samples are required.  Blood-side 
methods are also only accurate if urea follows single pool kinetics.  In contrast, dialysate-
side methods do not require knowledge of clearance, and can in fact accommodate 
sessions where the clearance rate changes over the session.  This method can work under 
conditions of rapid dialysis where urea may follow multiple pool kinetics [6].  Finally, 
dialysate-side methods eliminate the need for further breaks in the sterile circuit by 
eliminating the need for blood samples. 
4.4 Comparison with Presently Available Technology 
In recent years, several attempts have been made to simplify the process of quantifying 
the efficiency of dialysis by introducing automatic on-line monitoring instruments.  Four 
separate instruments have been developed. (Many other researchers have shown methods 
of measuring urea in either blood or dialysate, but we restrict discussion here to those 
who have been reported to show on-line feasibility.) All four instruments use a urease 
catalized conductivity cell to provide urea measurements.  Only the Baxter device, the 
Biostat 1000® has been approved for sale in the United States [9,16,27,38].  A second 
device, the Ureascan P2 Hospal, is only available in Europe [4].  The other two devices 
are currently not commercially available.    Both devices cost approximately $1000.  For 
reference purposes, the average cost of a new dialysis machine is between $17,000 and 
$22,000. 
 
Our device has the potential to solve many of the problems with the existing technology 
in that the cost per test would be far lower due to the lack of reagents and electrodes.  The 
setup requirements would be minimal, and the final system could be designed to interface 
to any dialysis machine.  The final cost of the system is projected to be around $3000-
$5000.  (Future research involving the use of tunable diode lasers as light sources could 
bring the cost of this device into the $300-$500 range).  The extra cost of the instrument 
could be easily offset by the cost of disposables that are required for existing instruments.  
Assuming that one machine can support 10 patients, who are each dialyzed three times 
per week, 52 weeks per year, at $10.50 per session, the disposable cost per machine per 
year is approximately $16380 [50].  This figure only includes electrodes and reagents, not 
extra supplies such as tubing, syringes, or laboratory tests.  These cost figures are 
summarized in Table 4.4.1: 
Table 4.4.1: Cost comparison of proposed system vs. existing technology. 
Instrument Conductivity based sensors Reagentless urea monitor 
Device cost $1000 $4000 
Disposable cost per session $10.50 (reagents, tubing) $0.50 (tubing) 
Sessions used per year 1560 1560 
Disposable cost per year $16,380 $780 
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While these devices have all been shown to provide acceptable accuracy in the clinical 
setting, they have not found widespread use.  First, they are expensive to use due to the 
need for disposables.  Second, the devices require extra maintenance and setup by the 
clinical personnel.  Finally, the devices are often machine-specific, preventing their use in 
centers that do not own compatible hemodialysis equipment [50].  
 
A summary of each device and any relevant clinical studies performed to evaluate them is 
given here.  
 
Baxter Healthcare, Inc. – Biostat 1000.  This device, approved for use by the FDA in 
1995, uses a urease-immobilized cap in a flow-through design to measure urea in spent 
dialysate.  The sensor provides a near-continuous measure of dialysate urea content, 
allowing for good curve fitting, early estimation of intradialytic kT/V, and an increased 
precision calculation of total urea removal.  The instrument also includes a bacterial filter 
that prevents loss of dialysate urea caused by urease producing bacteria.  Independent 
studies using this instrument have found that it agrees well with results of traditional 
methods of urea kinetic monitoring such as DDQ and VVSP models [2].    
 
Garred et al. – This sensor is also based on a flow-through cell, but instead of 
immobilized urease it uses a liquid form that is filled through a port with a syringe.  An 
ammonia sensor with a calomel reference electrode is used to provide a conductivity 
measurement.  This urea sensor provided kT/V values that were reasonably well related 
to blood-side kT/V measurements for four dialysis patients [26]. 
 
Jacobs et al. – In this research, the group developed a screen printed planar urea sensor.  
The sensor displayed acceptable accuracy of approximately 1.2 mg/dl, but its linear range 
was only up to 90 mg/dl, which is not enough to accurately reproduce the 6-180 mg/dl 
expected range.  The sensor is also complicated to produce and displays a limited shelf 
life of five days [7]. 
 
Calzavara et al. – Ureascan P2 Hospal.  This European device also utilized a standard 
urease flow-through cell.  Its accuracy is approximately 1.3 to 2.5 mg/dl.  The authors of 
the study note that they were unable to relate the output of their dialysis sensor to the 
plasma urea content [4].   
4.5 Classical Absorption Spectrometry – The Beer-Lambert Law 
The underlying principle for using light transmission to measure analyte concentration is 
the Beer-Lambert Law.  This law states that equal thicknesses of an absorbing medium 
will absorb an equal amount of light.  Stated differently, the amount of light absorbed 
when traversing through a medium is linearly dependent on the concentration of the 
absorbing substance, the thickness of the sample, and a characteristic parameter called the 
extinction coefficient that depends on wavelength.  In equation form, A(λ) = a(λ)⋅C⋅x, 
where A(λ) is the absorbance, a(λ) is the absorbance coefficient in units of dl/cm⋅mg, C 
is the concentration in mg/dl, and x is the distance in cm.  Note that absorbance is the 
logarithm of transmittance, which is the fraction of light transmitted through the sample.  
Transmittance can therefore be defined as Io/Ii, or 10-a(λ)⋅C⋅x, where Ii is the transmitted 
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light intensity in Watts and Io is the light intensity at the exit of the sample. The product 
of the absorbance coefficient a(λ) and the concentration C is a value known as the 
extinction coefficient (k) of the sample, which has units of 1/cm.  The transmittance of 
the sample can therefore be written as 10-kx. 
 
The extinction coefficient for a given molecule is a complex function of wavelength.  The 
shape of the function depends on the vibrational, translational, and rotational 
characteristics of the particular molecule.  Just as the mechanical systems represented by 
mass, spring, and dashpot models have preferred frequencies at which they will vibrate 
when excited, so do all molecules.  These molecules will absorb some frequencies more 
than others as the chemical bonds become excited by the addition of light energy.  This 
excitation will cause the bonds to stretch, twist, or vibrate, then relax.  Since frequency 
and energy are proportional, and inversely related to wavelength, we obtain a spectrum 
by looking at this characteristic absorbtion over a range of wavelengths.  Each molecule 
has its own characteristic “fingerprint” that can be used to identify it.  By identifying 
certain characteristic bands, it is possible to discriminate one molecule from another.  
Optical instruments have been developed that can detect the presence of a given 
substance in a sample, and detect the concentration of that substance by using the Beer-
Lambert Law. 
4.6 The Optical Bridge 
When performing conventional optical measurements of physiological analytes in the 
near infrared, two main problems exist.  First, the analyte to be measured is usually found 
in concentrations several orders of magnitude smaller than that of water.  Second, the 
extinction coefficient (and hence the absorbance) of water is often several orders of 
magnitude larger than that of the analyte.  In a conventional system, the information that 
relates to analyte concentration is far below the noise level of the measurement system.   
 
The problem is the extreme dynamic range of signal: In biologic samples, there is an 
abundance of water (that strongly absorbs in the spectral region of interest), and traces of 
analytes (that absorb weakly in the spectral region of interest).  The result is that both the 
optical signal and its transduced electrical equivalent posses a huge “quasi DC” 
component (“background”), and a tiny variable component (“signal”).  The limiting 
factor of the optical measurements is the present level of technology: existing 
measurement systems do not possess the dynamic range that would enable sufficiently 
accurate measurement of the “signal” in the presence of the “background”.  As we would 
say, the information about the analyte content of the sample lies below the noise level of 
the system.  This problem is currently solved by adding special reagents to the sample to 
amplify the response.  These reagents react with the analyte, producing a visible color-
change reaction.  The new sample is then analyzed with a conventional absorption 
spectrophotometer.  This method, while relatively simple, has several drawbacks.  First, 
these reagents are expensive, and often quite toxic.  Second, it is an added task for the 
personnel operating the instrument to change reagent packs every time a measurement is 
to be made.   
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We wish to make an automated urea measurement without the need for reagents, so we 
must find a way to null out the complex near-IR background spectrum that arises mainly 
from the water in the dialysis fluid.  The Optical Bridge is a method that can be used to 
solve this problem.  In the following section, we describe the basic principles and define 
the basic terms associated with its operation. 
4.6.1 Definition and Principles 
With the technology existing in the year 2000, reagentless absorption measurements 
cannot be used to make determinations of biological analyte levels.  For example, after 
the optical signal is transduced into an electrical signal, and digitized, the “background” 
will use approximately ¾ of the analog-to-digital converter’s full scale, e.g. 10 V.  At the 
same time, the analyte’s contribution is only a few tens of microvolts (for urea, the 
extinction coefficient is 100,000 times smaller and the concentration 5000 times smaller 
than that of water).  In order to resolve and measure 1% variations of the analyte 
concentration, this would require the A/D convert’s effective resolution to be over 32 
bits, which is, with the existing technology, practically impossible to achieve.  Therefore, 
mathematical manipulation of the digitized data cannot be used to extract the signal from 
the background, or yield any other useful information.  To solve the problem, signal 
processing must be implemented that removes the unwanted background component at 
the front end, before the signal enters the section of the signal path that cannot handle the 
extreme dynamic range – before the optical signal is digitized.  In other words, the 
intrinsic optical properties of the sample must be used to reduce the level of background 
signal inherent in the system.  What we must do is to make the background optically 
“transparent” to the system; make it contribute little or not at all to the overall signal.  
This way, the resultant AC signal can now be sufficiently amplified, so that the required 
resolution can be achieved. 
 
The Optical Bridge is similar to the well-known Wheatstone bridge, which is often used 
to make strain gauge and other measurements.  A strain gauge has a static resistance 
distributed evenly across the four “arms” of the bridge.  The output of the Wheatstone 
bridge is fed to a differential amplifier.  When no load is applied, the Wheatstone bridge 
is “balanced” – all four arms have the same resistance, and therefore the Wheatstone 
bridge amplifier has a zero output voltage, regardless of the size of the resistance per arm.  
When a load is applied across one pair of the arms, their resistance changes slightly, 
yielding an output from the bridge amplifier that is directly proportional to the resistance 
change.  A conventional amplifier cannot readily detect this small change in resistance 
when it is accompanied by a large common mode signal, but the Wheatstone bridge 
output only produces differential signals caused by changes in the resistance of the arms 
of the bridge.  
 
The Optical Bridge is designed to overcome a similar problem.  As explained previously, 
it is not possible to detect a small signal caused by a change in urea concentration in the 
presence of the large background water signal.  Therefore, a null balanced method is 
applied.  While the Wheatstone bridge uses a differential amplifier to measure small 
changes in resistance across the arms of the strain gauge, the Optical Bridge measures the 
difference in light transmission between two wavelengths across the sample.  To continue 
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the analogy to the Wheatstone bridge, the absorbance at each measurement wavelength of 
the Optical Bridge can be likened to the resistance of each arm of the Wheatstone bridge.  
Small changes in absorption caused by the addition of analyte cause a proportional 
change in the output signal, regardless of the overall absorbance of the system.  The 
measurement wavelengths are selected to fulfill two criteria: 
 
1. The analyte should have a different absorption at each wavelength, preferably 
strong at the principal wavelength and weaker at the reference wavelength. 
2. The background must have the same absorption at both wavelengths. 
 
The output AC signal is proportional to the difference in the intensity of the transmitted 
light recorded at the two wavelengths.  When the wavelengths are selected according to 
the listed criteria, the output signal is proportional to the analyte concentration only.  If 
there is no analyte in the optical path, the signal is zero.  As the analyte concentration 
increases, so does the AC signal.  Figure 4.6.1 illustrates this principle. 
 
 
 
 
 
 
 
Figure 4.6.1: The Reference and Principal wavelengths are selected according to the 
criteria stated in §4.4.1.  With no analyte present, the output signal, represented by the 
line connecting the absorbance at the two wavelengths is zero.  This is true even when 
the sample thickness changes.  When the analyte is present, the absorbance at the 
Principal wavelength changes, causing a change in the output signal.  This change is 
shown greatly magnified in the figure. 
We have stated that the Optical Bridge is capable of nulling out a background signal from 
the sample by measuring the difference in light transmission at pair of wavelengths.  The 
measurement is more than a simple subtraction of two absorbance measurements, since 
this would involve analog to digital conversion of the entire sample. (background + 
analyte).  This would result in a large quantization noise, effectively obscuring the 
desired signal.  Instead, the background component is eliminated prior to data acquisition, 
so that a larger gain can be used and therefore a larger signal to noise ratio can be 
achieved.  Since the composition of the background is variable, the best wavelengths for 
effectively “balancing out” the background are selected in real time during each 
measurement.  
Wavelength
Transmittance 
Reference Principal 
No Analyte 
Analyte Present 
 40
 
The first major problem is due to the fact that the exact composition of a physiological 
sample is unknown.  For this reason, it is impossible to select, either theoretically or 
empirically, the best pair of wavelengths to use for any one measurement.  The best 
solution to this problem is to design the system such that it selects its own wavelengths in 
order to “balance out” the absorbance of the undesired background.  This indicates that 
the system must also have some means of performing measurements separately on the 
background (without the presence of the analyte being measured).  (The method for doing 
this will be described in §5.2).   
 
First, the Principal wavelength is chosen empirically by using known absorbance peaks 
for the analyte.  Then, with only the background fluid in the optical path, the system 
performs a series of measurements to select the ideal Reference wavelength (while the 
Principal wavelength is held constant).  When the optimal Reference Wavelength has 
been identified (thus balancing out the background), the analyte is allowed to re-enter the 
optical path, and the analysis takes place.  In this way, the large undesired background 
absorbance is removed from the signal, allowing a large degree of AC amplification to be 
applied to the desired signal without saturating the system.   
 
This measurement technique has two distinct stages.  The first stage is called balancing, 
and the second stage is measuring.  During balancing, as described previously, the optical 
path only contains clean dialysis fluid, the “background” for the measurement.  A beam 
of nearly monochromatic light, alternating between the Principal and Reference 
wavelengths, is directed into the sample.  See Figure 4.6.3.  This beam is generated using 
an Acousto Optical Tunable Filter (AOTF), which is manufactured by Brimrose 
Corporation (Baltimore, MD).  Appendix F includes a description of AOTF’s.  This 
device acts as a rapidly tunable narrow bandpass filter for a light source, which is a 100 
W halogen lamp.  A radio-frequency signal is applied to the AOTF that controls both the 
intensity and the wavelength of the light.  The light is amplitude and frequency 
modulated at 60 Hz producing, a two-phase beam at the Reference and Principal 
wavelengths.   
 
During the first phase, the transmitted light consists of the Principal wavelength, and 
during the second phase, it consists of the Reference wavelength.  At the entrance to the 
sample, the light intensity of the two phases of the beam is equal.  Initially, at the exit of 
the sample, one phase of the beam will be attenuated more than the other.  See Figure 
4.6.2.  During the balancing stage, the Principal wavelength (which is absorbed by urea) 
is held constant, and the reference wavelength is adjusted until the exit intensities are the 
same for both phases (or wavelengths).  This can be explained graphically by examining  
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Figure 4.6.1.  The bottom curve represents a typical spectrum of dialysate in water.  The 
balancing process can be represented graphically by the shifting of the reference 
wavelength left or right until the line connecting the two wavelengths is parallel to the x 
axis. When this is achieved, the system is considered balanced, and the measurement 
stage can begin.  The real time nature of this procedure accounts for possible changes in 
the composition of the fluid or temperature of the fluid from measurement to 
measurement, rather than relying on a fixed set of wavelengths.  At the end of this 
balanced stage, the output signal is approximately zero.   
 
At this point, we introduce a notation convention.  Data that is recorded from the 
instrument during the balancing phase of the measurement is given the suffix 00.  Data 
that is recorded from the instrument during the measuring phase is given the suffix 1.  
Therefore, the AC signal during the balancing phase is represented by AC00, while the 
AC signal during the measuring phase is represented by AC1.  Additionally, the term 
position 00 is used to represent the compressed state of the sample during the balancing 
phase.  The term position 1 is used to represent the uncompressed state of the sample 
during the measuring phase. 
 
The output signal itself is actually obtained from a lock in amplifier (LIA) that is tuned to 
the wavelength chopping frequency. A LIA consists of a phase sensitive detector that is 
followed by a low-pass filter. The LIA outputs a signal that is proportional to the 
difference between the two phases of its input.  During balancing, the system adjusts the 
reference wavelength to minimize this signal.  The input to the LIA at the beginning of 
the balancing phase is roughly a small amplitude square wave.  At the end of balancing, 
the amplitude of the square wave is very small. (Ideally, it is zero, but this cannot be 
achieved in practice due to noise).  Once the analyte is allowed to enter the path, the 
sample absorbance at the principle wavelength, which responds to the presence of urea, 
increases, and the AC signal becomes large.  This signal is then recorded. This process is 
demonstrated in Figure 4.6.2. 
Figure 4.6.2: The Optical Bridge input signal during three phases of the measurement.  
 
When the measurement process begins, the optical path is changed, allowing the spent 
dialysate into the sample path.  The mechanism for this operation is described in 
Appendix E.  The addition of this “incremental sample” causes a change in the output 
signal that is proportional to the analyte concentration.  The term incremental sample 
refers to the addition of the portion of the sample that contains the analyte.  
prior to balancing     balancing complete         urea added, bridge unbalanced
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Geometrically, the incremental sample is located next to the background sample that 
contains no analyte – see Figure 4.6.3.   
 
Once the measuring stage begins, the optical path contains both the background and 
incremental analyte sample.  At this point, the light intensity exiting the background is 
equal for both wavelengths, because the wavelengths have been selected so that the 
background attenuates both phases of the transmitted light equally.  So, the intensity of 
light at the entrance to the incremental sample is the same for both wavelengths.  The 
only thing that can contribute to an unequal attenuation of either wavelength phase is the 
presence of the analyte in the optical path.  
 
While it is true that certain substances can interfere with this measurement, it should be 
possible to avoid this effect by careful selection of wavelength pairs and possibly by 
using multiple wavelength pairs. The measurements resulting from the use of other 
wavelength pairs could be used to extract the urea signal from the undesired analyte by 
regression analysis, deconvolutions, or other similar techniques. This would involve 
careful studies of how the interfering analyte affects the measurement at both sets of 
wavelengths, and the development of a mathematical model based on the analysis of the 
experimental data.  §4.8 discusses the possible effects of interfering substances on the 
measurement.  Figure 4.6.3 shows a schematic diagram of the balancing and 
measurement stages and the light intensity at each position in the sample. 
Figure 4.6.3: Light intensity at the entrance and exit of the sample is represented for 
each wavelength phase by the length of the arrow.  It is always equal entering the 
sample.  In (a), prior to balancing; the light intensity at the exit is unequal.  At (b), 
after balancing, the light intensity for both phases is the same.  In (c), the 
measurement stage has begun, and the spent dialysate sample is included.  The light 
intensity exiting the clean sample is equal, but it is different after exiting the spent 
“incremental sample”. 
4.6.2 Ideal Mathematical Model for the Optical Bridge 
The Optical Bridge signal, S, is equal to the difference between the signal power at the 
two measurement wavelengths.  During balancing, where the sample is most tightly 
compressed, the analyte has been squeezed from the sample.  Since there is no analyte in 
the optical path, the AC signal will be zero: 
 
S00 = ∆P = Pλ1 – Pλ2 = 0     ( 4.16 ) 
 
During the measuring phase, where the sample has been uncompressed, and the analyte 
has re-entered the optical path, there is a non-zero signal.  The absorption coefficient k 
over the sample has now changed by some ∆k due to the resulting addition of analyte 
when the sample is uncompressed.  The signal can now be represented by: 
C
lean
C
lean
C
lean
Spent 
    (a)                                                       (b)                                                             (c) 
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S1 ≠ 0 = P0 [10-(k-∆k)⋅x – 10-k⋅x] = P0 10-k⋅x [10∆k⋅x - 1]   ( 4.17 ) 
=
∆k·x « 1, so it is possible to use a well-known Taylor series approximation:          
 
10∆k⋅x = 1 + ∆k⋅x                 ( 4.18 )  
 
So, in the final form, the signal is represented by: 
 
S1 = P0⋅∆k⋅x⋅10-k⋅x     ( 4.19 ) 
 
The ∆k term is directly related to the analyte concentration, and Equation 4.19 
demonstrates that the signal obtained from this system is directly related to this term.  
The signal is also affected by the power incident on the sample, the pathlength traversed 
in the sample, and the logarithmic reduction in signal power due to Beer’s law.  Equation 
4.19 can be solved for ∆k to obtain the following result:  
xkxP
Sk
⋅−
⋅⋅
=∆
10
1
0
     ( 4.20 ) 
 
In order to obtain a concentration estimate from ∆k, a two-point calibration may be used.  
This involves the linear fit of two sample concentrations to obtain slope and intercept 
information. The slope should be related to the difference in extinction coefficients for 
the analyte in question between λ1 and λ2. 
 
This mathematical model is for an ideal system, and it therefore has somewhat limited 
application in practice.  Chapters 5 and 7 describe this system in greater detail, and 
propose compensations for this algorithm that are required for it to function in the 
presence of noise and other complicating factors. 
4.6.3 Application of the Optical Bridge to Urea Measurements in Dialysate 
The Optical Bridge technique has undergone several years of development in the area of 
non-invasive monitoring of blood glucose for diabetics.  For this measurement, a 
capillary-rich site such as the earlobe is used.  The glucose is assumed to reside mainly in 
the blood, and the system is balanced by gently squeezing the tissue to displace blood and 
glucose from the measurement site.  Once balancing is complete, the squeeze is relaxed, 
and the measurement takes place.  While it has been assumed, since the inception of this 
approach that it is possible to measure other analytes with this method, only glucose 
research has been done in that area with the exception of this thesis.  Two major obstacles 
must be overcome when attempting to measure a new analyte with this method.  First, a 
method of separating the background from the analyte must be determined, similar to the 
technique of squeezing blood out of the tissue to displace glucose.  For in vivo 
measurements, this involves determining whether or not tissue squeezing displaces the 
substance in question.  For our application, this measurement is performed on spent 
dialysate, rather than tissue, thus we have a natural background in the clean dialysis fluid.   
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Second, a pair of measurement wavelengths must be found that satisfies the wavelength 
criteria.  This can be done by dissolving high concentrations of urea in water or dialysis 
fluid, and analyzing them with a conventional spectrophotometer.  By making a series of 
measurements on increasingly diluted samples, it is possible to find wavelengths at which 
the absorbance is strongly dependent on urea concentration.  These wavelengths become 
the potential Principal wavelengths.  By looking only at clean dialysate, we then attempt 
to find other wavelengths where the absorbance is equal (isoabsorbance) to the Principal 
wavelength.  These wavelengths become the Reference wavelengths.  It should be noted 
that the Reference wavelength selected by this method is only a starting point for the 
adaptive balancing algorithm.  As has been described in this section, the Reference 
wavelength is actually selected automatically each time during the balancing stage of the 
measurement. 
4.7 The Near-IR Absorbance Characteristics of Urea and Water 
In this section, we will discuss the IR absorption spectrum of urea in terms of its 
functional groups, in order to support our hypothesis that energy at 1486 nm can be used 
to measure urea.   
 
Urea (CN2H4O) is a single carbon molecule that is derived from the breakdown of 
protein.  It consists of two amide (R-CONH2) functional groups.  There are two main 
absorptions due to the amide groups.  The first is a carbonyl (C=O) stretching vibration 
occurring at 5945 nm (1682.1 cm-1), known as the amide I band.  This frequency is 
slightly higher than for other carbonyls due to resonance effects with the NH2 group.  The 
second band, known as the amide II band, is derived from N-H bending, and occurs at 
6254 nm (1599.1 cm-1).  A weaker absorption band occurs at 6640 nm (1506.1 cm-1) due 
to an interaction between the N-H bending and the C-N stretching.  The C-N stretch itself 
gives rise to a very weak band near 7143 nm (1400 cm-1).  Finally, a broad, medium 
strength band between 16 and 23 nm (660 and 440 cm-1) occurs due to out-of-plane N-H 
wagging. 
 
The amine group shows two bands due to N-H stretching vibrations.  The first occurs at 
2906 nm (3440.6 cm-1), and the second occurs at 2914 nm (3234.2 cm-1).  The first is due 
to a symmetrical stretch, and the second is due to an asymmetrical stretch of the N-H 
bond.  The amine group also gives rise to an N-H bending vibration at approximately 
6173 nm (1620 cm-1), but this peak is almost completely merged with the N-H bending 
band of the amide group.  N-H wagging also occurs in this group, but it is blended with 
the N-H wagging of the amide group.  Finally, a C-N stretching vibration also gives rise 
to a band at 8658 nm (1155 cm-1). 
 
We have determined that urea is sensitive to energy at 1486 nm.  This is the fourth 
harmonic of the carbonyl band at 5945 nm.  The carbonyl band was chosen because it is a 
characteristically strong, stable peak.  In addition, this peak is shifted to a relatively 
unique position due to the N-H resonances on either side of the C=O bond, which is an 
important consideration in the specificity of the measurement.  The fourth harmonic was 
chosen for a number of reasons, mainly having to do with optical hardware 
considerations.  We require a source of radiation which: 
 45
 
•= Has a narrow linewidth 
•= Is rapidly tunable 
•= Preferably has no moving parts 
•= Can be acquired at a reasonable cost 
 
As has been discussed elsewhere, the device that best fits these requirements is an AOTF.  
The upper range of AOTF operation is approximately 4500 nm.  As the operating range 
increases, the spectral resolution becomes worse.  The operating range of the AOTF used 
in this research is 1200-1800 nm, where the spectral resolution is approximately 2 nm.  
Indium Gallium Arsenide (InGaAs) detectors have a fairly low noise level and function 
in the same spectral region.  Urea still has a reasonable absorption at the fourth harmonic 
(it decreases by approximately a factor of four from the primary band), so this represents 
the ideal tradeoff in terms of available hardware.   
 
The chosen urea peak lies on the side of a steep water peak that is the third harmonic of 
an O-H bending band.  In dialysate, the nearest balance point to the 1486 nm occurs at 
approximately 1393 nm.  This wavelength will vary with sample composition at 
measurement time. 
4.7.1 Optical Characteristics of Absorbing Substances in the near-IR 
Here we explore how overtone bands in the near-IR arise from fundamental absorption 
bands in the mid-IR.  Using water as an example, we will show how the magnitude and 
bandwidth of the relevant bands are changed as the wavelength decreases into the near-
IR.  The fundamental water absorption band (caused by an OH stretch) occurs at 
approximately 3500 cm-1 (2891 nm).  It has a bandwidth of approximately 340 nm.  This 
curve can be seen below in Figure 4.7.1.   
 
 
Figure 4.7.1: Absorbance spectrum for water in the mid-IR.  
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Figure 4.7.2 shows that this fundamental absorbance band gives rise to an overtone band 
in the near-IR at approximately 1445 nm.  Overtone bands occur as harmonics at 
multiples of the fundamental frequency. The bandwidth of this peak is approximately 135 
nm. The peak absorbance at 1445 nm is approximately 0.22. The near-IR spectrum of 
water is shown in Figure 4.7.2.  
 
It is difficult to draw conclusions about the relationships between bandwidths and 
absorbance values in the fundamental and overtone bands.  The spectra presented here 
were recorded with different instruments and at different sample pathlengths, which 
prevents a direct comparison.  It does seem clear that the overtone peak is the second 
harmonic of the fundamental peak, as the peak wavelength is almost exactly a factor of 
two lower.  However, the bandwidth and peak absorbance values do not follow the same 
reduction at first glance.  The factors are 2.5 and 4.4, respectively.  It seems likely that 
the NIR spectrum was recorded from a sample where the pathlength was greater than for 
the mid-IR sample.  This is because water absorbs more strongly in the mid-IR, and 
therefore thinner samples are required in this region.  The thicker sample would lower the 
overall transmission in the NIR spectral scan.  This could also produce a decrease in the 
apparent spectral bandwidth.  Despite this information, it seems reasonable to conclude 
that decreases in both bandwidth and amplitude are of the same order of magnitude as the 
overtone itself.   
 
 
Figure 4.7.2: Absorbance spectrum for water in the Near-IR.  
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4.7.2 Reflectance spectrum of urea in the NIR 
Figure 4.7.3 shows a curve of the reflectance of dry urea in the near-IR.  Note the 
absorbance band centered at 1485 nm, which is an overtone of the fundamental carbonyl 
stretch band at 5945 nm.  The aqueous spectrum displays similar features.  
 
Figure 4.7.3: Reflectance spectrum for dry urea in the Near-IR. 
4.8 Analysis of Potential Interfering Substances 
In this section, we will discuss the potential effects of other organic solutes on the 
measurement of urea in dialysate by optical means.  A list of potential interferences will 
be identified and grouped by category.  Whenever possible, the identifying IR 
characteristics of these molecules will be presented.  Molecules or groups of molecules 
that have similar absorbance characteristics to urea will then be identified.  If they are 
present in dialysate at a significant concentration level, they will be considered to be 
potential interferents.  Note that inorganic ions will not be considered, as they do not 
vibrate strongly in the region of interest.   
 
The first step in this analysis is to determine what the composition of spent dialysate is. 
Many of the molecules making up spent dialysate are well known to physicians and 
researchers.  Others have simply been termed “middle molecules”.  Their molecular 
weights have been determined by mass spectrometry or gas chromatography [64,67,70].  
These middle molecules have not been structurally identified, but are widely believed to 
be protein fragments and amino acid chains.  Table 4.8.1 shows a listing of the categories 
of substance contained in dialysate, and examples of compounds in each category where 
appropriate.  
 
IR Spectra of most of these compounds were obtained from the Aldrich FT-IR Spectral 
Library [74].  In some cases, spectra were not available. These compounds appear in 
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italic type in Table 4.8.1.  For those compounds, the spectral characteristics were 
estimated from principles of IR analysis [75,76].  For each compound, the following data 
was recorded: 
 
•= Name 
•= Chemical structure 
•= Molecular weight 
•= Maximum absorbance value at each significant peak 
•= Absorbance value at 5945 nm (since this wavelength is hypothesized to be urea-
sensitive).  We are using the primary absorbtion wavelength rather than the 
overtone absorbtion wavelength because it is not possible to measure the 
absorbance of many of these compounds at the overtone wavelength. 
•= Unit absorbance value: Defined as the absorbance value per mg/dl (Calculated 
from the spectrum on the basis of solute/solvent mole fraction and Beer’s Law) 
•= Mean concentration in dialysate.  While mean concentrations of many of these 
substances vary widely among uremic patients, the values should be appropriate 
to an order of magnitude at least. 
 
From this information, a sensitivity factor was derived.  This number is the unit 
absorbance value multiplied by the mean dialysate concentration.  From this, we can 
determine which molecules or categories of molecules are likely to interfere with our 
measurement.  Figure 4.8.2 shows the relative magnitude of the sensitivity factor of 
possible interfering substances to that of urea. This graph is plotted logarithmically, since 
the sensitivity factors for all other substances are orders of magnitude smaller than that of 
urea.  The data used to arrive at the sensitivity factors for these compounds can be found 
in Appendix E. 
Table 4.8.1: List of potential interferents in spent dialysate.  Compounds for which 
spectra are not available are in italics. 
Substance/Category Example (if applicable) 
Urea  
Guanidines Methylguanidine, guanidine, β-guanidinopropionic acid, 
Guanidinosuccinic acid, γ-guanidinobutyric acid, Taurocyamine, 
Creatinine, Creatine, Arginic acid, Homoarginine, N-α-
acetylarginine 
Phenols o-cresol, p-cresol, benzyl alcohol, phenol, tyrosine 
Phenolic acids P-Hydroxyphenylacetic acid, β-(m-Hydroxyphenyl)-Hydracrylic 
acid 
Hippurates p-Hydroxyhippuric acid, o-Hydroxhippuric acid, Hippuric acid 
Benzoates Benzoic acid 
Polypeptides  
β2-microglobulin  
Indoles Indol-3-acetic acid, Indoxyl sulfate, 5-Hydroxyindol acetic acid, 
Indol-3-acrylic acid, 5-Hydroxtryptophol, N-acetyltryptophan, 
Tryptophan 
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Middle Molecules  
Ammonia  
Alkaloids  
Trace metals Bromine 
Uric acid  
Cyclic AMP  
Amino acids Glycine, Leucine, Cysteine, Arginine 
Myoinisitol  
Mannitol  
Oxalate  
Glucuronate  
Glycols Glycolic acid 
Lysozyme  
Hormones Parathormone, Natriuretic Factor, Glucagon, Growth Hormone, 
Gastrin, Prolactin, Catecholamines 
Xanthines Xanthine, Hypoxanthine 
Furanproprionic 
acid 
 
Amines Putrescine, Spermine, Spermidine, Dimethylamine, Polyamines 
Endorphines  
Pseudouridine  
Potassium  
Calcium  
Sodium  
Phosphorous  
 
On the basis of absorbance values alone, the following groups were determined to be 
significant: guanidines, phenolic acids, benzoates, some indols, uric acid, oxalalates, 
glycols, and xanthines.  Amines, amino acids and polypeptides were not shown to have 
significant absorbance values in the region of interest.  It is unlikely that hormones or 
middle molecules show significant absorbtion in this region due to their similarities to 
these molecules.  Any absorbance value greater than 10% the value of urea is deemed to 
be significant.  The unit absorbance values are shown in Figure 4.8.1. 
 
In terms of potential interferences based on significant concentrations, only glucose, uric 
acid, and amino acids are found at concentrations similar to that of urea.  In some patients 
with high protein intake, creatinine may be significantly increased.  Any mean 
concentration greater than 10% of the mean urea concentration value is deemed to be 
significant.  The mean concentration values are shown in Figure 4.8.2.  
 
In the final analysis of the sensitivity factor, no compounds interfered at a level greater 
than 5%.  Creatinine (3.4%), uric acid (1.6%), glucose (1.0%) and total amino acids 
(0.8%) provided the most significant sensitivity factors.  The overall results are shown in 
Figure 4.8.2.  The sensitivity scale is normalized to the sensitivity to urea, which is 
around 0.2 mAbs. Since the sensitivity factors for substances other than urea are very 
small, the graph is plotted logarithmically.  Compounds that are represented with a 
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diamond symbol in Figure 4.8.2 were determined to have absorbance peaks near that of 
urea. 
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Figure 4.8.1: This bar graph shows the unit absorbance (per mg/dl) of many potential 
interferents in the spent dialysate fluid.  The mean concentration of each substance in 
dialysate is superimposed on the graph as a line plot.   The mean concentration figures 
are those for a typical dialysis patient.  
Since we are actually using harmonics of the 5945 nm band, it is necessary to check if the 
interfering substances may also have harmonics occurring at or near 1485 nm.  In the 
Figure 4.8.3, the desired urea measurement wavelength is marked with large square 
symbol.  Harmonics of bands attributed to other compounds are represented as triangular 
symbols (2nd harmonic) and diamond symbols (4th harmonic).  There are a few bands 
within a ±5 nm range of 1485 nm.  These bands can be attributed to: o-cresol, benzyl 
alcohol, benzoic acid, and cyclic AMP.  None of these compounds appear at a high 
enough concentration relative to urea to significantly affect the measurement, and their 
sensitivity factors are at least 10,000 times below that of urea.  For this reason, the 
analysis was not repeated at the reference wavelength.  The effects of water absorbance 
will overshadow all other absorbers at that point. 
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Figure 4.8.2: This graph shows the logarithm of the sensitivity factor of each 
compound.  All compounds not listed have sensitivity factors that are more than an 
order of magnitude lower than urea. Compounds that have harmonic absorption bands 
near that of urea are marked with diamonds on the figure. 
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Figure 4.8.3: This graph shows the location of harmonics bands of potential 
interferents.  These Near-IR harmonic bands are derived from fundamental bands in 
the IR.  Several compounds show peaks near the desired urea peak, (those that appear 
within the band on the figure) but do not appear in dialysate at a concentration that 
could interfere with the measurement.  These compounds are also identified on the 
sensitivity graph, Figure 4.8.2. 
 
4.9 Multiple Linear Regression 
  MLR is a powerful tool that requires careful application.  It assumes that a linear 
relationship exists between a dependent variable Y and k independent variables X1, X2, …, 
Xk [77].  Stated differently: 
 
yj = β0 + β1x1j + β2x2j + ⋅⋅⋅ + βkxkj + ej,    (4.21) 
 
Here, ej is the deviation of the regression from the actual value of yj and βj are the 
individual weighting coefficients for the independent variables.  In order to obtain the 
partial regression coefficients β0:βk, the method of partial least squares is used.  The sum 
of the squared deviations of the observed Y vs. the value obtained from the regression 
equation is minimized [77].  In equation form, this means that we select β0:βk such that 
the following expression is minimized:  
 
( )−−−−= 221102 kjkjjjj xxxye βββ    (4.22) 
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This quantity is referred to as the sum of squares of the residuals (SSR).  It is written in 
short form as: 
 
      − 2)ˆ( yy j      (4.23) 
 
This equation can then be solved by any convenient means to obtain the partial regression 
coefficients [77]. 
 
Once the partial regression coefficients have been obtained, they must be evaluated for 
significance to the data both individually and collectively.  We need to know if each 
individual variable makes a statistically significant contribution to the overall model, and 
whether or not the overall model is not only a good fit of the data, but is also statistically 
significant.  To test the goodness of fit, we calculate the coefficient of multiple 
determination according to the following formula [77]: 
 
 
−
−
= 2
2
2
)(
)ˆ(
..1 yy
yy
R
j
y k      (4.24)  
 
The quantity in the numerator of equation 4.24 is known as the explained sum of squares. 
It represents the sum of squares of the deviation of the calculation from the mean value of 
y (SSE).  The quantity in the denominator is called the total sum of squares (SST).  It 
represents the sum of squares of the deviation of each individual y from the mean value 
of y.  Therefore, the quantity Ry1…k2 is a measure of what percent of the variation in the 
data can be explained by the regression. 
 
In order to evaluate the significance of the model, a hypothesis test is performed.  The 
null hypothesis, H0, is that β0 = β1 = … = βk = 0, or that none of the variables are of value 
in explaining the variation in Y.  The alternate hypothesis, HA, is that not all βk = 0.  An 
ANOVA (Analysis of Variance) table can then be constructed for the regression1: 
Table 4.9.1: Analysis of Variation (ANOVA) Table 
SOURCE SS d.f. MS V.R. 
Due to 
Regression 
SSR k   MSR = SSR / k MSR  / MSE 
About 
Regression 
SSE n – k – 1  MSE = SSE /  
(n – k – 1) 
 
Total SST n – 1   
 
H0 should be rejected if the value of the variance ratio (V.R.) is greater than the critical 
value of the F statistic for k and n-k-1 degrees of freedom.  If H0 is rejected, then we can 
conclude that the regression model is a good fit to the data.  The individual variables can 
                                                 
1 (SS = Sum of Squares, d.f. is the degrees of freedom, k is the number of variables, n is the number of data 
points, MS is mean square, V.R. is variance ratio, SSR is the regression (explained) sum of squares, SSE is 
the error (unexplained) sum of squares. 
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also be checked for goodness of fit with a student’s T test.  The computer program that 
does the analysis (in this case Microsoft Excel™) returns both the coefficient (βk) and the 
standard error (sek) for each variable.  The t statistic is βk/sek.  The variable is significant 
if t is greater than tcritical at the chosen level of significance [77]. 
 
When developing a model based on the MLR approach, there are several pitfalls that 
must be approached carefully.  First, it would be very easy to “overfit” the data.  
Obviously, if a large number of variables are fit to a small amount of data, the model 
carries very little statistical weight.  A general rule of thumb is that the number of data 
points should be at least three times greater than the number of variables [77].  Second, it 
is important that the variables that are fit to the data “make sense” given the functioning 
of the system.  In other words, the selection of a variable for inclusion in the model 
should have logical reasoning behind it.  This reduces the risk of developing a 
statistically insignificant model.  Finally, the regression statistics must be considered 
carefully.  Each variable should be checked for significance to the model using a 
student’s t test, and the significance of the overall regression should be tested using 
analysis of variance (ANOVA). 
4.10 Summary of Background Information 
It is possible to draw a number of conclusions from the material presented in the previous 
sections of this chapter, and from the literature.  These include: 
 
•= There are a number of physiological manifestations of kidney failure, and a number 
of metabolic causes.  Kidney failure may be acute or chronic.  Cases of acute kidney 
failure may often be cured, while chronic kidney failure is usually degenerative and 
permanent.  Both types of kidney failure are eventually fatal if not treated promptly.  
•= Dialysis is a viable method of substituting or assisting the function of ailing or 
diseased kidneys.  Hemodialysis and peritoneal dialysis are two of the most common 
methods of renal function replacement therapy. 
•= When dialysis is used to replace the function of failed kidneys, changes in urea 
concentration are the most obvious physiological change. 
•= Presently, there is no dialysis monitoring technique that satisfies the major 
requirements for a clinically accepted and useful instrument. 
•= Many investigators have shown that urea concentrations in blood and spent dialysis 
fluid correlate with the expected prognosis of dialysis patients. 
•= The Optical Bridge presents a viable method of monitoring concentrations of 
physiological analytes without reagents or user intervention. 
•= It is possible to develop a mathematical model relating the output of the instrument to 
the concentration of urea in spent dialysate. 
•= Urea levels in spent dialysate present a good estimator of the performance of the 
dialysis session 
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5 DIALYSIS EFFICIENCY MONITORING SYSTEM  
DESIGN OVERVIEW 
In this chapter, we begin by introducing the design process that was undertaken in the 
construction of this Optical Bridge based system.  Some of the more advanced topics 
concerning the operational principles of this technique are discussed as well.  At the most 
basic level, the dialysis monitoring instrument must direct a beam of light into the 
dialysate sample and record the amount of light exiting the sample.  This light signal 
must be converted to an electrical signal, amplified and filtered, and converted to a digital 
signal so that it may be processed by a special software algorithm.  The block diagram of 
the system is shown in Figure 5.1.1.  The details of these subsystems are described in the 
Appendices.   
5.1 Design Overview 
In order to obtain a sufficiently accurate measure of urea concentration using an optical 
method, it is necessary to balance out the much larger absorbance signal that arises from 
the rest of the sample matrix (background) - See §4.6.  This section describes a 
measurement that relies on the selection of two wavelengths.  The absorption at one of 
these wavelengths, the Principal wavelength, is sensitive to the presence of urea.  The 
other wavelength, the Reference wavelength, is automatically tuned during the 
measurement to achieve exactly the same absorbance (isoabsorbance) in the background 
as with the Principal wavelength.  The system output signal, which is proportional to the 
difference in sample absorbance between the two wavelengths, is therefore able to nullify 
the contribution of the background signal.  All that is left is the signal from the desired 
analyte, urea, which can then be amplified and processed sufficiently to yield an accurate 
measurement.   Refer to §4.6 for a more complete discussion of the Optical Bridge. 
 
It is necessary to decide upon a starting point in the explanation of the system.  Since we 
have stated that the main function of the system, at its most basic level, is to monitor light 
transmission, we will begin at that point. 
 
The light that has passed through the sample (i.e. the light that was not absorbed by the 
sample) hits a photodetector and is converted to an electrical signal.  It must be processed 
in several steps by the system hardware to obtain the desired information, namely the 
Optical Bridge signal.  A discussion of the hardware subsystems and components of this 
system can be found in the Appendix. (This material appears in the Appendix since the 
focus of this research is on algorithm development rather than instrument design.)  The 
general signal processing and control tasks performed by the hardware include:  
 
•= Generating intensity and wavelength control signals for modulating the light 
output of the system. 
•= Transducing the received light into an electrical signal. 
•= Amplifying and filtering the resulting signal. 
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•= Demodulating the signal into two component parts, one for each phase of the 
beam (Reference and Principal). 
•= Producing an analog signal that is proportional to the difference in light 
transmission between the Principal and Reference wavelength beam phases.  
•= Converting the analog signals to digital signals and transferring the results to the 
PC.   
•= Protecting the patient from possible harmful currents and the instrument from 
noise from the PC. 
•= Generating the movements of the position control system. 
 
Figure 5.1.1: Signal block diagram of the system. Symbols used in the diagram are 
defined in Table 5.2.1. 
The hardware is responsible for measuring the transmitted light and controlling its 
intensity and wavelength.  There are several important considerations in how this light is 
delivered to the sample.  The physical and optical layout of the system is discussed in 
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Appendix E.  This layout includes the optical components required to focus the light, 
component mounting hardware, a measurement cuvette for holding the dialysis fluid, the 
interface to the dialysis machine, and the position control system.  We also discuss how 
the light is filtered and the desired wavelengths are generated, and calculate the expected 
light throughput. 
 
This system requires control software that is responsible for both controlling the 
hardware and analyzing the data.  Appendix B gives a description of the special control 
software that was developed to complete the system design.  This software is responsible 
for several tasks, including: 
 
•= Managing data flow between the PC and the hardware via the PC’s parallel port. 
•= Overseeing data acquisition operations. 
•= Sending the intensity and wavelength control information to the hardware. 
•= Automatic Reference wavelength selection during the balancing phase of a 
measurement. 
•= Applying the signal processing algorithm to the acquired data to yield a urea 
concentration measurement and a measure of dialysis efficiency.  
•= Directing the movements of the position control system. 
5.2 Description of Measurement Principles 
In §4.6, the Optical Bridge principle was introduced.  It was noted that the measurement 
involves balancing out the strong absorbance of the background by automatic selection of 
the Reference wavelength.  In addition to balancing the background signal by changing 
this wavelength, the system may also vary the intensity of the beam. The light beam 
alternates between energy at the Principal wavelength and energy at the Reference 
wavelength with a 50% duty cycle.  The intensity of the Principal wavelength phase, 
known as P_INT, of the beam is held constant throughout the measurement, just like the 
Principal wavelength itself.   
 
The intensity of the Reference wavelength phase of the beam (R_INT) is a slave control 
to the intensity of the Principal wavelength phase. A proportional-integral controller 
(PIC) is used for this purpose. (Note that although we speak of intensities here, we are 
really dealing with voltages that result from the conversion of the light intensity to an 
electrical signal).  
 
The system has the ability to automatically and precisely control the intensity difference 
between the Principal and Reference phases of the beam.  This is done by summing a 
control signal into the PIC.  This control signal is called OFFSET.  Stated differently, the 
PIC sets the Reference intensity (R_INT) equal to the Principal intensity minus a value 
that is proportional to the offset.  The offset control is also used to balance the output 
signal during the first stage of a measurement.  The Principal wavelength and intensity 
are held constant throughout the measurement, so the PIC is used to turn the beam 
intensity at the Reference wavelength intensity into a slave to the intensity at the 
Principal wavelength. If both controls were independent, variations in the sample or 
system during the measurement could affect the measurement.  This approach minimizes 
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the number of variables due to transmitted, rather than received intensity.  Note that 
P_INT and R_INT are electrical signals that set the transmitted intensity incident on the 
sample. The system also records received intensity signals.  The first is DCIP, which is 
proportional to the incident radiation on the optical detector at the principal wavelength.  
The second is DCIR, which is related to the incident radiation on the optical detector at 
the reference wavelength.  These two signals are recorded by an auxiliary detector (AD) 
that receives a portion of the transmitted light via a beam splitter.  The third signal, 
DCSP, indicates the amount of power at the principal wavelength received at the detector 
after the beam traverses the sample.  The final signal, DCSR, is related to the received 
intensity of energy at the reference wavelength.   
 
The differential transmission signal is derived from the signals DCSP and DCSR.  These 
two signals are AC coupled (to remove drift) into a phase sensitive detector (PSD). The 
PSD output is a signal that is equal to the difference between the two phases of the beam.  
This signal is then amplified and low pass filtered. The resulting signal is known as AC.  
 
Three other signals are recorded by the system.  Two are temperature measurements.  The 
first is the temperature of the optical detector, DETTEMP, and the second is the 
temperature of the sample, SAMTEMP.  The final parameter is the pathlength through 
the sample, DIS. A summary of the relevant parameters and their symbols is given in 
Table 5.2.1. 
Table 5.2.1: List of system parameters and their symbols. 
AC Electrical signal proportional to the difference in transmission through 
the sample between the principal and reference wavelengths. 
P_INT Electrical control signal used to set the intensity of the principal 
wavelength phase of the light beam. 
R_INT Electrical signal used to set the intensity of the reference wavelength 
phase of the light beam. 
OFFSET Electrical control signal used to set the difference between P_INT and 
R_INT.   
DCSP Electrical signal proportional to the intensity of light received at the 
principle wavelength after the beam traverses the sample. 
DCSR Electrical signal proportional to the intensity of light received at the 
reference wavelength after the beam traverses the sample. 
DCIP Electrical signal proportional to the intensity of light incident on the 
auxiliary detector (AD) at the principal wavelength.  Related to 
transmitted signal power. 
DCIR  Electrical signal proportional to the intensity of light incident on the 
auxiliary (AD) detector at the reference wavelength.  Related to 
transmitted signal power. 
DETTEMP Electrical signal proportional to the temperature of the optical detector. 
SAMTEMP Electrical signal proportional to the temperature of the sample. 
DIS Electrical signal proportional to the thickness of the sample 
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These parameters can be related to the mathematical model proposed in §4.6.2.  This 
model stated that the analyte concentration was proportional to the following formula:  
 
    xkxP
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⋅⋅
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1      (5.1) 
=
∆k is the differential transmission, S1 is the measured signal, P0 is the incident signal 
power, x is the pathlength, and k is the extinction coefficient of the medium.  Using the 
symbols described in this section, Equation 5.1 could be re-written as  
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The proportionality constant, G, can be determined experimentally by calibrating against 
a known standard. 
5.3 Measurement Procedure 
Now that we have described the hardware capabilities of this instrument, we must discuss 
how this measurement is made. During the balancing stage of the measurement, only 
clean dialysis fluid is in the optical path, without the presence of the analyte being 
measured.  At this time, two sets of adjustments are made to try to null the background as 
completely as possible.  First, the system software adjusts the offset in an attempt to 
equilibrate the amount of light received through the sample at the Principal wavelength 
and at the Reference wavelength. The system attempts to minimize the AC signal by 
adjusting the OFFSET control, and thus the intensity of the Reference wavelength phase 
of the beam (R_INT).  See Figure 4.6.2.  
 
The change in offset results in a change in the Reference intensity.  This in turn causes a 
change in the AC signal depending on the properties of the sample.  When this signal is 
sufficiently close to zero (usually less than 10 mV), the second part of the balancing stage 
begins.  This involves adjusting the Reference wavelength, again trying to zero the AC 
signal.  Stated differently, both the frequency and the intensity of the energy transmitted 
during the Reference wavelength phase of the beam are adjusted in an attempt to 
minimize the AC signal. These two adjustments are repeated in an iterative fashion until 
the background is sufficiently balanced out, and the signal effectively minimized.   
 
Note that each of the parameters listed in Table 5.2.1 may appear alone or with a numeric 
suffix. The suffix may be 00, 0, or 1.  The suffix is used to denote the particular phase of 
the measurement.  For example, AC1 is the differential signal recorded during the 
measurement phase (after balancing when the spent dialysate has been returned to the 
optical path).  AC00 refers to the same signal, but recorded at the completion of the 
intensity-balancing portion of the measurement.  AC0 is then equal to the differential 
transmission signal after the completion of the wavelength-balancing phase of the 
measurement. 
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Practically, it is not possible to perfectly balance the system (null the background) using 
either the wavelength or intensity adjustment.  This is due to noise, both optical and 
electrical that is present in the system.  The balancing process is completed at some 
acceptable level, and the residual signal is recorded.  This residual signal from the 
incomplete balancing will contribute to errors once the urea-laden dialysate enters the 
optical path during the measurement.  If we know how large the error is during the 
balancing stage, it will be possible to correct for the error in the final analysis, since the 
error should project linearly with distance through the sample. (This claim results from 
the application of Beer’s Law). We shall now attempt a mathematical explanation of this 
claim.   
 
We have two sources of error, (intensity balance residual signal: εi, and wavelength 
balance residual signal: εw).  The final induced error will also depend on the overall 
pathlength through the sample.  The two error sources also depend on the thickness of the 
sample (DIS).  If both steps of the balancing process were done at the same pathlength, it 
would be impossible to determine the effect these errors have on the overall result, (AC 
after the urea laden dialysate re-enters the path.) This is because the sample transmission 
depends on both the extinction coefficient of the sample and the sample pathlength. 
Therefore, we have two variables and only one data point.  This problem is solved by 
performing the two balancing steps at different sample pathlengths, from which a second 
data point is obtained.  See Figure 5.3.1.     
 
We can perform a “triangulation” to determine how much the residual signals have 
affected the measurement.  This triangulation is illustrated in Figure 5.3.1.  The abscissa 
of the graph is the sample pathlength.  The ordinate is the log of the received light 
intensity through the sample.  The first two sets of highlighted points are measured 
during the balancing stage, when only clean dialysate was in the path.  The first set is 
measured during the intensity balancing procedure.  The second set is measured during 
the wavelength balancing procedure.  The final set of points was taken during the 
measuring stage, when both clean and spent dialysate (urea present) are in the path.  The 
residual error signals εi and εw are the differences between intensities on the two curves 
for each set of points.   
 
The AC signal is represented by the difference between the Principal Intensity and the 
Reference Intensity at the third set of points located to the right of the first two. (and 
therefore at a longer pathlength)  Two straight lines have been drawn to extrapolate these 
readings to the measurement stage.  The final point on the Principal Intensity curve is 
lowered because the addition of urea into the measurement path causes an increased light 
absorbance. The residual signal in the balancing stage has affected the AC signal, and 
therefore would affect the urea reading.  This can be further explained by referring again 
to Figure 4.6.2.  In this figure, the middle curve still shows a small signal.  This signal 
would add into the final measurement, which should only depend on urea in the ideal 
case.  This error must be corrected as part of the concentration determination algorithm.   
 
Figure 5.3.1 can also be used to illustrate the two-step iterative balancing process.  
During the intensity balancing step, the Y-intercept of the Reference Intensity line would 
 61
be shifted up or down to match to Principal Intensity.  During the wavelength balancing 
step, the slope of the Reference Intensity line would be changed until the Reference 
Intensity matches the Principle Intensity at that point.  (Recall that Beer’s Law states that 
absorption is proportional to the extinction coefficient, which is a function of wavelength.  
A change in wavelength causes a change in extinction coefficient, and therefore a change 
in the slope of the absorbance curve.  Since the process is iterative, the system alternates 
between shifting the slope of the Reference Intensity line and Y-intercept of the line until 
it matches (has the same slope and intercept) the Principal Intensity line satisfactorily.  
The position control system changes the pathlength back and forth between the Intensity 
Balancing position and the Wavelength balancing position. 
 
Figure 5.3.1: Simulated data showing that the residual AC signal in each of the 
balancing positions (intensity and wavelength) is extrapolated out to an induced error 
in the measurement position.  
5.4 Measurement Implementation 
In order to perform urea measurements in the manner described in the previous section, 
special software has been developed, along with two generations of measurement 
cuvettes.  These will be described in general terms here; a more detailed description can 
be found in the appendices. The data recorded by the system software that results from 
the use of these cuvettes is then input to the urea-estimation algorithm.   
 
This software system allows the operator to control the urea level measurements and the 
overall operation of the instrument.  The program can change the operating parameters, 
perform near-continuous urea level measurements, present both measured and calculated 
data, and store obtained results.  A simplified block diagram of the software system is 
presented in Figure 5.4.1.   
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Figure 5.4.1: Urea monitoring system software block diagram. 
 
The operator interacts with the software system through a GUI (Graphical User Interface) 
within the MS-Windows environment. The operator can select one of several options in 
the main interface window, and the software activates a corresponding function to handle 
the event.  See Appendix B for more details about the GUI operation.  The general 
functions that can be performed with this software system through the GUI are: 
 
•=Read current system parameters; 
•=Set new system parameters; 
•=Initiate a urea concentration measurement, save the output data and plot the results. 
•=Calibrate the urea measurement system and change, load, or save calibration data 
files. 
5.4.1 Measurement Cuvette 
A special measurement cuvette (see Figure 5.4.3) was designed to fulfill these 
requirements.  The measurement cuvette has two compartments.  The cuvette itself is 
manufactured from a block of Delrin.  It has two drainage holes in the bottom, and a 
keyway that holds a moveable piece of 1/8” thick acrylic.  The movements of the slider 
control the degree of compression of both bags.  These movements are under user control 
through the PC interface. At the front of the cuvette, a piece of ¼” thick acrylic is 
attached.  A slider made from another Delrin block fits into the keyway cut into the back 
face.  The Sample Light Detector is mounted inside this slider.  The thin acrylic piece 
floats in the center of the cuvette, and is held in place by two leaf springs made from ¼” 
thick spring steel. This forms a two-chamber cuvette.   
 
A clear bag made of Teflon is placed in each chamber.  (see Figure 5.4.2).  The bag 
closest to the front face contains the clean dialysate.  The second bag contains the spent 
dialysate.  During the balancing stage of the measurement, the slider is moved into the 
cuvette, and it displaces the spent fluid from the spent dialysate bag, leaving only the 
clean dialysis fluid in the optical path.  A limit switch is used to stop the mechanism 
when the bag is sufficiently compressed.  When the measurement stage begins, the slider 
 
GUI 
Result 
Storage 
Urea 
Measurements
Dialysis 
Efficiency 
Measurements
model 
parameter 
calculation/ 
application 
Result 
Presentation
User 
 63
moves out of the compartment, which allows the spent fluid back into the bag, and 
therefore into the optical path.  Figure 5.4.3 is an isometric drawing of the measurement 
cuvette.   
 
Figure 5.4.2: The measurement fluid is contained in a Teflon bag. Figure adapted 
from [78]. Dimensions are in inches (due to machinist conventions). 
 
 
Figure 5.4.3: The measurement cuvette has two chambers, each of which contains a 
teflon bag (not shown.)  A slider moves in and out of the cuvette to change the 
pathlength and occlude the spent dialysate from the optical path. Figure adapted from 
[78]. 
 
In order to get the sample fluid into the Teflon bags, several sub-systems were required.  
First, a motor controlled pump was used to transfer the fluid into the bags.  A heating 
control system was used to keep the fluid temperature stable.  Finally, a set of four 
solenoid pinch valves was used to control the flow of fluid into or out of the bag.  These 
solenoids, one on the inlet of each bag and one on the outlet were used to alternately trap 
or expel fluid from the bag depending on the current stage of the measurement.  For 
example, during the measurement stage, no spent fluid should be in the bag.  Therefore, 
the inlet valve of the spent dialysate bag is closed to prevent fluid from flowing in, and 
the outlet valve is open to allow any residual fluid to drain out.  For the clean dialysate 
bag, the opposite is true.  The outlet valve is closed to hold fluid in the bag, and the inlet 
valve is open to allow the bag to fill.  For a more complete description of the operation of 
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the pump system, solenoid valves, and temperature control system, please see the 
Appendices.  The block diagram of this control system is shown in Figure 5.4.4. 
 
Figure 5.4.4: Diagram of fluid control unit.  Figure adapted from [78] 
5.4.2 Measurement Cuvette for Use in NIV Instrument 
One of our goals was to compare the performance of our instrument to that of a second 
Optical Bridge system.  The second system is a prototype instrument designed for the 
non-invasive (NIV) monitoring of blood glucose levels in diabetic patients.  To compare 
the performance of our instrument with the NIV instrument, it was necessary to design 
and build a measurement cuvette that would fit into the NIV instrument.  This presented 
somewhat of a practical challenge, as the NIV instrument was designed to measure a 
human earlobe rather than an aqueous sample.  The cuvette had the following design 
requirements: 
 
•= Two compartments, one of which contains the sample and the other contains the 
background fluid 
•= The sample compartment must be completely compressible 
•= The background fluid compartment must be slightly compressible 
•= The cuvette must transmit adequate light at the measurement wavelengths 
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•= The cuvette must be thermally conductive in order to keep both samples at or near 
the same temperature 
•= The cuvette must fit into the measurement head of the NIV instrument, shown in 
Figure 5.4.5. 
 
Figure 5.4.5: Dimensions of the measurement head of the NIV Prototype. Dimensions 
are in inches. 
The final design of the tissue simulator is shown in an assembly drawing in Figure 5.4.7.  
It consists of three 1” square copper plates with holes in the middle.  Copper was chosen 
to maximize the transfer of heat between the two compartments, thus minimizing the 
temperature difference between them.  The bottom plate contains a piece of 1 mm thick 
optical glass that has been fixed to the copper plate with optical adhesive.  The 
background fluid is inserted into the resulting well.  A sheet of 0.010” silicon membrane 
(Allied Biomedical, Santa Clara, CA) is placed over this compartment.  Earlier tests had 
used a piece of latex as a barrier.  It was determined that the latex could be easily 
punctured when stretched, and did not have uniform transmission characteristics.  The 
silicon membrane was much more resilient and uniform, and transmitted more light.  
Figure 5.4.6 shows the transmission of two layers of the silicon sheeting as a function of 
wavelength.  
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Figure 5.4.6: Transmission of two layers of 0.01" silicon membrane. 
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 A second copper plate is then placed over the sheeting, and the sample fluid is placed 
into the top well. This compartment is also covered with a piece of silicon membrane, 
and the final copper plate is placed on top.  The copper plates have grooves and ridges 
that help to position them properly and keep the fluid from leaking.  The entire cuvette is 
held together with machine screws.  The assembly of this cuvette is somewhat tedious by 
hand, and would not be suitable for clinical use.  The concept could be easily adapted to a 
more automated design.  For dimensioned drawings, see Appendices.   
 
In order to perform measurements using the NIV system, the assembled cuvette was 
placed into the measurement head of the device.  (See Figure 5.4.5).  The measurement 
head of this device can open and close under user control. The head is opened wide 
enough to insert the cuvette, and then closed.  A constant-force limit switch is used to 
stop the closure mechanism. The cuvette was designed so that the limit switch stopped 
the closure mechanism at a point where the spent dialysate compartment was totally 
compressed.  Results obtained using the NIV instrument with this cuvette are described in 
Chapters 7 and 8. 
 
 
Figure 5.4.7: Assembly drawing and picture of the measurement cuvette. 
5.5 Summary 
In this chapter, we have described the principles of operation of the urea estimation 
system. We have also described how this measurement is implemented using two 
different prototype systems.  While the details of hardware and software design have 
been left to the appendices, the information presented here should give the user sufficient 
information about these prototype systems to understand the algorithm development and 
studies undertaken in subsequent chapters.  
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6 DESCRIPTION OF TESTING METHODOLOGY 
In order to evaluate the performance of the system, several series of tests were performed.  
This chapter describes the experimental protocols that were used in this research.  Three 
basic types of tests were performed: 
 
•= Baseline (pure water) studies 
•= Urea studies 
•= Hemodialysis patient studies 
 
The urea studies were done on two separate instruments: First, on the experimental 
prototype described in this document, and second on the NIV prototype.  The other two 
studies were performed exclusively on the NIV instrument.   At an early stage of testing, 
it became apparent that temperature control is a critical factor in the design of the 
instrument.  The prototype developed in this research conducted too much heat in an 
uncontrolled manner to the sample, preventing us from obtaining accurate results.  In 
addition, the NIV prototype was designed with higher quality optical components and 
provided a much more accurate testing apparatus. 
6.1 Baseline Studies 
A series of 50 measurements were performed using the NIV prototype. The following 
protocol was used to obtain these measurements: 
 
1. The measurement cuvette (See Chapter 5) was filled with 400 µl of distilled water 
in each compartment with a Finpipette digital micropipette.   
2. The simulator was then placed in the machine by opening the device head 
manually to 10 mm.   
3. The device head was then closed until the limit switch opened.   
 
At this point, measurement was ready to begin.  The following set of parameters was 
used: 
 
•= P_WL: 1485 nm
•= R_WL: 1393 nm
•= P_INT: 5.0 V
•= R_INT: 0.0 V
•= DETTEMP: 30.0ºC
•= Balancing distance: 0.1 mm
•= Measuring distance: 0.5 mm
Data was obtained using the following protocol:  
 
1. Move in until limit switch opens, compressing sample compartment. 
2. Balance intensity. 
3. Move out 0.1 mm. 
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4. Balance wavelength. 
5. Move in 0.1 mm. 
6. Re-balance intensity and record 00 data. 
7. Move out 0.1 mm and record 0 data. 
8. Move out 0.5 mm, uncompressing sample compartment. 
9. Record 1 position data and check for errors. 
 
This protocol was repeated 50 times to obtain 50 data sets.   
 
A second series of baseline experiments were also performed to gain information about 
the response of the instrument to temperature.  In this experiment, full measurements 
were not performed.  The tissue simulator was filled with 400 µl of fluid in each 
compartment again, and placed in the instrument.  The AC signal was balanced manually 
by adjusting the OFFSET to obtain a near-zero starting point.  The sample was originally 
heated to 32 ºC, and increased by to 0.5 ºC increments to 38 ºC using a resistive heating 
element.  The set temperature was increased as soon as the sample temperature reached 
the set point.  The data was recorded to a file every 20 seconds.  Once the sample 
temperature reached 38 ºC, the set point was then decreased in equal steps back to 32 ºC 
to determine if the measurements are affected by drift.  This experiment was repeated 
three times at three different principal wavelengths: 1600, 1620, and 1640 nm.  The 
reference wavelength was held constant at 1379.6 nm. 
 
6.2 Urea Studies 
6.2.1 Dissertation Prototype 
The prototype developed for this research is capable of performing a measurement 
automatically.  As a result, it was only necessary to determine the best way to use the 
capabilities of the instrument for making a series of measurements of dialysis fluid. 
Considerations included: 
 
•= How much fluid should be pumped into the Teflon bags,  
•= In what order should the solenoid valves be opened and closed, 
•= How fast to run the pump.   
 
An iterative approach was taken to sort out many of the particulars concerning the 
measurement protocol.  Most of this optimization was performed by Jamie Murdock for 
his Master’s Thesis [78].  The resulting final protocol is presented below: 
 
1. Open all solenoid valves.  
2. Pump 8 ml of fluid at maximum pump speed. 
3. Wait 30 seconds for temperature equalization in temperature control system 
4. Pump 1 ml @ maximum speed to remove air from tubing connecting the 
temperature control system to Teflon bags. 
5. Close inlet valve of the measurement fluid line and outlet valve of the background 
bag.  
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6. Pump 1.5 ml into background bag. 
7. Move photodetector to balancing position. 
8. Close all valves.  
9. Balance signal. 
10. Move photodetector to 3 mm from balancing position. 
11. Open inlet and outlet valves of the measurement fluid line.  
12. Pump 2 ml of measurement fluid at maximum pump speed to remove air from 
tubing. 
13. Pump 1.5 ml of measurement fluid into measurement bag. 
14. Move photodetector to 1 mm from balancing position. 
15. Close all valves.  
16. Measure light intensity and calculate analyte concentration. 
17. Open all valves and pump 10 ml of fluid to clear tubing of measurement fluids. 
 
The protocol can be divided into two sections.  The first encompasses steps 1-9 and 
reflects the balancing portion of the measurement.  The second encompasses steps 10-17 
and represents the steps necessary to add the measurement analyte into the light path to 
determine analyte concentration. 
 
Five solutions were prepared at concentrations of 1250 mg/dl, 625 mg/dl, 312 mg/dl, 162 
mg/dl, and 81 mg/dl by performing serial dilutions.  Approximately 30 measurements 
were performed on each sample in a randomly chosen order. 
6.2.2 NIV Prototype 
 
This was a series of measurements taken over two days, the first of which was used as a 
training (calibration) set, and the second of which was used as a prediction data set.  
Eight urea solutions were prepared at concentrations of 50 mg/dl, 75 mg/dl, 100 mg/dl, 
125 mg/dl, 150 mg/dl, 175 mg/dl, 200 mg/dl and 225 mg/dl.  For each concentration, the 
bottom compartment of the tissue simulator was filled with 400 µl of distilled water, and 
the top compartment was filled with 400 µl of the chosen urea solution.  Forty 
measurements were performed at each concentration.  On the first day of testing, the 50, 
100, and 200 mg/dl solutions were used to create a training/calibration data set.  On the 
subsequent testing day, the other five solutions were chosen at random and used as 
prediction data sets.  The measurement procedure is the same as given in §6.1.  The 
parameter list for these measurements is: 
 
•= P_WL: 1485 nm
•= R_WL: 1393 nm
•= P_INT: 5.0 V
•= R_INT: 0.0 V
•= DETTEMP: 30.0ºC
•= Balancing distance: 0.1 mm
•= Measuring distance: 0.5 mm.
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6.3 Hemodialysis Patient Studies 
A limited pilot study was undertaken in the hemodialysis units of Saint Vincent’s 
Hospital, and the Worcester Medical Center (Worcester, MA).  The hemodialysis unit 
services the thrice weekly needs of about 60 patients at the present time.  The study was 
done in accordance with the Human Subjects protocol found in Appendix C.  One 50 ml 
sample of effluent dialysate was collected from each of 35 patients in the center over a 
period of four days.  The patients were chosen randomly, and the samples were taken at 
varying times over the course of a treatment session. The samples were then sealed and 
frozen, and marked with an identifying number.   
 
The samples were first thawed and allowed to reach room temperature.  They were then 
analyzed using the NIV instrument.  Three samples were randomly selected as 
calibrators.  Each was measured 20 times with the instrument according to the protocol in 
§6.1 in order to obtain training data for the MLR algorithm described in §7.2.  The 
reference (background) solution was clean dialysate obtained from the dialysis centers. 
The parameter list for the measurement is: 
 
•= P_WL: 1485 nm
•= R_WL: 1393 nm
•= P_INT: 5.0 V
•= R_INT: 0.0 V
•= DETTEMP: 30.0ºC
•= Balancing distance: 0.1 mm
•= Measuring distance: 0.5 mm.
In order to validate the urea content of the samples, they were independently analyzed 
using a Beckman CX7 instrument (stated accuracy: <1 mg/dl).  The results of all tests 
except the three calibrator samples were hidden until after data processing of the NIV 
instrument data. 
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7 ALGORITHMS FOR MONITORING DIALYSIS 
PERFORMANCE 
It has been stated that the instrument responds linearly to an increase in analyte 
concentration.  In theory, a simple transformation of the form y =  ax + b could be used 
to obtain the analyte concentration from a measurement.  Preliminary results have shown 
that this type of approach does not yield acceptable results for in vitro measurements.  
Certain non-linear effects and the presence of noise complicate the simple linear 
relationship.   
 
In this chapter, we shall attempt to explain some of these effects and propose means to 
compensate for them.  In particular, two different algorithms will be presented. The first 
is a linear model with correction factors.  While this algorithm has been shown to work 
well for in vivo glucose testing, its performance for in vitro application has been poor due 
to noise variations.  We then present a second algorithm that is statistically optimized for 
characterizing the urea content of a sample in the presence of large variability in the 
operating state of the instrument and in the sample data. 
7.1 Linear Model with Correction Parameters 
The application of a linear model assumes that the independent variable can be fit to the 
dependent variable with a simple y = ax + b relationship.  The slope a represents the 
sensitivity of the system to the analyte, while b represents a shift, or blanking signal. 
Before these coefficients can be determined, there are four corrections that are applied to 
the data: 
 
•= Projection  – Corrects for the residual signal that remains after balancing by 
determining how the residual error can be extrapolated over the change in distance.   
•= Sample Transparency – As the overall extinction coefficient of the sample changes 
due to variations in the composition of the dialysis fluid or the geometric 
characteristics of the sample, the sensitivity of the system to urea will vary. 
•= Temperature – The optical spectrum of the sample changes with temperature.  This 
will cause drift in the optical signal, along with changes in sensitivity of the 
measurement.   
•= Reference Intensity – In a noise free environment, the reference intensity would 
remain constant once balancing is complete.  Small fluctuations do occur however, 
causing further drift of the optical signal. 
7.1.1 Projection Correction  
Balancing involves iterating both the reference wavelength and signal intensity to 
minimize the AC signal.  This is done with only the background sample (clean dialysate) 
in the path.  The residual AC signal that remains after balancing will be projected into the 
overall measurement.  It is therefore necessary to correct for this effect.   In other words, 
given a residual signal after balancing, we must attempt to find a measure of what the AC 
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signal would have been in the measurement position in the absence of any analyte.  Any 
change would be solely due to a difference in pathlength in that case. 
 
The graph in Figure 7.1.1 shows how the residual AC signal in positions 00 and position 
0 “projects” to position 1. Figure 7.1.1 shows the AC signal plotted vs. the sample 
transmission signal (DCSP).  The sample transmission is used because it is proportional 
to sample thickness.  Since we assume the projection of the error is linear as a function of 
transmission, it can be characterized with a slope and an intercept.  The slope is: 
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Once the slope has been determined, the intercept can be found using the equation y = ax 
+ b.  Picking one of the two known points, we obtain: 
 
bDCSP
DCSPDCSP
ACACAC +⋅
−
−
= 00
000
00000    (7.2) 
 
The resulting intercept is: 
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which simplifies to: 
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In order to arrive at the value of the correction parameter, the linear model is simply 
applied for x equal to DCSP1.  The full formula is: 
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In practice, this correction is often too “harsh” to be applied to the data directly.  Prior 
research has demonstrated that it may be better to break the projected error into several 
components, and to apply them separately.  Using this approach, the error is partitioned 
into “shift” and “slope” terms.  In Figure 7.1.2(a), the two solid lines represent the DC 
transmission through the sample.  The thick line is the sample transmission at the 
principal wavelength, while the thin line is the sample transmission at the reference 
wavelength.  The AC signal is equal to the difference between the two lines, representing 
a slope error (due to a small difference in extinction coefficients), and a shift error (due to 
a small difference in intensity).   
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Figure 7.1.1: The residual AC signal in the 00 and 0 position is projected into the 1 
position. 
When partitioning the error into the slope and shift terms, a reference point is needed.  
The 00 position is chosen.  The shift at this point is equal to AC00, which is proportional 
to the difference in intensity of the two phases of the light beam.  Therefore, the shift 
error term is proportional to AC00.   
 
The remaining “rotation” of the AC signal (see Figure 7.1.2) is due to the slope error. If 
the slope error were zero, the AC signal at positions 00 and 0 would be the same. (In this 
case, the extinction coefficients for both wavelengths would be identical, and the only 
change over distance would be in intensity.)  By extension, the slope error must therefore 
be proportional to the difference between AC00 and AC0, since this represents the rate 
of change of the intensity difference over thickness.  A graphical representation of this 
phenomenon is shown in Figure 7.1.2. 
 
The preceding analysis showed that the calculated shift and slope terms are proportional 
to the error.  The question remains as to how to find the proportionality constants.  In 
terms of the shift error, we can assume that a relationship based on Beer’s Law holds.  
This would suggest that a logarithmic correction is required.  In practice however, we are 
working over very small distances, and therefore we can approximate the curve to be 
linear in the region of interest.  We therefore use a proportionality constant of 
DCSP1/DCSP00.  This number approximates the transparency of the sample, or the 
attenuation over distance.  Therefore, the final form of the shift error correction is  
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The slope error term also receives a correction factor of DCSP1/DCSP00, but an extra 
coefficient is added to account for the fact that the error changes with distance.  
Therefore, the constant should be approximately equal to the ratio between the balance 
distance and the measurement distance (usually about eight).  It is often smaller than this 
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in practice, generally having a value of two.  The final form of the slope error term is 
then:  
00
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The overall projection correction formula is given by:  
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Figure 7.1.2: The residual AC signal after balancing must be partitioned into a shift 
term and a slope term. In the top part of the figure, the thicker line represents the 
transmitted intensity at the principal wavelength through the sample, while the 
reference intensity is the thinner line.  In the bottom left figure, the shift term, which is 
proportional to AC00 has been extracted by constructing a line parallel to the principal 
intensity at the 00 position.  In the bottom right figure, the slope term has been 
extracted by finding the “rotation” around the constructed line found while calculating 
the shift error.  This “rotation” is proportional to the slope error. 
7.1.2  Transparency Correction 
In the previous section, the slope and shift error terms were normalized by the 
transparency of the sample, which was represented by DCSP1/DCSP00.  The bridge 
value itself should also be corrected for the sample transparency, as this will have an 
effect on the magnitude of AC.  Again, a linear correction is used here rather than a 
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logarithmic correction due to the small distances involved in the measurement.  The 
proportionality constant here is simple, and again it should be equal to the ratio between 
the measurement distance and the balance distance.  Experience has shown that this 
constant has a value of approximately 5.  The transparency correction is therefore:  
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7.1.3 Temperature Correction 
It is well known that temperature affects the optical spectrum of a sample, drastically 
affecting the outcome of a measurement.  While the design of the system includes 
measures to control temperature, it cannot be controlled tightly enough to prevent this 
effect.  Fortunately, simple corrections can be applied here as well.  The AC signal 
increases linearly with sample temperature.  This has been verified through 
experimentation.  Therefore, the appropriate correction is of the form: 
 
AC1 –α⋅SAMPTEMP1     (7.10) 
 
where α is the proportionality constant.  This constant has been found experimentally to 
be approximately 0.004. 
7.1.4 Reference Intensity Fluctuation Correction 
  Once the intensity-balancing portion of the reading is complete, the reference intensity 
(R_INT) should remain the same over the course of the measurement.  Minor 
fluctuations do occur however, and they do have an effect on the measurement.  A 
correction parameter can be found for this as well.  Since the DC signals appearing at the 
auxiliary detector (AD) are immune to sample variations, they are solely affected by the 
R_INT variations.  After the intensity balancing, the DC signals at the AD are DCIP00 
and DCIR00.   
After the measurement is complete, the measured signals are DCIP1 and DCIR1.  The 
variation between DCIP1 and DCIP00, known as DDCIP1, represents drift in the 
intensity of the principal wavelength phase over the course of the measurement.  Drift 
also occurs in the reference wavelength phase of the beam, and is represented by the 
difference between DCIR1 and DCIR00, known as DDCIR1.  This drift includes effects 
from the principal wavelength of the beam as well as from drift in the reference intensity, 
since the R_INT voltage is a slave control.   
We wish to find the variation that is only due to the changes in the R_INT voltage. The 
R_INT variation is actually proportional to the difference in drift (that is to say, it is the 
difference of the difference) between Sample Detector (SD) and the Auxiliary Detector 
(AD).  (Recall that R_INT is a slave control to the Principal Intensity (P_INT)).  Before 
the two drift values can be subtracted, they must be scaled.  The AD gain is different 
from the SD gain.  Since we are trying to correct the AC signal, which is derived from 
SD signals, we must normalize to this value.  Therefore, the DCIP drift is scaled by a 
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factor known as DCRATP1, which has a value of DCSP1/DCIP1, while the DCIR drift 
is scaled by a factor known as DCRATR1, which has a value of DCSR1/DCIR1.  The 
resulting factor, called CORR1 is therefore proportional to:  
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A similar expression can be found for the 0 (wavelength balancing) position by replacing 
the 1 suffixes with 0’s.  This expression is known as CORR0.  Before this correction can 
be used, a final proportionality constant is required however.  Since we are dealing with 
measurements on the DC channel, the extra gain in the AC channel over the DC channels 
is the appropriate correction value.  This number is 35. 
7.1.5 Putting It All Together – The Algorithm 
The correction factors discussed in the previous sections are subtracted from the Optical 
Bridge signal, AC1, and the resulting value is then normalized by DCSP1.  A simple 
linear model is then applied (i.e. the number is multiplied by a sensitivity coefficient, and 
a shift term is added.)  The sensitivity and shift terms are experimentally determined, but 
can be calculated from the absorbance of the analyte and the electrical gains in the 
system.  The final equation is therefore:  
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7.2 Multiple Linear Regression Approach 
In the past, analyte concentration levels have been obtained from Optical Bridge data 
using the simple linear model described in the previous section.  The signal was 
normalized, certain correction parameters were applied, and finally a slope and intercept 
were used to arrive at the final concentration estimate.  While this linear model has 
yielded good in-vivo results, it has shown limited applicability to recent in-vitro tests 
using a tissue simulator.   
 
We hypothesized that certain factors, temperature especially, have a detrimental effect on 
the quality of our in-vitro results, and therefore began to look for a more descriptive 
model.  When the original model was applied to our data, the results were extremely 
poor.  To start, the data was noisy.  The standard deviation for repeated measurements of 
the same sample was generally over 50 mg/dl and significant drift was seen to occur in 
the measurements, sometimes as much as 100 to 200 mg/dl per hour.  It became clear that 
a new algorithm was needed to obtain accurate urea results. 
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One solution to this problem would have been to take all of the available data from the 
instrument and apply a neural network or other type of data fitting algorithm to obtain a 
model for the desired output.  This type of blind approach is very dangerous, and rarely 
takes into account the physical basis for variations in data.  In addition, neural networks 
and other types of non-linear models do little to explain the variation in a system in a 
physical sense.  Much of the processing involved in these algorithms is hidden from the 
user, in many cases preventing a true picture of the system from emerging.  It is very easy 
to generate false correlations with this type of blind modeling.  In order to develop a 
model that accurately represents the system in a predictable way, it is necessary to 
understand how the individual data items relate, (at least in an empirical sense), to each 
other and to the system as a whole.  
 
When modeling data, there are two possible approaches to take.  The first approach 
assumes that all physical effects can be explained and modeled mathematically, and that 
by including them in the model, they can be compensated for.  The linear model presently 
in use is an example of this approach.  The second approach assumes that observed 
effects on the system can be explained heuristically, and mathematical information about 
them can be extracted by statistical methods. While we are able to derive a mathematical 
model for the ideal operation of this system (see §4.6.2), the presence of noise and 
uncontrollable variations like temperature induce some non-linear effects on the system 
that prevents the development of an analytical model.  Therefore, the parameters will 
have to be selected from empirical knowledge of the system, and analysis of data, and 
new models will be developed using least-squares fitting techniques. 
 
When developing this algorithm, we had several performance goals in mind, representing 
major improvements over existing algorithms. (See Chapter 2).  First, the algorithm 
needs to be robust enough to accurately predict dialysate urea concentration for any 
patient without the need for frequent recalibration.  Second, measurements recorded with 
the existing algorithm require a tight set of operating parameters.  The algorithm 
developed here must be valid for all patients and to any operating state of the instrument 
other than extreme failure (catastrophic failure of the instrument, such as loss of RF or 
light power).  It is therefore necessary to understand and characterize how the instrument 
operates, and to then develop models based on this understanding, rather than blind 
applications of mathematical/statistical computing techniques. 
 
Developing a model based on this approach involves making a list of factors based on 
causative relationships that are hypothesized to produce variation in the data recorded by 
the instrument, and then attempting to fit the data to the desired output.  This fitting is 
accomplished using a Multiple Linear Regression (MLR) analysis.  (See §4.9) Here we 
discuss the evolution of our MLR algorithm and the pitfalls of applying this type of 
algorithm to our data, and how we avoided them. 
7.3 MLR fitting concerns 
The first concern when using an MLR approach is to make sure that the problem is well-
specified, and not over-fit.  The predictive power of a model is poor when a large number 
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of variables are fitted to a small amount of data.  In addition, if the range of the model 
data is small, it may not be possible to adequately predict the full range of the output 
variable when the model is applied.  It is therefore important that the data be normally 
distributed and that an adequate amount of data is used to construct the model.  Urea 
values in dialysate can be assumed to follow a normal distribution, since they are linearly 
related to blood urea concentration, which follows a normal distribution [79]. 
 
In many cases, the definition of “adequate amount” follows a rule of thumb rather than 
hard and fast numerical formulas.  In general, data should outnumber model variables by 
a factor of at least three [77].  We will use no more than 16 MLR variables, so we need at 
least 48 tests.  Our calibration set consists of 60 measurements that were derived from 
repeated measurements on three different samples.  Because the sample data contains 
information about variation in the instrument that is unrelated to the sample, and because 
the number of modifying factors is large, the repeated measurements can be assumed to 
be independent [80].  The size of the data set thus exceeds the requirement that the 
number data points be greater than three times the number of variables [80].  In addition, 
several tests can be done using the ANOVA to check for significance of the model.  The 
R2 value of the model is a good starting point for determining whether or not the chosen 
variables can be used to fit to the desired output.  This value alone carries little weight 
however.  The significance of the model can be determined using an F-test.  The value of 
the F-test is related to the probability that the observed relationship between the observed 
value of the output and the model value occurred by chance [81].  This value can then be 
converted to a significance level by considering the degrees of freedom in the model.  
The F distribution is used to compare the variances of two sets of data.  Here, the degrees 
of freedom are related to the ratio of regression variables to total data points. 
 
A second rule of thumb is that the value of the F distribution obtained from the regression 
should exceed the value of R2 by a factor of 10.  (i.e. if R2 = 0.75, then F should have a 
value of at least 7.50.  If these conditions are met, then the probability that the data set 
occurred by chance is low [82]. 
 
Arnold et al. [83] recently demonstrated that they were able to produce a phantom 
glucose calibration model using a multivariate model when the data was collected in a 
time dependent manner.  This study used tissue simulators that contained no glucose, 
only water and bovine albumin in a phosphate buffer.  First, the authors tried to predict 
the “glucose” level of the tissue simulator using a randomly assigned glucose 
concentration for each sample.  They were unable to predict glucose concentration, with 
standard errors over 110 mg/dl and an R2 of 0.13.  The samples were then reassigned a 
different glucose concentration that resembled one of three daily glucose profiles as 
reported in other studies.  These glucose profiles were obtained by patients who were 
undergoing either an oral glucose tolerance test or injecting insulin.  The authors were 
then able to predict the assigned glucose concentration, (standard error 24 to 66 mg/dl, R2 
=0.54 to 0.84) even though there was no actual glucose in the sample.  They concluded 
that an uncontrolled experimental parameter is responsible for the apparent good fit of the 
model.  It was necessary to keep these results in mind when designing the experiment and 
interpreting the results of this multivariate approach. 
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Since we designed our experiments and were aware of these potential problems in 
applying the MLR algorithm, we can be confident that our algorithm will be able to 
produce predicted urea levels that are not correlated by chance to the actual urea 
concentration.   
7.4 Choosing the Model Factors – The Evolution of the MLR Algorithm 
For each measurement, a large amount of data encompassing many variables is saved to a 
file.  In total, 36 individual data items are saved for each measurement.  With MLR, the 
objective is to determine which variables are the most important to the model.  We expect 
that the signal will be strongly related to factors such as sample temperature and sample 
transmission.   
   
There are two possible reasons to discount a variable.  First, the variable may be 
redundant if it is strongly correlated to one or more other variables in the data set.  
Second, the variable may not show a strong correlation to the resulting AC signal, and is 
therefore deemed to be unrelated to the urea concentration.  In order to perform the task 
of parameter reduction in a systematic way, we evaluate the partial correlation of each 
variable with the others in a “correlation matrix”.  The correlation matrix gives us an easy 
way of viewing the relative strength of relationships between variables.  It is important 
not to completely rely on statistical correlation however.   Inclusion of a particular factor 
in the model must “make sense” from our knowledge of how the Optical Bridge works.  
In order to develop a robust algorithm, we must combine the statistical data with our 
physical knowledge to arrive at a model that can accurately predict the sample urea 
content.  
 
The 36 variables that are saved to the file after each measurement are listed in Table 
7.4.1. Variables that are used in the model are shown in bold type. 
Table 7.4.1: List and description of data items obtained from each measurement. 
(Bolded variables are used in MLR model). 
PRI_WL Principal wavelength 
REF_WL Reference wavelength 
PRI_INT Intensity of principal wavelength phase of the light beam 
OFFSET Used to set difference between P_INT and R_INT 
AC00 Differential sample transmission signal after intensity balancing 
AC0 Differential sample transmission signal after wavelength balancing 
AC1 Differential sample transmission signal with spent dialysate in optical path 
DCSP00 Sample transmission at principal wavelength after intensity balancing 
DCSP0   Sample transmission at principal wavelength after wavelength balancing 
DCSP1 Sample transmission at principal wavelength with spent dialysate in optical path 
DCSR00 Sample transmission at reference wavelength after intensity balancing 
DCSR0 Sample transmission at reference wavelength after wavelength balancing 
DCSR1 Sample transmission at reference wavelength with spent dialysate in optical path 
R_INT00 Intensity of reference wavelength beam phase after intensity balancing 
R_INT0 Intensity of reference wavelength beam phase after wavelength balancing 
R_INT1 Intensity of reference wavelength beam phase with spent dialysate in optical path 
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DCIP00 Incident power at AD at principal wavelength after intensity balancing 
DCIP0 Incident power at AD at principal wavelength after wavelength balancing 
DCIP1 Incident power at AD at principal wavelength with spent dialysate in optical path 
DCIR00 Incident power at AD at reference wavelength after intensity balancing 
DCIR0 Incident power at AD at reference wavelength after wavelength balancing 
DCIR1 Incident power at AD at reference wavelength with spent dialysate in optical path 
SAMPLET00 Temperature of the sample after intensity balancing 
SAMPLET0 Temperature of the sample after wavelength balancing 
SAMPLET1 Temperature of the sample with spent dialysate in optical path 
DETT00 Temperature of the SD after intensity balancing 
DETT0 Temperature of the SD after wavelength balancing 
DET1 Temperature of the SD with spent dialysate in optical path 
DIS00 Sample thickness after intensity balancing 
DIS0 Sample thickness after wavelength balancing 
DIS1 Sample thickness with spent dialysate in optical path 
K Ratio of DCSP1 to DCSP00 
ACC1 AC1 corrected for residual balance signals 
DELK00 ACC1/DCSP00 
DELK0 ACC1/DCSP0 
DELK1 ACC1/DCSP1 
 
In general, we attempted to find an optimal set of parameters that explain both the 
variation in the data due to changes in urea content and instrumental fluctuations.  We 
needed a method to reduce the number of variables in the analysis from 36 to something 
more reasonable.   Sets of variables that contained the same basic information (redundant 
variables) were the first to be eliminated.  Redundant variables were considered to be 
those that were more than 99% correlated with another variable in the set. The correlation 
data was derived from the results of the baseline (water only) study data.  The 
relationships were analyzed using a correlation matrix, which is a tool used to graphically 
represent the degree to which a set of variables relate to each other (See §8.1). Physically, 
these variables generally have direct relationships with each other as a consequence of 
hardware design.  Only one variable of any related set was included.  The following 
variables were eliminated on the basis of redundancy: 
 
DCSP00, DCSP0, DCSP1, DCSR00, DCSR0, DCSR1, DCIP00, DCIP0, 
DCIP0, DCIP1, DCIR00, DCIR0, DCIR1, R_INT00, R_INT0, R_INT1 – all 
of these are strongly correlated with OFFSET; 
DIS00, DIS0 – both of these are directly related to DIS1; 
SAMPLET0 – strongly related to SAMPLET00. 
 
After this first step, 17 variables remain.  
 
The detector temperature variables (DETT00, DETT0, and DETT1) in the baseline 
study correlation matrix showed little or no relationship to the signal variations.  They 
can be omitted, reducing the count to 14. 
 
Next, there are certain variables that are held constant or rarely change.  These are 
PRI_WL and P_INT.  This step reduces the variable count to 12. 
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It is not only necessary to determine which variables can be excluded, but also to 
determine which variables must be included.  To do this, we must determine which of the 
remaining variables have the strongest power in estimating sample urea content. These 
may be variables that relate to urea information, or to variations in the instrument, or 
both.  This involved analysis of both the baseline studies and preliminary urea/water 
studies.  The results of these measurements were analyzed for significant relationships by 
the development of a correlation matrix to determine how strongly each variable relates 
to the others.  Most importantly, we were interested in how each of the remaining signals 
correlated to the measured signal, AC1.   
 
Results of these preliminary tests had shown that the most significant non-urea related 
variations in the data were caused by: 
 
a) sample temperature 
b) fluctuations in transparency of the sample 
c) residual signal after balancing 
 
The preliminary tests also showed that the most significant variations in the data caused 
by urea were related to: AC1, ACC1, DELK00, DELK0, and DELK1.  It was therefore 
necessary to include variables that would compensate for these effects.  The possibilities 
are: 
 
a) sample temperature variations: SAMPLET0, SAMPLET1, OFFSET, REF_WL.  
The offset and reference wavelength data are indirectly related to temperature, 
because the spectrum of the sample shifts as temperature changes.  Therefore, the 
values of these two items can be useful in predicting temperature shifts. 
b) Sample transparency: K, DIS1.  The transmission data that results from the 
measurement must be normalized for sample thickness and how well the sample 
transmits light.  K is related to the extinction coefficient at the principal 
wavelength, and DIS1 is an indication of the thickness of the sample. 
c) Residual signals: AC00, AC0.  These signals indicate how well the system was 
able to balance out the background sample. 
 
In order to select the optimal set of parameters for the algorithm from this sub-set, several 
regressions were performed on the remaining variables, bearing in mind the results of the 
baseline studies.   
 
First, each of the variables that were observed to correlate with urea concentration 
(AC00, AC0, ACC1, DELK00, DELK0, and DELK1) was included.  None was 
significantly correlated with any other variable enough to warrant exclusion.  AC00, 
AC0, and ACC1 are un-normalized differential transmission signals.  AC00 is the 
residual signal in the thinnest sample position after intensity balancing.  AC0 is the 
residual signal in the middle sample position after wavelength balancing. These two 
signals are therefore included in the algorithm because they form a starting basis for the 
rest of the measurement.  ACC1 is the differential transmission signal in the thickest 
sample position, after the urea-laden dialysate has entered the path.   
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Using Equation 4.19, we know that the analyte signal should be proportional to the value 
of ∆k.  The combination of temperature and geometry-related variations on the data 
obscures this relationship, and possibly introduces some non-linear effects.  DELK00 is 
normalized by the starting thickness and corrected for the transparency of the sample and 
residual signal after balancing.  DELK0 is a similar parameter, but its normalization is by 
the middle sample thickness, while DELK1 is normalized by the final sample thickness.  
Inclusion of all three parameters gives the algorithm a truer picture of how the 
transmission of the sample changes with sample and thickness composition.   
 
Next we need to determine which of the temperature related factors to include.  Here 
again, we decided that all factors are important to the analysis, because they each provide 
different information.  REF_WL is included as a measure of the temperature stability at 
the actual measurement wavelength.  As the wavelength shifts, the temperature 
sensitivity changes.  This is because the reference wavelength is located on a steep slope 
of the water peak, resulting in large changes in the transmission signal.  The slope also 
changes as a function of temperature.  The two sample temperatures SAMPLET0 and 
SAMPLET1 are both included because they give not only a measure of what the sample 
temperature is, but also a measure of how fast it is changing through the course of the 
measurement.  Finally, OFFSET is included because it gives a measure of how the AC 
signal is drifting as a function of temperature.  This phenomenon is explained more fully 
in §8.3.1. 
 
Both variables relating to sample transparency were included as well. The extinction 
coefficient of the measurement and the sample thickness are both important to the goal of 
establishing a universal calibration for all patients and all instrumental variations.  
Therefore the DIS1 and K variables are also included.   
 
After analyzing the correlation matrices for the baseline and urea studies, the following 
twelve variables and functions of variables were selected for inclusion in the model: 
REF_WL, OFFSET, SAMPLET0, SAMPLET1, DIS1, K, AC00, AC0, ACC1, 
DELK00, DELK0, and DELK1.  These variables have been found to be the most 
significant to the overall result.   
 
Once the factors for the algorithm had been identified, the next task was to determine a 
“weight” for each variable according to the regression equation.  This was done by giving 
the algorithm a set of training data consisting of several measurements repeated on the 
same sample.  In this way, data related to both instrumental variations and urea level 
variations was presented to the algorithm.  Using Microsoft Excel, we then performed a 
linear fit on the data to obtain the weight for each variable in the algorithm.  Once this 
was accomplished, we needed to determine if each variable was actually significant to the 
algorithm.  The algorithm was then used to predict the urea content of a number of other 
samples recorded on different days and under different conditions. The results of this 
process are described in Chapter 8.  We were able to conclude that all variables are 
significant and provide a useful contribution to the algorithm, and that the algorithm was 
able to accurately predict sample urea content for all tested samples. 
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The resulting algorithm is therefore: 
 
     ⋅=
k
kk xdlmgUrea β)/(     (7.13) 
 
The weights (βk) of each variable (xk) in the algorithm are given in Table 7.4.2. 
 
Table 7.4.2: Weighting coefficients for the MLR algorithm. 
k Variable Name (xk) Coefficients (βk)
0 Intercept -3793.048861 
1 REF_WL 2.738386369 
2 OFFSET 11.78231559 
3 SAMPLET0 -15.08450145 
4 SAMPLET1 8.278386882 
5 DIS1 21.1473092 
6 K 17.11947157 
7 AC00 8.097130604 
8 AC0 20.2117165 
9 ACC1 266.3492255 
10 DELK00 -40175.72805 
11 DELK0 39278.75765 
12 DELK1 -5.857607611 
  
7.5 Dialysis Efficiency Monitoring Algorithm 
Once the estimate of urea level has been obtained using the algorithm described in the 
previous section, it is possible to arrive at a measure of dialysis efficiency.  This measure 
of efficiency is related to the total urea removed during the dialysis session, and is 
therefore a simple integration.  Due to the fact that the measurement is semi-continuous, a 
Riemann sum type of approximation can be used: Utot = ∆⋅= ttUUtot )(  , where U(t) 
is the estimated urea concentration and ∆t is the time interval between samples.  The 
sample urea content can also be used to estimate more traditional dialysis efficiency 
parameters such as kT/V.  kT/V is related to the slope of the dialysate urea curve, as 
shown by Garred et al. [25]. kT/V can be expressed as: 
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The second term in Equation 7.14 relating to changes in body water is required to correct 
for changes in the urea distribution volume.  This does not require any extra 
measurement, as these parameters are measured for all dialysis patients to determine the 
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required amount of fluid lost.  Use of this formula can provide a projection of the value of 
kT/V that will be obtained during the session at an early time in the process, allowing the 
physician to change the patient’s treatment course if goals will not be met. In general, the 
dialysis session is considered accurate if kT/V is above 1.  See §4.2.6 for a discussion of 
kT/V.  Now that time dependent information concerning the urea content of the dialysate 
is available, future research may lead to the development of more efficiency parameters 
related to this measurement.   
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8 EXPERIMENTAL RESULTS 
The experimental portion of this research consisted of several stages: 
 
•= Preliminary studies measuring urea in water using the first generation prototype; 
•= Preliminary studies measuring pure water and urea in water using the NIV prototype; 
•= Analysis of the measured data, modeling, and extraction of urea estimation 
parameters; 
•= Development of an algorithm based on multiple linear regression for urea estimation 
and dialysis efficiency monitoring; and, 
•= Performance testing of the urea estimation algorithm with hemodialysis patient 
studies. 
 
In this chapter, a summary of all experiments is presented first.  Then, results from each 
set of measurements are presented and some specific characteristics of the measurements 
are described.  The results of the algorithm development process are then shown.  Finally, 
the results of applying this algorithm to samples of patient dialysate are presented.  
8.1 Summary of Experiments 
During the course of three years, over 2000 optical measurements were performed using 
three different prototypes.  Approximately 1000 of these measurements were performed 
with the prototype instrument used in this research to measure urea.  Almost 600 
measurements were performed using the NIV prototype to measure the effects of 
temperature on the optical measurement in the absence or urea.  50 measurements were 
done to obtain data about the system variability in the absence of urea.  160 
measurements were performed on samples of urea in water using the NIV prototype.  
Finally, 154 measurements were performed on samples of spent dialysis fluid using a 
new prototype of the NIV system.   
 
The results of the studies using the prototype developed for this research are extremely 
poor.  They will be described in the next section.  Subsequent sections will detail the 
results of testing using the NIV prototypes.  At first, results with these instruments were 
poor as well.  However, after the development of the new algorithm, the results were 
greatly improved, and shown potential for clinical success.  The final set of 
measurements recorded with the newest NIV system are extremely good, and show 
accuracy near that of standard reagent/electrode based instruments.  
  
Table 8.1.1 is a record of the studies performed during the course of this research.  It 
indicates the type of study, the instrument used to obtain the data, the algorithm used to 
process the data, the number of measurements recorded, and whether or not the study was 
successful.  A CD-ROM with all of the recorded data is available from WPI – Biomedical 
Engineering Department Library. 
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Table 8.1.1 : Overview of the performed experiments and measurements. 
Experiment 
Description 
Prototype Algorithm Number Results 
Urea in water Dissertation 1 1000 not successful 
Temperature NIV1 N/A (training data) 600 successful 
Baseline NIV1 N/A (training data) 50 successful 
Urea in water NIV1 1 160 not successful 
Urea in water NIV1 2 160 successful 
Spent dialysate NIV2 1 154 not successful 
Spent dialysate NIV2 2 154 successful 
 
8.2 Results of Proof of Principle Studies 
As has been stated before, the results of the preliminary studies using the prototype 
developed for this research were very poor.  Two independent sets of measurements were 
done.  For the first, the temperature of the instrument and sample was allowed to vary 
freely.  Figure 8.2.1 shows the results for this test.  No sensitivity to urea is seen, and in 
reality the calibration graph is merely an average of the actual urea concentrations used in 
this study.   
Figure 8.2.1: Estimated vs. Actual Urea for the dissertation prototype. Actual urea 
content was determined by weight (accurate to 0.1 mg) when samples were prepared. 
Temperature was allowed to vary freely.  The graph shows that the correlation between 
the two measurements is almost non-existent (R2 = 0.0012). The standard error for this 
measurement series was over 500 mg/dl. 
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A second study was performed after adding better temperature control to the 
measurement.  The temperature variation was now kept to within ±1°C.  After this 
modification, some dependence on the actual urea level was seen.  As seen in Figure 
8.2.2, the R2 value has improved to 0.94, but the system still had errors of over 100 mg/dl 
that could not be compensated for.  In addition, the system had noise levels in hardware 
of well over 5 mV, which translated to approximately 25 mg/dl.  The remaining error was 
attributed to temperature variations, and sample thickness variations.  The sample 
thickness variations were thought to cause air bubbles and other types of sampling effects 
that degraded measurement accuracy.  Even if these could be sufficiently modeled, the 
hardware noise alone would prevent adequate measurement accuracy.  At this point, the 
decision was made to perform the rest of the studies with the NIV prototype. 
Figure 8.2.2: Estimated vs. Actual Urea, dissertation prototype. Actual urea content 
was determined by weight (accurate to 0.1 mg) when samples were prepared. For this 
experiment, temperature variations were controlled to within ± 1° C.  Standard error is 
still over 100 mg/dl. Approximately ¼ of the measurements were rejected for 
instrumental variations. 
Despite the apparently poor results of these preliminary studies, important information 
about the effects of uncontrolled temperature and position variation on the data came to 
light.  Compounding the problem was that the prototype could not reliable measure either 
sample temperature or sample thickness due to design considerations.  For this reason, it 
is difficult to gain a true picture of the exact variation due to these factors.  The results of 
testing with the NIV instrument were able to provide this information, however, which is 
described in the following sections. 
8.3 Baseline (no urea) studies  
One of the most important results of this research is a set of baseline data.  The baseline 
studies were performed exclusively with the NIV prototype instrument, since it was 
deemed to be the more accurate and stable of the two.  This baseline data was used to 
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show relationships between different parameters and variables in the measurements.  This 
data was then used to establish factors that were used in the development of the 
algorithm. One of the first steps in this procedure was to determine the extent to which 
certain variables correlate with each other.  This is useful for several reasons.  First, it 
may reduce the number of variables that must be used to characterize the system by 
pointing out which variables depend strongly on the others. For example, the R_INT 
signals and the DCIR would be expected to correlate strongly, and it would be 
unnecessary to include both of them as part of an algorithm.  Second, it can suggest 
possible sources of error.  For example, if the AC signal were found to depend strongly 
on temperature, a correction could be applied.  Since there is a large amount of data, 
(approximately 36 variables), finding these relationships can be somewhat tedious.   
 
In an attempt to simplify the task, a graphical approach was taken.  A “correlation 
matrix” was developed in Microsoft Excel as a starting point for determining which 
variables where strongly related.  This correlation matrix was then plotted as a contour 
map in order to ease the task of identifying strong correlations.  Once regions of high 
correlation values were identified, a list of factors to use in developing the algorithm was 
made. Figure 8.3.1 shows this contour plot.  Areas of high correlation are shown in red 
and yellow.  Areas of high negative correlation are shown in gray and black.  Note that 
this graph is symmetrical about the diagonal. Any correlation over ±0.50 was deemed to 
be of interest. If no position (i.e. 00, 0, or 1) is given, then the relationship held true over 
all positions.  (In other words, R_INT includes R_INT00, R_INT0, and R_INT1, for 
example). These groupings are listed in Table 8.3.1.  These relationships will be explored 
in more detail in this section. (Basic definitions can be found in Table 5.2.1 and Table 
7.4.1).  Parameters such as K, ACC1, and DELK1 are not listed in the table because they 
are calculated, rather than measured.  The overall signal value (DELK1) is listed in the 
table however because it may help to illustrate how several factors that do not correlate 
significantly to any of the raw data may combine to affect the calculated concentration 
value.  In other words, it can lend validity to some of the correction factors discussed in 
§7.1, and possibly suggest new ones as well.  This correlation matrix shown in Figure 
8.3.1 was also used as a starting point for statistically optimized variable selection for the 
MLR algorithm, along with the results of the urea in water studies described in §8.4 and 
our knowledge of how this system works. 
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Figure 8.3.1: Plot of the correlation matrix for a baseline study.  Red and yellow 
indicate strong positive correlations, while gray and black indicate strong negative 
correlations. 
Table 8.3.1: Groupings of variables showing possible dependencies.  The strength of 
the relationship between  the variables in gray and the listed parameters is given by the 
correlation coefficient. 
Strong Correlations (± 0.75 to 1.0)  Correlation Coeff. 
Offset  
sample temperature  -0.944 to -0.955 
all DC and R_INT Signals -0.787 to -0.984 
AC00   
AC0 0.914 
DC signals (DCSP, DCSR, DCIP, DCIR)  
All other DC signals  0.753 to 0.998 
R_INT signals 0.753 to 0.995 
sample temperature 0.752 to 0.973 
Sample thickness  
DCSP   0.809 to 0.856 
DCSR 0.805 to 0.853 
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It is now possible to explain some of these relationships in detail.  First, there is a 
relationship between OFFSET and sample temperature.  This relationship can be seen in  
Figure 8.3.2(left).  This is due to a cause and effect relationship between AC and 
OFFSET.  Since AC varies with temperature, the value of OFFSET required to balance 
the system will also vary with temperature. The relationship is seen have a negative slope 
of approximately 10 mV per degree.  The curve seems to lose its linearity in the lower 
temperature range.  This may be due more to a poor temperature calibration than to any 
real effect.  In the right half of Figure 8.3.2, the relationship of the offset control to 
R_INT is shown.  This graph is representative of the relationship of the offset control to 
other DC signals, such as DCSR and DCIR, as well.  In this case, the offset varies about  
–1.4 V/V of change in R_INT. 
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Figure 8.3.2: Offset is strongly related to (left) sample temperature (slope = -0.012, R2 
= 0.87) and (right) DC intensity signals (slope = -1.41, R2 = 0.98) .  R_INT is shown as 
a representative example. 
We expect that AC00 and AC0 will be strongly related, since they involve no changes in 
sample composition.  Figure 8.3.3 (left) shows this to be true.  While there is a fair 
amount of scatter in this plot, a definite linear relationship is shown.  The slope is not 1 
because of a decrease in sensitivity caused by the slight change in sample thickness.  
When AC00 and AC1 are compared (Figure 8.3.3, right), the correlation becomes much 
weaker.  A greater variation in sample temperature moving from position 00 to position 1 
and a greater pathlength change can be used to explain this difference. 
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Figure 8.3.3: AC00 and AC0 are strongly correlated (slope = 0.89, R2 = 0.72) with each 
other (left).  AC00 and AC1 do not have a strong relationship(slope = 0.55, R2 = 0.08) 
(right). 
A final strong relationship can be seen between the sample thickness and the DC 
transmission parameters such as DCSP and DCSR.  A representative relationship is 
shown in Figure 8.3.4 between sample thickness and DCSP.  DCSP changes by about 
117 mV per mm of change in sample thickness. 
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Figure 8.3.4: Sample thickness is strongly related (slope = 0.12, R2 = 0.47) to DC 
values at the sample detector.  DCSP is shown as a representative example. 
Many of these relationships that are seen to exist from analyzing Figure 8.3.1 can be 
explained from direct hardware principles.  Direct hardware relationships like DCSR vs. 
R_INT are not of interest here, but some of the other less direct relationships presented in 
this section are of interest.  The most important of these variations is that of temperature.  
A separate study involving over 570 optical spectra was performed to characterize the 
temperature response of the system. In addition, the 50 baseline measurements were 
analyzed for temperature dependence of data. The following sections present an 
explanation of some of the results of these studies.  
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8.3.1 Temperature Variation Study Results 
It is a well-known fact that optical spectra show a dependence on temperature.  
Absorbance peaks may shift up or down in wavelength and in magnitude with very small 
changes in temperature.  It is important for us to know how this affects our measurement.  
We have two semi-independent measures of temperature available in the system.  The 
first is a temperature reading of the optical detector, and the second is a temperature 
reading of the sample itself.  The temperature of the detector can be set independently.  
Recall that the baseline study involved taking 50 measurements of pure water.  Five 
measurements were rejected due to operator error, leaving 45 useable data sets.  In 
analyzing the data taken during the baseline study, it is apparent that the sample 
temperature has a strong effect on the OFFSET, R_INT, and all of the DC signals.  The 
detector temperature does not strongly correlate with any of these signals.   Each of these 
signals changes at its own rate with sample temperature.  A simple linear regression 
yields the rate.  These are listed in Table 8.3.2: 
Table 8.3.2: Rate of change of various signals with temperature. 
Position Factor  
Variable 00 0 1 
DCSP 0.045 V/°C 0.048 V/°C 0.039 V/°C
DCSR 0.047 V/°C 0.049 V/°C 0.038 V/°C
DCIP 0.002 V/°C 0.002 V/°C 0.002 V/°C
DCIR 0.004 V/°C 0.004 V/°C 0.005 V/°C
R_INT 0.016 V/°C 0.016 V/°C 0.019 V/°C
OFFSET -0.022 V/°C -0.022 V/°C -0.025 V/°C
 
Next, we wish to determine if the sample temperature has a statistically significant effect 
on each variable.  The ANOVA table (Table 8.3.3) shows that in each case, sample 
temperature is significant to p < 0.0001 (N=45). 
Table 8.3.3: ANOVA table for the temperature study. 
Variable p R2 
DCSP 4.2E-08 0.51
DCSR 8.0E-08 0.49 
DCIP 7.3E-28 0.94
DCIR 2.4E-26 0.93
R_INT 1.2E-20 0.87
Offset 1.5E-22 0.89
 
The following four figures show the data relating the sample temperature to the DC 
transmission parameters (DCSP, DCSR, DCIP, DCIR), R_INT voltage, and offset 
voltage.  For simplicity, only the 1 position data is shown, since the other positions do not 
differ significantly.  Figure 8.3.5 shows that DCSP increased by a factor of 0.039 V/ºC.  
DCSR increases at a similar rate of 0.038 V/ºC.   
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Figure 8.3.5: The light transmission through the sample is an increasing function of 
temperature (DCSP vs Temperature: slope = 0.04, R2 = 0.49, DCSR vs. Temperature: 
slope = 0.04, R2 = 0.51). DCSP is plotted with diamonds, DCSR is plotted with squares. 
It is important to note that the rate of change of signals with respect to temperature is not 
the same for the SD and the AD.  The increase in the factor between DCSP and DCIP is 
approximately 17.7, which is far greater than the actual gain of 6 between the SD and the 
AD.  See Figure 8.3.6.  This suggests that the temperature effects arise mainly from the 
physical properties of the sample, rather than the properties of the instrument.  The data 
also shows that the temperature effects are more significant at the reference wavelength 
for the AD.  The increased sensitivity of the reference wavelength is to be expected, since 
it lies on the edge of a strong water absorbance peak.  The slope of the absorbance curve 
is steeper there, leading to a greater change with temperature. This data suggests that any 
correction based on temperature may be related to the slope of the spectrum around the 
reference wavelength.   The fact that the SD did not show this dependency on wavelength 
can be explained by the fact that the data was recorded after the balancing phase of a 
measurement, causing the system to adjust to the spectral changes in the sample. 
 94
 Sample Temperature  vs. DCIP and DCIR
0.1615
0.162
0.1625
0.163
0.1635
0.164
0.1645
0.165
0.1655
0.166
28 28.5 29 29.5 30 30.5
Sample Temperature, ºC
D
C
IP
, V
0.15
0.152
0.154
0.156
0.158
0.16
D
C
IR
, V
 
Figure 8.3.6: The sensitivity of the AD (DCIP vs. Temperature: slope = 0.002, R2 = 
0.94, DCIR vs. Temperature: slope = 0.005, R2 = 0.93) to increasing sample 
temperature is an order of magnitude lower than that of the SD and shows a 
dependence on wavelength. DCIP is plotted with diamonds, DCIR is plotted with 
squares.   
While the R_INT and OFFSET voltages both appear to respond to temperature, in fact, 
neither is directly affected.  Instead, it is the AC signal that is affected.  As the 
temperature rises, so does the AC signal.  This causes the offset required to balance the 
system during measurement to decrease.  It changes with a slope of –0.025 V/ºC.  As the 
OFFSET decreases, the R_INT voltage increases with a slope of 0.019 V/ºC.  The only 
question is whether or not the R_INT is independently temperature sensitive.  It does not 
appear so, as the ratio of temperature sensitivity factors is –1.35, which is very close to 
the OFFSET/R_INT gain of –1.30.  The plots of R_INT voltage and OFFSET voltage 
vs. Sample Temperature during measurement are shown in Figure 8.3.7 and Figure 8.3.8.   
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Figure 8.3.7: The R_INT voltage also increases linearly with sample temperature 
(slope = 0.019, R2 = 0.87) . 
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Figure 8.3.8: The offset voltage that was required to balance the bridge decreased as a 
function of sample temperature (slope = -.025, R2 = 0.89). 
 
Since we have determined that the fluctuations in the Offset and R_INT voltages are in 
fact induced by changes in the AC signal, the question remains of what is the true 
sensitivity of the instrument to temperature.  Since any changes are balanced out during 
the measurement, this sensitivity must be measured separately.  The water-filled tissue 
simulator was tested at three different wavelength pairs: 1600.0/1379.6, 1620.0/1379.6, 
1640.0/1379.6.  These wavelengths were selected because they could all be balanced with 
the same reference wavelength, thus reducing the number of variables.  We were not able 
to find similar pairs in the range of urea measurements. The system was initially balanced 
manually, and then the system temperature was adjusted.  The system data was then 
recorded every 20 seconds.  The temperature was adjusted both up and down to eliminate 
variations due to drift. The results of this test are shown in Table 8.3.4.  The AC signal 
tracked the temperature variations very closely.  The results of this study are shown in 
Figure 8.3.9.  The larger difference in the first part of the data can be accounted for by a 
poor initial balanced condition. 
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Figure 8.3.9: Response of the signal to temperature variations.  The three groupings 
represent data taken at 1600 (left data group), 1620 (middle data group), and 1640 nm 
(right data group). 
 
Using this data, we can attempt to find a rate of change of the AC signal with 
temperature.  A simple linear regression is used here as well.  Table 8.3.4 shows that the 
slope does vary with wavelength, and that temperature is has a statistically significant 
effect at all of the test wavelengths to p < 0.0001. The slope effect is on the order of 400 
mV/ºC, which is very significant considering the magnitude of changes that are generally 
induced by the presence of an analyte in the signal.  (On average, this change is a few 
tens of millivolts at physiological concentrations.  The results of this testing are shown in 
Figure 8.3.10 
Table 8.3.4: The rate of change of AC vs. temperature depends on wavelength. 
Wavelength Slope Factor p value N 
1600 0.43 3.1 E-119 190 
1620 0.42 1.9 E-198 190 
1640 0.49 2.1 E-208 191 
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Figure 8.3.10: Variation of the AC signal with sample temperature at three 
wavelengths.  At 1620 nm (squares), the sensitivity is 0.42V/ºC (R2 = 0.99).  At 1640 nm 
(triangles), the sensitivity is 0.49 V/ºC (R2 = 0.99) 
In analyzing the results of the baseline study, we have gained significant understanding in 
the effects of temperature and other system variations such as sample thickness on the 
data.  It shows that sample temperature must certainly be included in any kind of MLR 
algorithm, as well as the offset.  This analysis has also allowed us to determine which 
parameters are redundant in the analysis and can therefore be omitted in favor of others in 
the MLR algorithm.  The extraction of the remaining parameters will be accomplished by 
analyzing the results of the urea in water studies.  
8.4 Results of the Urea Level Estimation Studies: Urea in Water Studies 
This section explains the results of the urea in water measurements that were performed 
using the NIV prototype.  First, the results of the measurements using algorithm 1 will be 
presented.  As was stated in the introduction to this chapter, this algorithm could not be 
used to successfully estimate the urea level of the samples.  The remainder of this section 
will then show how algorithm 2 evolved from the results of these studies.  We will show 
how successfully this algorithm is able to estimate the sample urea concentration when 
applied to the data.  Finally, we will show that the results indicate that the algorithm is 
able to fulfill the performance goals laid out in Chapter 2. 
8.4.1 Results of application of Algorithm 1 
It is not possible to use algorithm 1 to estimate urea concentration using this method.  
The results of this study when algorithm 1 is applied to the data are shown in Figure 
8.4.1.  The calibration line shows no sensitivity to the presence of urea.   
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Figure 8.4.1: Urea Estimation Calibration curve for algorithm 1.  Actual urea content 
was determined by weight (accurate to 0.1 mg) when samples were prepared.  The 
algorithm shows no predictive power for this study (R2 = 0.04). 
We have not yet provided an explanation from the data as to why the mathematical model 
developed in §4.6.2 cannot be used here.  We have hypothesized that temperature and 
sample thickness variations prevent sufficient measurement stability. The graph in Figure 
8.4.2 shows a plot of 40 measurements that were recorded from the same sample.  In 
addition to a fairly significant noise level, there is a large drift happening in the AC1 plot.   
The noise in AC1 appears to be directly related to the noise in AC00 and AC0.  These 
two factors are therefore useful in explaining variation in AC1, and will be included as 
parameters in the development of algorithm 2.  
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Figure 8.4.2: This graph shows a series of 40 measurements taken over a 4 hour period 
using the same sample. The figure shows that significant drift occurs in the baseline 
level of AC1 over the course of the measurement series. 
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The inclusion of DELK00, DELK0, and DELK1 in the model is based on similar 
reasoning.  These are really just normalized versions of AC00, AC0, and AC1. The 
graphs of these variables look very similar to that of Figure 8.4.2. 
 
The graph in Figure 8.4.3 demonstrates that the signal AC1 does indeed vary strongly 
with sample temperature.  The right hand plot in the figure shows a strong linear 
relationship with the sample temperature.  Several outliers can be seen in this plot that are 
the result of other types of variations. The left hand side of the figure shows the time 
course of both the temperature measurement and AC1.  Visual inspection of the course 
indicates that the drift in AC1 is strongly related to the sample temperature. 
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Figure 8.4.3: These two figures demonstrate the variation of AC1 with sample temperature. The 
right hand side of the figure shows a scatter plot of temperature vs. AC1 (slope = 0.39, R2 = 
0.60), while the left hand side shows the time course of both variables.  
Two other system variables also show this drift characteristic during repeated 
measurements of the same sample: OFFSET and REF_WL.  Since the value of these 
parameters are set by balancing, in order to minimize AC00 and AC0, it makes sense that 
the drift would be seen in the offset and reference wavelength, rather than in AC00 and 
AC0.  The four graphs pictured in Figure 8.4.4 show how the drift in AC1 is mimicked 
by drift in OFFSET and REF_WL. 
 
So the results of this study indicate that OFFSET, REF_WL, and SAMPLE_TEMP are 
all useful parameters in explaining drift that occurs in the optical signal.  Further 
characterization of the data is required to sufficiently explain rest of the variation in the 
data. 
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Figure 8.4.4: These four graphs show how the drift in AC1 is related to drift in the 
offset (slope = -3.5, R2 = 0.64) and reference wavelength (slope = 0.28, R2 = 0.74).   
 
We have also suggested that the pathlength of the sample has an affect on AC1.  The 
graph in Figure 8.4.5 shows that this relationship only holds true some of the time.  For 
certain portions of the study, the two graphs tend to follow a trend.  At times however, 
the two graphs diverge.  The reason for the divergence is probably temperature related 
again.  It appears that temperature has a stronger effect on the data than sample thickness.  
Regardless, it seems that sample thickness is also an important parameter to include the 
MLR based algorithm. 
 
 
 
 
 
 
 
 101
-0.8
-0.7
-0.6
-0.5
-0.4
-0.3
-0.2
-0.1
0
0.1
0.2
A
C
1,
 V
5.4
5.5
5.6
5.7
5.8
5.9
6
6.1
D
IS
1,
 m
m
AC1 DIS1
 
Figure 8.4.5: Variation of AC1 with sample thickness.  At times, the two graphs seem 
to follow a trend together, but they occasionally diverge. 
The variations in AC1 are also expected to relate to K, the transparency of the sample.  
This relationship is expected to be inversely proportional, since K is usually used as a 
normalizing factor.  This also makes sense empirically.  A higher value of K means that 
the sample is less transparent.  Therefore, the transmission through the sample will be 
smaller.  The graph in Figure 8.4.6 confirms this prediction.  K can therefore be added to 
the list of factors used in algorithm 2. 
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Figure 8.4.6: AC1 and K, the transparency ratio, follow inverse trends to each other.   
This completes the list of parameters that are used in algorithm 2.  We have presented 
results that indicate how each of the factors affects the differential transmission signal 
AC1, and shown that the results agree with our predictions of how the data should 
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behave.  In the following section, we present results of the MLR fitting of these 
parameters to develop algorithm 2. 
8.4.2 Model Development Results 
The results described in the previous section were used to arrive at a list of twelve 
parameters that will be fit by a least-squares algorithm to the data to obtain a urea 
concentration estimate.  Forty measurements were performed on each of three different 
samples.  This data was then used as a training set, with the actual urea content of the 
sample being used as the desired output.  The least-square fitting is a computation 
intensive technique, but it can be easily handled for this many variables by MS-Excel.  
The results of the least-square fit are given in Table 8.4.1.  The results of the fit are given 
in several parts.  First, we wish to know how strongly the urea estimate obtained from the 
algorithm relates to the actual value for this training data set.  This is given by the R2 
value, which is 0.982.   
 
Second, we need a measure of how significant the regression equation is.  The 
information can be determined from the ANOVA table that is given in the second part of 
Table 8.4.1.  The important values are F and the significance of F.  Note that the value of 
F, 444.8 satisfies the rule of F=10R described in the previous chapter.  The significance 
value is the probability that a similar data set could have occurred by chance.  The value 
of 2.4⋅10-87 means that this probability is very low. 
 
The final part of Table 8.4.1 gives the relative weights for each parameter used in the 
algorithm, along with a standard error for the weight, a student’s T statistic, and a p-value 
for the parameter.  Not all of the variables in the algorithm are significant (to a level of 
0.05) according to the p-value.  The inclusion of insignificant variables in the model is 
not wrong, but they may not have a strong effect on the quality of the model [80].  We 
have chosen to leave them in because they provide a modest improvement in the accuracy 
of the model, and because we have reason to include them based on our knowledge of the 
system.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 103
Table 8.4.1: MLS Result Table: urea in water study. 
Regression Statistics     
R Square 0.980     
Observations 121     
ANOVA      
  df SS MS F Significance F
Regression 13 440306.7 33869.8 444.8 2.4E-87 
Residual 108 8908.2 82.5   
Total 121 449214.96    
Variable Name Coefficients 
Standard Error 
(mg/dl) t Stat P-value  
Intercept -193676.3587 15117.9 -12.8 2.1E-23  
REF_WL 135.9786546 10.8 12.5 8.5E-23  
OFFSET 2462.927493 212.8 11.6 1.3E-20  
SAMPLET0 -297.1233721 18.1 -16.4 4.6E-31  
SAMPLET1 419.3035103 19.6 21.3 1.5E-40  
DIS1 -107.9165421 18.6 -5.8 6.7E-08  
K 827.21904 18.6 44.5 2.9E-71  
AC0 -63.45139936 106.3 -0.6 5.5E-01  
AC1 -1353.567637 1251.3 -1.1 2.8E-01  
ACC1 3456.430981 3772.5 0.9 3.6E-01  
DELK00 17651.44236 8053. 1 2.2 3.1E-02  
DELK0 -8667.813973 3803. 9 -2.3 2.5E-02  
DELK1 -5371.793321 4707.1 -1.1 2.6E-01  
 
The standard error of calibration for this model is 8.7mg/dl.   
8.4.3 Results of urea estimation model application  
Now that algorithm 2 has been developed, we need to test it to see if it is able to predict 
urea values from new samples.  A new test was run approximately 1 week later with a 
new sample.  The algorithm accurately predicted the urea concentration of the sample.  
The standard error of prediction was found to be 9.2 mg/dl.  The standard error for all of 
the tests that were run using this instrument are summarized in Table 8.4.2. 
Table 8.4.2: Results of Urea Estimation Study 
Model    
Std Error    
8.7 mg/dl (1.4 mM) 
Prediction   
Std Error     
9.2 mg/dl  (1.5 mM) 
 
The number of samples tested for this study is admittedly small, since the true test of the 
system is in measuring hemodialysis samples, as described in the following section.  The 
real purpose of this part of the study was to obtain data with which to generate the 
algorithm, rather than to test the prediction capabilities of this algorithm.  We shall now 
describe the results of the hemodialysis patient studies and the application of algorithm 2 
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to the resulting data.  The resulting calibration curve (estimated urea vs. true urea) is 
shown in Figure 8.4.7.  
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Figure 8.4.7: Calibration curve for urea in water studies: estimated urea vs. actual 
urea (R2 = 0.97). Actual urea content was determined by weight (accurate to 0.1 mg) 
when samples were prepared. 
8.5 Results of the Urea Level Estimation Studies: Hemodialysis Patient Studies 
This section is intended to explain the results of the hemodialysis sample studies that 
were performed using the second generation NIV prototype.  First, the results of the 
measurement using algorithm 1 will be presented.  As was stated in the introduction to 
this chapter, this algorithm could not be used to successfully estimate the urea level of the 
samples. The remainder of this section will then show how algorithm 2 (described in the 
previous section and in Chapter 7) was applied to this data.  We will show how 
successfully this algorithm is able to estimate the sample urea concentration when applied 
to the data, even in the presence of multiple other analytes.  Finally, we will show that the 
results indicate that the algorithm is able to fulfill the performance goals laid out in 
Chapter 2. 
8.5.1 Results of Application of Algorithm 1 
As with the urea in water studies, it is not possible to use algorithm 1 to estimate the urea 
concentration of a dialysate sample using this method.  The results of this study when 
algorithm 1 is applied to the data are shown in Figure 8.5.1.  The calibration line shows 
no sensitivity to urea. 
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Figure 8.5.1: Urea Estimation Calibration curve for algorithm 1.  Urea content of the 
samples was measured using a Beckman CX7 autoanalyzer.  The algorithm shows no 
predictive power for this study (R2 = 0.002). 
8.5.2 Model Development Results 
Because this study was performed on an instrument with different hardware 
characteristics than the urea in water studies, it was necessary to recalibrate the 
algorithm.  The parameter list developed in this chapter and in Chapter 7 does not 
change, since the basic operating characteristics of the instrument have not changed. 
However, as some gains in the hardware have changed significantly, the weight of each 
parameter in the algorithm should be adjusted. 
 
In order to recalibrate the algorithm we selected three patient samples at random from all 
of the samples obtained at the dialysis center.  These three samples were each measured 
twenty times, and the data recorded.  These 60 data sets were then used to train the least-
squares algorithm in the same manner as the urea in water study.  The actual value of the 
urea level of the sample was assessed by a standard Biuret method using a Beckman CX7 
autoanalyzer. 
 
We were able to produce a significant model from this data as well.  A summary of the 
regression statistics for this model is given in Table 8.5.1.  The R2 value was 0.986, and 
the F value is far greater than 10R.  We can conclude that this model has a high degree of 
statistical significance. 
 
In the parameter list, all variables are highly statistically significant except for AC00, 
ACC1 and DELK1.  This is to be expected, since they were highly corrupted with noise 
and other variations to start with.  Including them in the model is not wrong, it is simply 
unlikely that they cause significant improvement in the accuracy of the model [80].  They 
are allowed to remain in the algorithm because there is physical and mathematical basis 
for including them (see §7.4). The standard error of the model was 0.4 mg/dl.  This 
represents a significant (over 20 times) improvement from the urea in water studies.  This 
can be attributed to an improved sample handling technique, and higher signal to noise 
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ratio in the prototype version of the instrument used for this study than the previous 
study.  Note that removing the non-significant parameters from the algorithm changes the 
standard error to 0.9 mg/dl.  This result is still within the limits of acceptable clinical 
accuracy, but does justify the inclusion of the extra factors.  Conversely, if even one of 
the significant parameters (such as SAMPLET0) is removed, the model loses a great deal 
of accuracy.  By removing SAMPLET0, for example, the standard error of prediction 
rose to 10.7 mg/dl. 
Table 8.5.1: MLS Result Table: Hemodialysis sample study. 
Regression Statistics     
R Square 0.986     
Observations 154     
ANOVA      
  Df SS MS F Significance F 
Regression 13 644.3 49. 6 278.8 7.6-40 
Residual 47 9.1 0.2    
Total 60 653.3     
Variable Name Coefficients Standard Error t Stat P-value  
Intercept -3793.048861 186.68 -20.3 6.4E-25  
REF_WL 2.738386369 0.14 19.6 2.9-24  
OFFSET 11.78231559 0.82 14.3 9.4E-19  
SAMPLET0 -15.08450145 2.73 -5.5 1.4E-06  
SAMPLET1 8.278386882 2.90 2.9 0.0064  
DIS1 21.1473092 1.89 11.2 7.0E-15  
K 17.11947157 1.89 9.1 6.6E-12  
AC00 8.097130604 6.03 1.3 0.19  
AC0 20.2117165 5.95 3.4 0.0014  
ACC1 266.3492255 253.97 1.0 0.30  
DELK00 -40175.72805 15445.25 -2.6 0.012  
DELK0 39278.75765 15406.57 2.5 0.014  
DELK1 -5.857607611 458.60 -0.01 0.99  
 
The resulting calibration curve is shown below in Figure 8.5.2.   
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Figure 8.5.2: Calibration curve of measured urea vs. estimated urea. Measured urea 
content of the samples was determined using a Beckman CX7 autoanalyzer. Data 
resulted from repeated analysis of three randomly selected patient samples (R2 = 0.99, 
N=60). 
8.5.3 Results of urea estimation model application 
Once the system was recalibrated using the training data set, it was necessary to test 
whether or not the algorithm could fulfill its goal of remaining valid for any patient 
sample over a period of at least one week.  In order to make sure that the study was 
statistically significant, we needed to ensure that we measured an appropriate number of 
samples.  The required sample size for a given study is given by the following formula:  
 
2



 ⋅
=
d
zn σ ,      (8.1) 
 
where z is computed from the normal distribution for a desired p value, σ is an estimate 
of the standard deviation, and d is the number of units that we are willing to accept on 
either side of σ.  Urea values in dialysate have been previously shown to be normally 
distributed.  From the urea in water studies, we expected σ to be approximately 9 mg/dl.  
(The true value is lower, but we are really looking for a ratio of σ to d, so the number is 
still valid.)  We want d to be no more than this on either side, so d = 4.5 mg/dl.  We wish 
to establish significance at the 0.01 level, so z = 2.58. (The value of z is obtained from a 
normal distribution table). Substituting these numbers into the formula gives n=26.6.  
Therefore, at least 27 samples are required.  We actually measured 34 samples, three of 
which were used in the calibration.  Each sample was measured three times to allow for 
repeated measurements if necessary.   The independently measured urea concentration 
was not known at the time the algorithm was applied to prevent bias in the results.   
 
It was important to establish whether or not the algorithm would remain valid without 
recalibration over time.  Therefore, the samples were analyzed in two batches 
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approximately one week apart.  No degradation of performance was seen over that time.  
In addition, the algorithm was able to successfully predict the urea concentration of all 
samples.  No sample was rejected or yielded a result that was outside of acceptable 
accuracy limits. 
 
The standard error of prediction for the algorithm over all of the remaining samples was 
0.5 mg/dl. The overall standard error including both calibration and prediction was 0.4 
mg/dl.  These figures are summarized in Table 8.5.2. 
Table 8.5.2: Results of the MLS urea estimation algorithm: hemodialysis study 
Model    
Std Error    
0.4 mg/dl (0.07 mM) 
Prediction   
Std Error     
0.5 mg/dl (0.08 mM) 
Overall    
Std Error     
0.4 mg/dl (0.07 mM) 
 
Figure 8.5.3 shows the results of this study in the form of a scatter diagram.  Estimated 
urea values produced by algorithm 2 are shown plotted against the measured urea values 
obtained from the standard instrument.  The plot is highly linear and has a very strong 
correlation coefficient. 
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Figure 8.5.3: Scatter diagram for the hemodialysis patient study.  The plot shows that 
the algorithm could be used to accurately predict the urea concentration of the sample 
(R2 = 0.997, N=154). 
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Once these results were obtained, several other statistical pieces of information should be 
determined in order to further evaluate the performance of the instrument. First, we wish 
to determine if there is any mean difference between the values given by our instrument 
and the conventional instrument.  This can be done with a simple hypothesis test.   
 
The null hypothesis is that the mean difference between the results given by the two 
instruments is less than 0.05 mg/dl.  We choose α = 0.01.  Therefore, using a student’s t 
test, the critical value of t for α =0.01 and 153 degrees of freedom is -2.4. The test 
statistic here is the mean of the errors (0.03) – the hypothesized difference (0.05) divided 
by the square root of the standard deviation (0.4) multiplied by n (154).  The value of the 
test statistic is -0.4.  Since this is in the acceptance region, we can conclude that the true 
mean difference between the two instruments is less than 0.05 mg/dl, with a p value of 
0.001.   
 
Next, we can determine a 95% confidence interval for the variance ratio of the two 
instruments using an F-test.  The result of this analysis is the conclusion that the true 
variance ratio between our method and the standard method is between 0.7 and 1.5 with 
95% confidence. 
 
The final test of the data is the linear regression analysis between the standard method 
and algorithm 2.  The summary of this analysis appears in Table 8.5.3.   
Table 8.5.3: ANOVA table comparing the urea results obtained with the MLS 
algorithm to the clinical standard instrument. 
Regression Statistics     
R Square 0.996     
Standard Error 0.4     
Observations 153     
ANOVA      
  df SS MS F Significance F
Regression 1 6658.5 6658.5 33575.4 2.9E-179 
Residual 151 29.9 0.2   
Total 152 6688.5    
  Coefficients 
Standard Error 
(mg/dl) t Stat P-value  
Intercept -0.05495066 0.06 -0.9 0.37  
Slope 1.010141649 0.006 183.2 2.9E-179  
 
The results of this analysis allow us to conclude that this algorithm is able to fulfill its 
goals of providing a stable, universal means of estimating the urea content of a 
hemodialysis sample over the clinically expected range of urea values. 
8.6 Results of Phantom Model Testing 
To prevent phantom modeling, we took precautions to ensure that our data did not 
contain any profiling information.  Each sample was taken from a different patient, and 
the samples were taken at random times during the dialysis process.  In addition, the 
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samples were analyzed in a random order.  This precludes any time-dependent variable 
from affecting the results.  In addition, we repeated the Arnold experiment [83] by 
applying our algorithm to: a) randomly assigned urea values; and, b) time dependent 
profiles (linearly increasing and decreasing).  For the randomly assigned urea profiles, the 
R2 value for the model ranged from 0.04 to 0.38.  The standard error of prediction (SEP) 
was usually about 30 mg/dl.  For the linearly increasing profile, the R2 value for the 
model was 0.96.  However, when the model was applied to the data, the calibration no 
longer held, and the R2 value was approximately 0.05.  The SEP was 44 mg/dl.  For the 
linearly decreasing profile, similar results were obtained, with an R2 value of 0.04 and an 
SEP of 44 mg/dl.  For the model alone, the R2 value was 0.989, but the F-value was only 
7.0, which does not satisfy the F=10R rule.  Therefore, we can conclude that this model 
holds little predictive power when applied this type of linear profile.  For the random 
case, ratio of F to R was usually about 0.04, showing that this model has extremely low 
significance.  We can then conclude that if the model holds higher predictive power 
compared to the true urea values of the patient samples, the correlation is not due to some 
time-dependent phenomenon.   
 
8.7 Medical Interpretation of Estimated Urea Level Results and Projected Use for 
Dialysis Efficiency Monitoring 
The estimated urea content of the dialysate over time is a good parameter for estimating 
the efficiency of dialysis. This parameter can be used to estimate the urea removal rate, or 
to calculate the total urea removed over the course of a dialysis session.  There is little 
widespread agreement as to what constitutes the optimum urea removal rate or how much 
total urea is removed, so the decision of what constitutes adequate therapy from these 
numbers is widely left to the discretion of the physician.   
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9 DISCUSSION 
In this chapter, a discussion of the urea monitoring system development is presented, as 
well as an analysis of the results achieved from testing of the instrument.  The 
development process and the final version of the instrument and urea monitoring 
algorithm are described.  Next, the testing protocol and results are discussed, including 
difficulties encountered during the testing process.  Finally, the performance of the 
instrument and accompanying algorithm are discussed and analyzed. 
 
9.1 Urea Monitoring System Instrument Design 
The Urea Monitoring Instrument developed during the course of this research was tested 
and evaluated with a series of in vitro studies.  During this process, important conclusions 
concerning the performance of the instrument were made that provided direction for 
future improvements in the system.  This information will lead towards development of 
future generations of the instrument. 
 
This first generation instrument did not possess sufficient capabilities to accurately 
measure urea levels in solution.  It was capable of generating light at the appropriate 
wavelengths for measuring urea, but the instrument had several insurmountable 
problems.  First, the quality of the optical components used in the design was not high 
enough to provide adequate light intensity to the sample.  (High quality optical 
components could not be obtained due to the limited budget of the project).  For this 
reason, a high gain was required, leading to a poor signal to noise ratio.  The SNR for this 
system was on the order of 15 dB.  In addition, the covered channel design of the system 
conducted too much heat in an uncontrolled manner to the sample, resulting in a high 
degree of drift in the measurement.  Drift values as high as 100 mg/dl per hour were often 
observed when testing this system.  The high degree of drift made it difficult to establish 
whether or not the system was responding to the presence of urea.  The instrument 
fulfilled the design goals in terms of light generation, control, and measurement, but the 
effect of uncontrolled temperature variations on the instrument were stronger than 
expected, preventing the system from achieving the desired accuracy. 
 
Once the problems with this instrument were identified, it became apparent that the 
necessary modifications were not feasible.  Further testing therefore continued with an 
existing prototype that possessed higher quality optical components and better 
temperature stability. The existing prototype (referred to as the NIV instrument), 
originally developed for a separate research project was designed to measure glucose 
levels in earlobe tissue.  Modifications were made to this instrument to permit in-vitro 
testing of urea by the development of a special fluid cuvette.  Preliminary tests with this 
instrument also showed significant drift, although the noise level was significantly lower.  
The SNR for this system is closer to 60 dB.  The drift seemed to be caused by 
temperature changes in the sample and in differences in sample thickness caused by 
variations in the way the cuvette was assembled for each measurement.  Despite these 
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improvements, the standard error of the measurements was still extremely high, and 
baseline shifts prevented any calibration from holding true for more than one sample.  It 
became apparent that temperature variations had a large effect on the in-vitro 
measurements and they prevented accurate determination of urea levels. 
 
9.2 Urea Monitoring Algorithm Design  
At this point, the focus of our experiments shifted towards developing a new algorithm 
that would be able to correct for these and other variations in the data.  This new 
algorithm provided the means to extract information about the urea content of the sample 
from data obtained from the NIV prototype instrument.  Using this algorithm, a 
significant improvement in performance was achieved with this instrument over both the 
old algorithm and the first generation prototype.  Level shifting and baseline drift were 
completely eliminated, and measurements and calibrations remained stable for several 
months.  The standard error of the measurements was reduced from well above 30 mg/dl 
to less than 0.5 mg/dl.  The algorithm completely met the stated goal of being able to 
estimate the urea level of a hemodialysis sample from the instrument data.   
 
This algorithm represents significant advances over previous versions.  For the first time, 
a stable, universal calibration was achieved.  Previous versions of the algorithm required 
a strict set of operating conditions for the instrument that often were not met.  This 
resulted in a large number of rejected measurements.  The older versions of the algorithm 
did not remain valid as the sample was changed.  The new algorithm is able to function 
over the full set of operating conditions for the instrument, and remains accurate for 
sample changes.  In addition, this algorithm also compensates for temperature variations 
in the sample that cause large changes in the signals obtained from the instrument.  In 
short, the algorithm developed during the course of this research makes possible the 
accurate reagentless monitoring of dialysate urea level where previous algorithms have 
failed. 
9.3 Proof of Principle Studies 
These experiments were performed using the NIV prototype in conjunction with a 
specially designed in vitro cuvette.  This presented some challenges and difficulties in the 
experimental procedure.  In this section, these difficulties are explained, and in some 
cases solutions for overcoming them are presented.  Any features of the measurements 
that yielded interesting results are also discussed. 
9.3.1 Baseline Studies Protocol 
The baseline studies provided a large amount of useful data in determining how 
variations in the system affected the measurement.  This data was then analyzed to arrive 
at the urea monitoring algorithm.  Some difficulties were encountered when performing 
these measurements however. The NIV instrument was originally designed to measure on 
a human ear lobe.  Designing a cuvette that could hold two separate fluid and displace 
one presented a serious design challenge in terms of space and shape considerations.  The 
resulting cuvette was adequate for the job, but was not very user-friendly.  A stepwise 
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assembly procedure had to be completed each time the sample was changed, and the 
quality of the results were somewhat dependent on the assembly technique.  If the screws 
holding the cuvette together were not adequately tightened, fluid could leak out of the 
cuvette.  Also, if the membrane surfaces separating the two fluids were not in contact 
with the sample, air bubbles occurred that degraded the quality of the results. Finally, due 
to the irregular geometry of the measurement head, it was impossible to place the cuvette 
in the same location each time.  Improper placement of the cuvette could lead to poor 
compression of the sample, which also worsens the measurement accuracy.  The 
algorithm is generally able to detect and compensate for these problems, but they do still 
contribute to errors.  Most notably the transparency ratio approaches 1 when an air 
bubble or improper placement occurs.  The instrument then warns the user to replace the 
sample. After a bit of practice, we gained significant experience in proper assembly and 
placement of the cuvette.  This experience helped to improve the accuracy of the 
measurement over the course of this research.  Future work with this method should 
include a redesign of the measurement head and cuvette to automate sample filling, along 
with a snap fit design to ensure exact placement.   
 
9.3.2 Baseline Studies Testing Results 
These studies yielded several important results that aided in the development of the urea 
estimation algorithm.  First, the responses of several system variables to fluctuations in 
temperature were quantified.  Temperature was found to have a very large effect on the 
magnitude of the optical transmission signals recorded from the instrument.  Almost all 
of the baseline drift that occurred in the measurements could be attributed to temperature 
variations in the sample.  Thickness of the sample was also determined to have an effect 
on the measurement.   
 
The baseline studies also allowed us to extract a set of parameters that could be used to 
model variations in the instrument that are unrelated to the presence of urea in the 
sample, and to eliminate factors that were redundant from the analysis.  Factors such as 
the reference wavelength and offset required to balance the system prior to measurement 
are also related to the temperature variations due to the dependence of optical spectra on 
temperature.  The baseline studies also showed how the transmission signal varies with 
sample transparency. Finally, a set of parameters that identified how the residual AC 
signals after balancing affected the outcome of the measurement.   
 
The identification of parameters explaining variation in the instrument data provided by 
the baseline study was a crucial step in the development of the urea estimation algorithm.  
Previously, the information contained in the data related to urea content of the sample 
was mixed with that of the instrumental variation.  This study provided a successful 
means of deconvolving the urea information from the instrumental variations.   
 
In addition, the added knowledge of how the instrumental variations affected the data 
allowed for a wider range of operating parameters for the measurement.  This reduces 
some of the performance demands on the instrument, and also significantly reduces the 
number of rejected measurements.  Using the old algorithm, 10-20% of all measurements 
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are rejected.  With the development of the new algorithm, only one measurement was 
rejected during the entire course of this study for reasons of catastrophic operator error 
(failing to close the measurement head).   
9.3.3 Urea in Water Protocol 
The protocol for the urea in water studies was very similar to that of the baseline studies, 
and similar difficulties were encountered.  Because of the experience we gained in 
performing the baseline studies, our technique for performing the measurements and 
assembly the sample cuvette was greatly improved, which improved the quality of the 
results.  Several known concentrations of urea in water were tested using the instrument.  
A Multiple Linear Regression analysis was used to arrive at estimates of the sample urea 
content in the presence of significant instrumental variations   Further testing was then 
done with other samples to test the predictive performance of the algorithm.  The testing 
was done on different days and with newly mixed solutions to provide independence of 
sampling. 
9.3.4 Urea in Water Testing Results 
Results obtained from the urea in water tests were generally good.  A set of 120 
calibration measurements was used to train the urea estimation algorithm described in 
this research.  This training data set contained three different urea concentrations that 
were within the normal range in spent dialysate.  The predictive power of the resulting 
algorithm was then tested on another 100 measurements.  These 100 measurements were 
taken on samples having five different urea concentrations from the original samples.   
 
The overall standard error of the measurement was approximately 9 mg/dl.  This is 
somewhat higher than the accuracy of a typical urease-catalyzed instrument, but is 
considered adequate for the stated purpose of the instrument.  The algorithm was able to 
prevent baseline drift in the measurement, even in the face of significant temperature 
variations.  The algorithm was also able to account for variations in sample thickness and 
placement that normally caused catastrophic errors with previous algorithms.  The most 
significant source of error seen with this new algorithm was determined to be random 
instrument noise, most likely arising from the optical detectors.  Residuals of all variables 
in the algorithm were normally distributed, leading to the conclusion that errors are 
random rather than correlated to any specific variable.  We can therefore conclude that 
the algorithm developed from the data in this study is able to provide an accurate estimate 
of the urea level of the sample when the sample contains only urea and water.  The 
parameters selected for inclusion in the algorithm are able to compensate for variations in 
the characteristics of the sample and the instrument at measurement time.  
9.4 Hemodialysis Patient Testing 
Although the preliminary studies measuring urea in water were successful, serious 
concerns existed as to whether or not the system would still be able to detect urea in 
actual patient samples.  The samples contain a large number of potential interferents, 
some known, some unknown.  While our preliminary analysis showed that the 
interferents would not significantly affect the measurement, this could not be verified 
without testing.  The testing protocol and results will be discussed in this section. 
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9.4.1 Hemodialysis Patient Testing Protocol 
We did not encounter any significant new problems when testing the hemodialysis patient 
samples.  A third generation NIV prototype was used for these studies, since it had a 
greater SNR than the previous instrument.  Experience from the preliminary studies had 
helped to develop consistent sample handling techniques.  Collection of the samples was 
relatively simple as well.  Sessions at the dialysis center are organized into four daily 
shifts.  Patients generally alternate days.  Samples were taken from the drain line of the 
dialysis machine and put into a 50 ml container, then sealed.  The samples were then 
marked with an identifying number and frozen until analysis.  Sample collection did not 
disturb the patients.  Although dialysis fluid is not considered a biohazard, a typical 
biohazard protocol was followed in terms of sample handling and workstation cleanup. 
9.4.2 Hemodialysis Patient Testing Results 
Using the algorithm developed from the urea in water studies, we were able to accurately 
estimate the urea level of the patient dialysate samples.  Three samples were measured 
repeatedly (20 times) to obtain a calibration for dialysis fluid.  31 additional samples 
were then analyzed, and the results were compared to results obtained using a reference 
method.  Overall, the standard error of prediction was 0.34 mg/dl.  This is well within 
acceptable clinical limits.  The correlation coefficient between this algorithm and the 
reference method was 0.998, to a significance level of p<10-197.  We were able to show 
that there was no mean difference between values given by our method compared with 
the reference method, and we found that the 95% confidence interval for the variance 
ratio of the two devices was very close to 1.  We were able to conclude that the presence 
of other analytes in the dialysis fluid does not cause significant error in the measurement.   
 
The improved accuracy of this test over the urea in water tests can be attributed to two 
factors.  First, our technique in performing the testing was improved by experience 
gained with earlier testing.  Second, improvements in the NIV prototype had further 
lowered the noise level and improved the signal power.  As with the urea testing, the 
residuals of the variables used in the algorithm were normally distributed, meaning that 
the measurement inaccuracy can be assumed to be random and therefore not significantly 
correlated with any of the other parameters.   
 
The measurement takes about 35 seconds to complete, and in this un-automated version 
takes about 3 minutes to set up.  This is still well within the performance limits required 
for the measurement, which was specified to be 15 minutes.  It is therefore possible to 
perform repeated measurements that would further improve the accuracy of this method. 
 
Most importantly, the algorithm remained valid for all patient samples that were tested 
over a period of over one week.  Universal, stable calibration was hypothesized to be one 
of the main advantages of this algorithm over previous versions.  The results of this study 
proved this hypothesis to be true. 
9.5 Significance of Results 
The MLR approach has shown a significant increase in performance over the simple 
linear algorithm for the in vitro tests.  Initial results using the linear algorithm were very 
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poor, having a standard deviation over 30 mg/dl and significant level shifts (sometimes 
over 100 mg/dl) when samples were changed.  (Because of the level shifting, it is 
difficult to obtain a measure of the standard error.) When the MLR approach was used, 
the standard error was reduced to approximately 0.5 mg/dl, and the level shifts were 
eliminated. Temperature effects were shown to be the major cause of variations in the 
signal.  The ANOVA showed incredibly high significance (p < 10-197 for urea, n=154).  
For the first time, a global calibration is possible that works for any patient tested over a 
wide range of operating conditions. This represents some significant advances: 
 
•= Reduces the need for lengthy calibration procedures and permits the monitoring 
of acute patients 
•= Dramatically reduces the number of rejected measurements by widening the 
acceptable operating limits of the instrument 
•= Relaxes some of the performance requirements of the system hardware by 
providing compensation for deterministic effects and variations, thereby reducing 
the expense of the system. 
 
To summarize, algorithm 2 as presented here provides the key to reagentless dialysate 
urea monitoring in a way that was not possible with previous versions of the algorithm. It 
provides long-term stability of results and universal calibration, and accomplishes its goal 
of being able to estimate sample urea concentration in the face of uncontrolled 
instrumental variations in the data. 
 
9.6 Dialysis Monitoring System Testing Results 
While no dialysis efficiency monitoring was actually undertaken during this phase of the 
research, testing results have shown the feasibility of using this technique for dialysis 
monitoring.  The system is capable of estimating dialysate urea levels in real-time and 
semi-continuously.  The measurement frequency is sufficient to provide an accurate 
picture of the instantaneous urea level, the total urea removed, and the projected kT/V.  
Results have proven to be stable over the required monitoring period of one week, 
proving that the method can be used for the purpose of monitoring dialysis efficiency.  In 
order to apply this method in the clinical setting, modifications to the existing instrument 
must be made to provide for automated operation. 
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10 CONCLUSION 
The overall goal of this research was to develop a method for optically monitoring the 
urea concentration of effluent dialysate without the need for reagents.  No successful 
results have been reported on this topic to date. We were able to accomplish the research 
goal.  By comparing the material presented in Chapters 4-9 of this dissertation with the 
specific aims of this research listed in Chapter 2, the following conclusions can be made: 
 
•= An Optical Bridge based instrument was developed and evaluated according to the 
requirements stated in Chapter 2.  The instrument was accompanied with special 
system software that controls the instrument and analyzes, stores, and displays the 
recorded data.  This system software was developed for the MS-Windows 95/98 
platform and was written in C/C++. The instrument fully satisfied the specifications 
set out in Specific Aim 1. 
•= Preliminary studies were performed with this instrument using samples of distilled 
water spiked with urea.  Existing algorithms failed to produce satisfactory results with 
this instrument.  Large uncontrolled variations in sample temperature were determined 
to cause unacceptable drift and noise levels in the results.  It was concluded at this 
point that the aluminum channel construction of the first prototype device prevented 
adequate temperature stability.  All further testing was done with a second prototype 
that had better temperature control properties.  Results using this instrument were 
somewhat improved, but still unsatisfactory.   
•= We defined a list of factors that were hypothesized to cause instrumental variations.  
These factors may relate to non-random system noise or sample variations.   
•= An algorithm relating data from the second instrument to the sample urea content was 
developed.  When this algorithm is applied to the data, the noise and systematic error 
is significantly reduced.  The algorithm can accurately predict urea concentration in 
dialysate, providing a measure of the efficiency of the dialysis session.  While the 
data analysis has elucidated many previously unknown properties of the instrument, 
many properties still remain unexplored.  We believe that significant effort should be 
expended to further explore these properties, and to extract parameters that can be 
used in the algorithm to represent them. 
•= Preliminary in vitro patient studies were performed using the newly developed 
algorithm to determine the urea content of hemodialysis samples.  The results of the 
study showed that this algorithm is capable of accurately determining the urea content 
of the dialysate sample, and therefore of providing useful data concerning the 
efficiency of the dialysis session.  This specific aim was fully accomplished.  
•= Using the results of these studies, we developed an algorithm for real-time estimation 
of dialysate urea level and real-time monitoring of dialysis efficiency. These 
algorithms were incorporated into the system software, and satisfy the requirements 
for this type of system.  The development of this system represents a major advance 
in the field of renal failure therapy by providing the groundwork for a “closed loop” 
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approach to determining adequacy of therapy and eliminating the guesswork involved 
in current methods.  The automatic, low maintenance nature of this system provides a 
high potential for clinical acceptance of the technology and the possibility of saving 
lives by reducing complications from poor dialysis. 
 
In Chapter 3, Hypotheses and Research , four hypotheses were introduced that describe 
the central ideas of this work.  We used the following scientific methods in the course of 
our research and hypothesis testing: statistical analysis of data, mathematical modeling, 
experimentation, induction, and deduction.  The validity of these three hypotheses can 
now be evaluated based on the application of these scientific methods. 
 
•= The first central hypothesis was that a method based on differences in 
transmission of near infrared light energy can be employed in the development of 
an instrument that could provide information about biologically relevant levels of 
urea in a strongly absorbing background matrix. 
This hypothesis was accepted.  An algorithm was developed that provides 
real-time estimates of dialysate urea levels from data recorded from such 
an instrument.  Its evaluation showed that urea levels could be accurately 
determined for each and every patient sample that was tested, but only a 
limited number of disturbance variables was investigated. 
 
At this time, we can conclude that this method can provide an accurate 
means of estimating dialysate urea levels within the normal range of 
operation of the instrument. 
 
•= The second central hypothesis was that it is possible to develop an algorithm 
using the data obtained from the instrument to quantitatively and qualitatively 
estimate the amount of urea in an effluent stream of dialysate, and from this to 
evaluate the effectiveness of the dialysis session. 
This hypothesis is accepted.  We developed and tested such an algorithm 
that is based on multiple linear regression analysis and time-wise 
integration of sample urea, and showed that it can be used to successfully 
monitor dialysate urea levels.  From this information we would be able to 
provide a measure of dialysis efficiency.  The accuracy of the 
measurement (<0.5 mg/dl) is approximately the same as traditional 
chemistry methods, and is considered acceptable for the stated purpose. 
 
•= The third hypothesis is that a list of major factors affecting the system response 
can be developed.   
There are a large number of factors affecting the system response that can 
be extracted from the instrument data.  We have identified a set of factors 
that are capable of representing the system response sufficiently to 
establish a relationship between the data and the sample urea level.  
Therefore, this hypothesis is also accepted, with the caveat that further 
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research could provide more information regarding the optimal set of 
factors. 
 
•= The fourth hypothesis is that a mathematical model and corresponding algorithm 
can be developed which approximate the expected response of the system to 
changing urea concentration in the presence of interferences such as temperature 
changes and the presence of other metabolic analytes. 
Preliminary patient studies confirmed that the algorithm developed for this 
research could be used to determine the urea content of hemodialysis 
samples.  Independent testing of the sample urea content showed high 
correlation with the results obtained using this algorithm even in the face 
of wide fluctuations in temperature, the presence of other analytes, and 
other varying instrument parameters.  The absolute error between the 
estimated and measured sample urea level is in an acceptable range.  
Therefore, this hypothesis is also accepted. 
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11 FUTURE WORK 
The research presented here concludes the first prototype phase in the development of a 
clinical instrument for monitoring dialysis efficiency by real-time estimation of dialysate 
urea levels.  At this point, the research should continue in the following areas: 
 
•= Development of a clinical instrument for dialysis efficiency monitoring, including a 
redesign of the instrument head and sample cuvette to provide automated operation. 
•= Additional investigation for improvement of the proposed urea estimation method. 
•= Direct comparison of this dialysate-side method with existing blood side techniques 
in clinical studies. 
 
The first two proposed research directions can be performed simultaneously.  
Development of a new clinical instrument and improvements in the method can be based 
on experience gained from the research described here.  The design of an automated  
system would greatly reduced operator-induced variation in the measurement, and greatly 
reduce the amount of work required by the system operator.  Once this newly developed 
system is complete, the true potential of this system can be put to the test by comparison 
with traditional blood side and other dialysate side methods of monitoring dialysis 
efficiency.  Due to its ability to provide time-based information about urea removal rates, 
this system has the potential to provide new information on how urea is removed from 
the body by dialysis, representing a significant advance in knowledge of urea kinetics. 
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12 DISCLAIMER 
This thesis employed the hardware principle known as the optical bridge, which was 
invented by Hannu Harjunmaa, and is currently being developed by VivaScan 
Corporation.  VivaScan Corporation was founded by Robert Peura for the purpose of 
commercializing a non-invasive blood glucose monitor.  The main contribution of this 
dissertation is the development of an MLR based algorithm that provided the key element 
for the reagentless optical measurement of urea. 
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